Quarterlytics / Basic Materials / Paper, Lumber & Forest Products / Clearwater Paper Corporation

Clearwater Paper Corporation

clw · NYSE Basic Materials
Claim this profile
Ticker clw
Exchange NYSE
Sector Basic Materials
Industry Paper, Lumber & Forest Products
Employees 2200
← All annual reports
FY2014 Annual Report · Clearwater Paper Corporation
Sign in to download
Loading PDF…
2

0

1

4

A   N   N   U   A   L       R   E   P   O   R   T

Dear Stockholders,

For Clearwater Paper, 2014 was a year full of record milestones and challenges. We

accomplished record net sales of $2 billion and record adjusted EBITDA of $239 million. As we

progressed through the year, it became evident that elevated competitive pressures and cost

input inflation within the Consumer Products business would not likely diminish. We determined

that significant and immediate actions would be required to reduce the Consumer Products

division’s cost structure and put us on a path to achieve our 15 percent consolidated cross-cycle

EBITDA margin model. This objective is our top strategic priority.

I am pleased to share additional highlights from 2014 and how we are paving the way to reach

our margin model objective:

• We achieved record net sales of $784 million in Pulp and Paperboard, with a strong

operating margin. We also achieved record net sales of $1.2 billion in Consumer

Products and shipped a record volume of Through-Air-Dried (TAD) products with our

Shelby mill now fully operational.

• We sold five specialty mills for approximately $114 million and are investing the net

proceeds of $107 million into strategic capital projects that are expected to permanently

reduce our cost structure and improve EBITDA margins.

• We announced several strategic investments for 2015, totaling approximately $85

million, funded by the proceeds from the sale of our specialty mills. The largest

investment is in pulp optimization that is expected to increase pulp output and quality

and lead to 100 percent softwood pulp integration. Other investments include robotics for

warehouse automation, high-speed bath and towel converting equipment and paper

machine upgrades.

• We established a cross-divisional supply chain function to improve and streamline

purchasing and supply management to drive out costs system wide, achieve operational

efficiencies and improve customer service performance.

• We are taking the next steps from Lean manufacturing to Total Productive Maintenance

(TPM) that we believe will increase our capacity to grow and focus on improving unit cost

through high-yield stable manufacturing processes.

• We returned $100 million of cash to stockholders through our stock repurchase program.

Since the 2011 inception of our stock repurchase program through the end of 2014, we

reduced shares outstanding by 20 percent, which reflects our focus to drive shareholder

value. On December 15, 2014 we announced another $100 million stock repurchase

authorization.

• We further reduced our weighted average cost of capital with the issuance of $300

million in 5-3/8 percent, and ten year senior notes in exchange for $375 million in 7-1/8

percent senior notes. Since our refinancing began in 2013 we have reduced our cost of

debt from 8.6 percent to 5 percent.

• We completed another year with an overall safety record better than the industry

average with several mills that exceeded their safety goals.

• We reduced manufacturing waste to landfills by nearly one-third in 2014, which far

exceeded one of our key long-term sustainability goals of a 20 percent overall reduction.

We have accomplished a lot in our first six years as a public company but we still have work to

do as we enter the third year of our DRIVE strategy. Through it, we are transforming the

company to an operationally efficient leader in private label tissue and SBS paperboard. I

believe the steps we have taken to date and the investments we are making will bring

Clearwater Paper to its full cash generating and earnings potential.

From all of us at Clearwater Paper, we thank our stockholders, customers and all stakeholders

for your support, and look forward to a successful 2015.

Sincerely,

Linda K. Massman

President and CEO

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 10-K

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2014 
OR

  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             
Commission File Number: 001-34146

CLEARWATER PAPER CORPORATION

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation or organization)

20-3594554
(IRS Employer Identification No.)

601 W. Riverside Avenue, Suite 1100
Spokane, Washington
(Address of principal executive offices)

99201
(Zip Code)

Securities registered pursuant to Section 12(b) of the Act:

Registrant’s telephone number, including area code: (509) 344-5900

TITLE OF EACH CLASS
Common Stock ($0.0001 par value per share)

NAME OF EACH EXCHANGE ON WHICH REGISTERED
New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    

 Yes    

 No

Indicate  by  check  mark  if  the  registrant  is  not  required  to  file  reports  pursuant  to  Section 13  or  Section 15(d)  of  the 
Act.    

 Yes    

 No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities 
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such 
reports), and (2) has been subject to such filing requirements for the past 90 days.    

 Yes    

 No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every 
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during 
 No
the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    

 Yes    

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not 
be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part 
III of this Form 10-K or any amendment to this Form 10-K.    

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller 
reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 
of the Exchange Act.

Large accelerated filer 
Non-accelerated filer 

  ¨ (Do not check if a smaller reporting company)

    Accelerated filer 
    Smaller reporting company 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    

 Yes    

 No

As of June 30, 2014 (the last business day of the registrant’s most recently completed second quarter), the aggregate market value 
of the common stock held by non-affiliates of the registrant was $1.21 billion. Shares of common stock beneficially held by each 
officer and director and by each person who owns 5% or more of the outstanding common stock have been excluded in that such 
persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other 
purposes.

As of February 20, 2015, 19,119,472 shares of the registrant’s common stock were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the definitive proxy statement to be filed on or about March 24, 2015, with the Securities and Exchange Commission in 
connection with the registrant’s 2015 annual meeting of stockholders are incorporated by reference in Part III hereof.

 
 
 
 
 
 
 
 
 
CLEARWATER PAPER CORPORATION
Index to 2014 Form 10-K

ITEM 1.

ITEM 1A.

ITEM 1B.

ITEM 2.

ITEM 3.

ITEM 4.

ITEM 5.

ITEM 6.

ITEM 7.

ITEM 7A.

ITEM 8.

ITEM 9.

ITEM 9A.

ITEM 9B.

ITEM 10.

ITEM 11.

ITEM 12.

ITEM 13.

ITEM 14.

Business

Risk Factors

Unresolved Staff Comments

Properties

Legal Proceedings

Mine Safety Disclosures

PART I

PART II

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer
  Purchases of Equity Securities

Selected Financial Data

Management’s Discussion and Analysis of Financial Condition and Results of
  Operations

Quantitative and Qualitative Disclosures About Market Risks

Financial Statements and Supplementary Data

Changes in and Disagreements with Accountants on Accounting and Financial
  Disclosure

Controls and Procedures

Other Information

Directors, Executive Officers and Corporate Governance

Executive Compensation

PART III

Security Ownership of Certain Beneficial Owners and Management and Related
  Stockholder Matters

Certain Relationships and Related Transactions, and Director Independence

Principal Accounting Fees and Services

PART IV

ITEM 15.

Exhibits, Financial Statement Schedules

SIGNATURES

EXHIBIT INDEX

PAGE
NUMBER

2-7

8-16

16

17

18

18

19

20

21-39

39

40-83

84

84

84

85

85

86

86

86

87

88

89-93

 
  
  
 
 
 
 
 
 
 
 
 
Part I

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Our  disclosure  and  analysis  in  this  report  contains,  in  addition  to  historical  information,  certain  forward-looking 
statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding 
the cost savings associated with the closure of our Thomaston, Georgia and our Long Island, New York facilities, as 
well as our specialty business and mills, sourcing of our pulp supply following the sale of our specialty business and 
mills,  energy  conservation,  cash  flows,  capital  expenditures,  return  on  investment  from  capital  projects,  tax  rates, 
operating costs, including energy costs, selling, general and administrative expenses, timing of major maintenance 
and repairs, liquidity, benefit plan funding levels, capitalized interest, interest expenses, and the tax treatment of the 
alternative  fuels  and  cellulosic  biofuels  tax  credits.  Words  such  as  “anticipate,”  “expect,”  “intend,”  “plan,”  “target,” 
“project,” “believe,” “schedule,” “estimate,” “may,” and similar expressions are intended to identify such forward-looking 
statements.  These  forward-looking  statements  are  based  on  management’s  current  expectations,  estimates, 
assumptions and projections that are subject to change. Our actual results of operations may differ materially from 
those expressed or implied by the forward-looking statements contained in this report. Important factors that could 
cause or contribute to such differences in operating results include those risks discussed in Item 1A of this report, as 
well as the following:

competitive  pricing  pressures  for  our  products,  including  as  a  result  of  increased  capacity  as  additional 
manufacturing facilities are operated by our competitors;

the loss of or changes in prices in regards to a significant customer;

changes in transportation costs and disruptions in transportation services;

manufacturing or operating disruptions, including equipment malfunction and damage to our manufacturing 
facilities caused by fire or weather-related events and IT system failures;

changes in the cost and availability of wood fiber and wood pulp;

labor disruptions;

changes in costs for and availability of packaging supplies, chemicals, energy and maintenance and repairs;

environmental liabilities or expenditures;

changes  in  the  U.S.  and  international  economies  and  in  general  economic  conditions  in  the  regions  and 
industries in which we operate;

changes in customer product preferences and competitors' product offerings;

changes in expenses and required contributions associated with our pension plans;

reliance on a limited number of third-party suppliers for raw materials;

cyclical industry conditions;

inability to successfully implement our operational efficiencies and expansion strategies;

inability to fund our debt obligations;

restrictions on our business from debt covenants and terms; and

changes in laws, regulations or industry standards affecting our business.

Forward-looking statements contained in this report present management’s views only as of the date of this report. 
Except  as  required  under  applicable  law,  we  do  not  intend  to  issue  updates  concerning  any  future  revisions  of 
management’s views to reflect events or circumstances occurring after the date of this report. You are advised, however, 
to consult any further disclosures we make on related subjects in our quarterly reports on Form 10-Q and current 
reports on Form 8-K filed with the Securities and Exchange Commission, or SEC.

1

ITEM 1.
Business

GENERAL

Clearwater Paper manufactures quality consumer tissue, away-from-home, or AFH, tissue, parent roll tissue, bleached 
paperboard and pulp at manufacturing facilities across the nation.  The company is a premier supplier of private label 
tissue to major retailers and wholesale distributors, including grocery, drug, mass merchants and discount stores. In 
addition, the company produces bleached paperboard used by quality-conscious printers and packaging converters. 
Clearwater Paper's employees build shareholder value by developing strong customer partnerships through quality 
and service.

On December 27, 2010, we acquired Cellu Tissue Holdings, Inc., or Cellu Tissue, a tissue manufacturing and converting 
company whose customers included consumer retailers and AFH distributors of tissue products, vertically integrated 
manufacturers  and  third-party  converters  serving  the  tissue  and  machine-glazed  tissue  sectors.  Cellu Tissue  sold 
product as finished cases and parent rolls.

On December 30, 2014, we sold our specialty business and mills to a private buyer. The specialty mill’s production 
consisted predominantly of machine-glazed tissue and also included parent rolls and other specialty tissue products 
such as absorbent materials and dark-hued napkins. The sale included five Clearwater Paper subsidiaries with facilities 
located at East Hartford, Connecticut; Menominee, Michigan; Gouverneur, New York; St. Catharines, Ontario; and 
Wiggins, Mississippi. 

Company Strengths

Leading private label tissue manufacturer with a broad footprint in North America. Our consumer products business 
is a premier private label tissue manufacturer. We have production facilities strategically located throughout North 
America, including through-air-dried, or TAD, tissue manufacturing facilities in Shelby, North Carolina and Las Vegas, 
Nevada and converting operations across the United States. We believe we were the sixth largest manufacturer in 
the  North  American  tissue  market  as  of  December 31,  2014,  based  on  tissue  parent  roll  capacity.  Our  broad 
manufacturing footprint allows us to better and more cost effectively service a diverse customer base, including major 
grocery store chains and retailers across the entire U.S.

High quality brand-equivalent tissue and other products to meet retailers' private label strategies.  Our 
consumer 
products business produces high-quality products that match the quality of the leading national brands. We focus on 
high value tissue products across a wide variety of categories and retail channels. We also manufacture a broad range 
of cost-competitive consumer products, as well as recycled tissue and tissue parent rolls.

High  quality  premium  bleached  paperboard  products.  Our  pulp  and  paperboard  business  produces  premium 
paperboard products with ultra-smooth print surfaces, superior cleanliness, and excellent forming and sealing ability. 
Products are available in several thicknesses to provide the rigidity and strength needed for a wide range of applications. 
The high quality of our paperboard allows buyers to use our products for packaging where branding and quality are 
critical, such as ice cream containers, health and beauty packaging, pharmaceutical packaging, and point of purchase 
displays.

Complementary, long-standing customer relationships. Our consumer products business supplies private label tissue 
products to several of the largest national retail chains. Our top 10 consumer products customers in 2014 accounted 
for approximately 54% of our total consumer products net sales. We did not have any single customer that accounted 
for 10% or more of our total net sales in either 2014 or 2012. However, our largest customer in 2013 was the Kroger 
Company, which accounted for 10.8% of our total company net sales. The average tenure of these customers was 
approximately 13 years. In addition to these long-standing customer relationships, throughout the year we maintained 
a diverse base of 116 customers across a broad geographic area, excluding customers associated solely with our 
specialty business and mills. We also have long-standing customer relationships with our paperboard customers. Our 
top 10 paperboard customers in 2014 accounted for approximately 45% of our total paperboard net sales. The average 
tenure of these customers was approximately 31 years.

Strategically positioned pulp and paperboard facilities. Our pulp and paperboard mill in Lewiston, Idaho is one of only 
two solid bleach sulfate, or SBS, paperboard mills, and the only coated SBS paperboard mill, in the Western U.S. to 
offer a full range of specialized products to meet the needs of customers for traditional folding carton, plates, cup and 
liquid packaging. This facility's geographic location reduces transportation costs to customers for the Western U.S. as 
well as Asia, which allows us to compete on a cost-advantaged basis relative to East Coast competitors. Our Cypress 
Bend, Arkansas mill is centrally located, which reduces transportation costs to the Midwestern and Eastern U.S. and 
complements the Lewiston mill in shipping to customers nationwide.

2

Largely integrated pulp and tissue operations. Our consumer products business sources a significant portion of its 
pulp supply internally from our pulp and paperboard operations in Idaho. This relationship provides our consumer 
products business with a secure pulp supply as well as significant transportation and drying cost savings, and provides 
our pulp and paperboard business with a steady demand source.

Strategy

Our long-term strategy is to grow the size and scope of our business and optimize the profitability of both our consumer 
products business and our paperboard business. In the near-term, our focus is on optimizing the operating efficiencies 
and cost effectiveness of both segments of our company.

ORGANIZATION

Our businesses are organized into two operating segments: Consumer Products and Pulp and Paperboard. Additional 
information relating to the amounts of net sales, operating income, depreciation and amortization, identifiable assets 
and capital expenditures attributable to each of our operating segments for 2012-2014, as well as geographic information 
regarding our net sales, is set forth in Note 18 to our consolidated financial statements included under Part II, Item 8 
of this report.

Consumer Products Segment

Our Consumer Products segment manufactures and sells a complete line of at-home tissue products as well as AFH 
products. Our integrated manufacturing and converting operations and geographic footprint enable us to deliver a 
broad  range  of  cost-competitive  products  with  brand  equivalent  quality  to  our  customers.  In  2014,  our  Consumer 
Products segment had net sales of $1.2 billion. A listing of our Consumer Products segment facilities is included under 
Part I, Item 2 of this report.

Tissue Industry Overview

Consumer Tissue Products. The U.S. tissue market can be divided into two market segments: the at-home or consumer 
retail purchase segment, which represents approximately two-thirds of U.S. tissue sales; and the AFH segment, which 
represents the remaining one-third of U.S. tissue market sales and includes locations such as airports, restaurants, 
hotels and office buildings. 

The U.S. at-home tissue segment consists of bath, paper towels, facial and napkin products categories. Each category 
is further distinguished according to quality segments: ultra, premium, value and economy. As a result of process 
improvements and consumer preferences, the majority of at-home tissue sold in the U.S. is ultra and premium quality.

At-home tissue producers are comprised of companies that manufacture branded tissue products, private label tissue 
products, or both. Branded tissue suppliers manufacture, market and sell tissue products under their own nationally 
branded labels. Private label tissue producers sell tissue products to retailers to sell as their store brand.

In the U.S., at-home tissue is primarily sold through grocery stores, mass merchants, warehouse clubs, drug stores 
and discount dollar stores. Tissue has historically been one of the strongest segments of the paper industry due to its 
steady demand growth and the relative absence of severe supply imbalances that occur in a number of other paper 
industry segments. In addition to economic and demographic drivers, tissue demand is affected by product innovations 
and shifts in distribution channels.

Our Consumer Products Business

We believe that we are the only U.S. consumer tissue manufacturer that solely produces a full line of quality private 
label tissue products for large retail trade channels. Most U.S. tissue producers manufacture only branded products, 
or both branded and private label products, or in the case of certain smaller or midsize manufacturers, only produce 
a limited range of tissue products or quality segments. Branded producers generally manufacture their private label 
products at a quality grade or two below their branded products so as not to impair sales of the branded products. 
Because we do not produce and market branded tissue products, we believe we are able to offer products that match 
the quality of leading national brands, but generally at lower prices. We are committed to maintaining a high level of 
quality for our products that matches the quality of the leading national brands, and we utilize independent companies 
to routinely test our product quality.

3

In bathroom tissue, the majority of our sales are high quality two-ply ultra and premium products, including TAD tissue 
products. In paper towels, we produce and sell ultra quality TAD towels as well as premium and value towels. In the 
facial category, we sell ultra-lotion three-ply and a complete line of two-ply premium products as well as value facial 
tissue. In napkins, we manufacture ultra two- and three-ply dinner napkins, as well as premium and value one-ply 
luncheon napkins. Recycled fiber value grade products are also available to customers who wish to further diversify 
their  product  portfolio.  We  compete  primarily  in  the  at-home  portion  of  the  U.S.  tissue  market,  which  made  up 
approximately 89% of our Consumer Products segment sales in 2014.

We manufacture and sell a line of AFH products to customers with commercial and industrial tissue needs. Products 
include conventional one- and two-ply bath tissue, two-ply paper towels, hard wound towels and dispenser napkins.

During 2014, our consumer products were manufactured on 21 paper machines in facilities located throughout the 
U.S. and in Ontario, Canada. However,  9 of these paper machines were included in the sale of our specialty business 
and mills on December 30, 2014. Parent rolls from our paper machines are then converted and packaged at our 
converting facilities located across the U.S. Two of our paper machines, located in Nevada and North Carolina, produce 
TAD tissue that we convert into national brand comparable, ultra quality towels and bath tissue.

In 2014 and 2013, through multi-outlet channels, which include grocery, drug, dollar, super and club stores, as well as 
military purchasing, we sold approximately 30% and 34%, respectively, of the total private label tissue products in the 
U.S. 

We sell private label tissue products through our own sales force, and we compete, based on product quality, customer 
service  and  price.  We  deliver  customer-focused  business  solutions  by  assisting  in  managing  product  assortment, 
category management, and pricing and promotion optimization.

Pulp and Paperboard Segment

Our Pulp and Paperboard segment manufactures and markets bleached paperboard for the high-end segment of the 
packaging industry and is a leading producer of SBS paperboard. This segment also produces hardwood and softwood 
pulp, which is primarily used as the basis for our paperboard products, and slush pulp, which it supplies to our Consumer 
Products segment. In 2014, our Pulp and Paperboard segment had net sales of $783.8 million. A listing of our pulp 
and paperboard facilities is included under Part I, Item 2  of this report.

Pulp and Paperboard Industry Overview

SBS  paperboard  is  a  premium  paperboard  grade  that  is  most  frequently  used  to  produce  folding  cartons,  liquid 
packaging, cups and plates as well as commercial printing items. SBS paperboard is used for such products because 
it is manufactured using virgin fiber combined with the kraft bleaching process, which results in superior cleanliness, 
brightness and consistency. SBS paperboard is often manufactured with a clay coating to provide superior surface 
printing qualities. SBS paperboard can also be extrusion coated with a plastic film to provide a moisture barrier for 
some uses.

In general, the process of making paperboard begins by chemically cooking wood fibers to make pulp. The pulp is 
bleached to provide a white, bright pulp, which is formed into paperboard. Bleached pulp that is to be used as market 
pulp  is  dried  and  baled  on  a  pulp  drying  machine,  bypassing  the  paperboard  machines.  The  various  grades  of 
paperboard are wound into rolls for shipment to customers for converting to final end uses. Liquid packaging and cup 
stock grades are often coated with polyethylene, a plastic coating, in a separate operation to create a resistant and 
durable liquid barrier.

Folding Carton Segment. Folding carton is the largest portion of the SBS category of the U.S. paperboard industry, 
comprising approximately 39% of the category in 2014. Within the folding carton segment there are varying qualities 
of  SBS  paperboard. The  high  end  of  the  folding  carton  category  in  general  requires  a  premium  print  surface  and 
includes uses such as packaging for pharmaceuticals, cosmetics and other premium retail goods. SBS paperboard is 
also used in the packaging of frozen foods, beverages and baked goods. 

Liquid Packaging and Cup Segment. SBS liquid packaging paperboard is primarily used in the U.S. for the packaging 
of juices. In Japan and other Asian countries, SBS liquid packaging paperboard is primarily used for the packaging of 
milk and other liquid items. The cup segment of the market consists primarily of hot and cold drink cups and food 
packaging. The hot and cold cups are primarily used to serve beverages in quick-service restaurants, while round food 
containers are often used for packaging premium ice-cream and dry food products. 

4

Commercial Printing Segment. Commercial printing applications use bleached bristols, which are heavyweight paper 
grades, to produce postcards, signage and sales literature. Bristols can be clay coated on one side or both sides for 
applications such as brochures, presentation folders and paperback book covers. The customers in this segment are 
accustomed  to  high-quality  paper  grades,  which  possess  superior  printability  and  brightness  compared  to  most 
paperboard packaging grades. Suppliers to this segment must be able to deliver small volumes, often within 24 hours. 

Market Pulp. The majority of the pulp manufactured worldwide is integrated with paper and paperboard production, 
usually at the same mill. In those cases where a paper mill does not produce its own pulp, it must purchase pulp on 
the open market. Market pulp is defined as pulp produced for sale to these customers and it excludes tonnage consumed 
by the producing mill or shipped to any of its affiliated mills within the same company.

Our Pulp and Paperboard Business

Our Pulp and Paperboard segment operates facilities in Idaho, which has two paperboard machines, and Arkansas, 
which has one paperboard machine. As of December 31, 2014, we were one of the five largest producers of bleached 
paperboard in North America with approximately 11% of the available production capacity.

Our overall pulp and paperboard production consists primarily of folding carton, liquid packaging, cup, plate, commercial 
printing grades and hardwood and softwood pulp. 

Folding carton board used in pharmaceuticals, cosmetics and other premium packaging, such as those that incorporate 
foil and holographic lamination, accounts for the largest portion of our total paperboard sales. We focus on high-end 
folding carton applications where the heightened focus on product quality provides for differentiation among suppliers, 
resulting in margins that are more attractive than less critical packaging applications.

Our  liquid  packaging  paperboard  is  known  for  its  cleanliness  and  printability,  and  is  engineered  for  long-lived 
performance due to its three-ply, softwood construction. Our reputation for producing liquid packaging meeting the 
most demanding standards for paperboard quality and cleanliness has resulted in meaningful sales in Japan, where 
consumers have a particular tendency to associate blemish-free, vibrant packaging with the cleanliness, quality and 
freshness of the liquids contained inside.

We also sell cup stock and plate stock grades for use in food service products. A majority of our sales in this area 
consist of premium clay coated cup stock grades used for high-end food packaging, such as premium ice cream.

We do not produce converted paperboard end-products, so we are not simultaneously a supplier of and a competitor 
to our customers. Of the five largest SBS paperboard producers in the U.S., we are the only producer that does not 
also convert SBS paperboard into end products. We believe our position as a non-integrated supplier has resulted in 
a diverse group of loyal customers because when there is decreased market supply of paperboard, we do not divert 
our production to internal uses. 

At our Idaho facility we produce bleached softwood pulp primarily for internal use, including in our Consumer Products 
segment.

Our pulp mills are currently capable of producing approximately 856,000 tons of pulp on an annual basis. In 2014, we 
utilized approximately 81% of our pulp production, or approximately 678,000 tons, to produce approximately 791,000 
tons of paperboard. The increase in tonnage from pulp to paperboard production is due to the addition of coatings and 
other manufacturing processes. We also used approximately 18% of our pulp production, or approximately 153,000 
tons, in our Consumer Products segment to produce tissue products. The remaining pulp production of less than 1%, 
or approximately 4,000 tons, was sold externally by our Consumer Products segment.

We utilize various methods for the sale and distribution of our paperboard and softwood pulp. The majority of our 
paperboard is sold to packaging converters domestically through sales offices located throughout the U.S., with a 
smaller percentage channeled through distribution to commercial printers. The majority of our international paperboard 
sales are conducted through sales agents and are primarily denominated in U.S. dollars. Our principal methods of 
competing are product quality, customer service and price.

RAW MATERIALS AND INPUT COSTS

For our manufacturing operations, the principal raw material used is wood fiber, which consists of purchased pulp and 
chips, sawdust and logs. During 2014, our purchased pulp costs were 17.3% of our cost of sales, while chips, sawdust 
and logs accounted for 8.9%. In 2014, our Consumer Products segment sourced approximately 26% of its total pulp 
supply from our Pulp and Paperboard segment, with the remainder purchased from external suppliers. With the sale 
of our specialty business and mills at the end of 2014, in 2015 we expect that our Consumer Products segment will 
source approximately 30% of its total pulp supply from our Pulp and Paperboard segment. We own and operate a 
wood chipping facility located in Clarkston, Washington, near our Lewiston, Idaho, facility, in an effort to bolster our 
wood fiber position and obtain short-term and long-term cost savings.

5

We utilize a significant amount of chemicals in the production of pulp and paper, including caustic, polyethylene, starch, 
sodium chlorate, latex and specialty process paper chemicals. A portion of the chemicals used in our manufacturing 
processes, particularly in the pulp-making process, are petroleum-based or are impacted by petroleum prices. During 
2014, chemical costs accounted for 12.1% of our cost of sales. 

Transportation is a significant cost input for our business. Fuel prices impact our transportation costs for delivery of 
raw materials to our manufacturing facilities and delivery of our finished products to customers. Our total transportation 
costs were 11.2% of our cost of sales in 2014.

We consume substantial amounts of energy, such as electricity, hog fuel, steam and natural gas. During 2014, energy 
costs accounted for 8.2% of our cost of sales. We purchase a significant portion of our natural gas and electricity under 
supply  contracts,  most  of  which  are  between  a  specific  facility  and  a  specific  local  provider.  Under  most  of  these 
contracts, the providers have agreed to provide us with our requirements for a particular type of energy at a specific 
facility. Most of these contracts have pricing mechanisms that adjust or set prices based on current market prices. In 
addition, we use firm-price contracts to mitigate price risk for certain of our energy requirements.

As a significant producer of private label consumer tissue products, we also incur expenses related to packaging 
supplies used  for retail chains, wholesalers and cooperative buying organizations. Our total packaging costs for 2014 
were 6.1% of our cost of sales.

Our maintenance and repairs represented 4.9% of our cost of sales for 2014 and are expensed as incurred. We perform 
routine maintenance on our machines and equipment and periodically replace a variety of parts such as motors, pumps, 
pipes and electrical parts. 

We also record depreciation expense associated with our plant and equipment. Depreciation expense was 4.6% of 
our cost of sales for 2014. 

SEASONALITY

Our Consumer Products segment experiences a decrease in shipments during the fourth quarter generally as a result 
of decreased consumer demand, retail brand holiday promotions, and end of year inventory management by non-
retail customers.  In addition, customer buying patterns for our paperboard generally result in lower sales for our Pulp 
and Paperboard segment during the first and fourth quarters, when compared to the second and third quarters of a 
given year.

ENVIRONMENTAL

Information regarding environmental matters is included under Part II, Item 7 “Management’s Discussion and Analysis 
of Financial Condition and Results of Operations” of this report, and is incorporated herein by reference.

WEBSITE

Interested parties may access our periodic and current reports filed with the SEC, at no charge, by visiting our website, 
www.clearwaterpaper.com. In the menu select “Investor Relations,” then select “Financial Information & SEC Filings.” 
Information on our website is not part of this report.

EMPLOYEES

As of December 31, 2014, we had approximately 3,290 employees, of which approximately 2,030 were employed by 
our Consumer Products segment, approximately 1,110 were employed by our Pulp and Paperboard segment and 
approximately 150 were corporate administration employees. This workforce consisted of approximately 690 salaried 
employees and approximately 2,600 hourly and fixed rate employees. As of December 31, 2014, approximately 52% 
of our workforce was covered under collective bargaining agreements.

Unions represent hourly employees at six of our manufacturing sites. There were two hourly union labor contracts that 
expired in 2014 at facilities we owned as of December 31, 2014, which are currently being negotiated: 

CONTRACT
EXPIRATION
DATE
August 31, 2014

August 31, 2014

DIVISION AND LOCATION
Consumer Products Division and Pulp
  & Paperboard Division-Lewiston, Idaho

UNION
United Steel Workers
(USW)

Consumer Products Division and Pulp
  & Paperboard Division-Lewiston, Idaho

International Brotherhood of
  Electrical Workers (IBEW)

APPROXIMATE
NUMBER OF HOURLY
EMPLOYEES

1,000

55

There are no collective bargaining agreements due to expire in 2015. 

6

EXECUTIVE OFFICERS OF THE REGISTRANT

The  following  individuals  are  deemed  our  “executive  officers”  under  the  Securities  Exchange Act  of  1934  as  of 
December 31, 2014. Executive officers of the company are generally appointed as such at the annual meeting of our 
board, and each officer holds office until the officer’s successor is duly elected and qualified or until the earlier of the 
officer’s death, resignation, retirement, removal by the board or as otherwise provided in our bylaws. There are no 
arrangements or understandings between any of our executive officers and any other persons pursuant to which they 
were selected as officers. No family relationships exist among any of our executive officers.

Linda K. Massman (age 48), has served as President and Chief Executive Officer, as well as a director, since January 
2013. Ms. Massman served as President and COO from November 2011 to December 2012. Ms. Massman served 
as CFO and Senior Vice President, Finance from May 2011 to November 2011, and as CFO and Vice President, 
Finance from December 2008 to May 2011. From September 2008 to December 2008, Ms. Massman served as Vice 
President of Potlatch Corporation pending completion of the spin-off of Clearwater Paper Corporation. From May 2002 
to August 2008, Ms. Massman was Group Vice President, Finance and Corporate Planning, for SUPERVALU Inc., a 
grocery retail company. Ms. Massman also serves as a director of Black Hills Corporation, an energy company, and 
as a member of Black Hills Corporation's Compensation Committee.

John D. Hertz (age 48) joined the company in June 2012 as Senior Vice President, and has served as Senior Vice 
President, Finance and Chief Financial Officer since August 2012. Before joining our company, Mr. Hertz was the Vice 
President and Chief Financial Officer of Novellus Systems, Inc., a position he held from June 2010 to June 2012. From 
October 2007 to June 2010, he served as Novellus' Vice President of Corporate Finance and Principal Accounting 
Officer and as Vice President and Corporate Controller from June 2007 to October 2007. From 2000 to 2007, Mr. Hertz 
worked for Intel Corporation where he held a number of positions, including Central Finance Controller of the Digital 
Enterprise Group, Finance Controller of the Enterprise Platform Services Division and Accounting Policy Controller. 
Prior to that, Mr. Hertz was a Senior Manager with KPMG. 

Michael S. Gadd (age 50) has served as Senior Vice President since May 2011 and General Counsel and Corporate 
Secretary since December 2008. In addition, he served as Vice President from December 2008 to May 2011. From 
March 2006 to December 2008, Mr. Gadd served as Associate General Counsel of Potlatch Corporation, and served 
as Corporate Secretary of Potlatch from July 2007 to December 2008. From January 2001 to January 2006, Mr. Gadd 
was an attorney with Perkins Coie, LLP in Portland, Oregon.

Thomas A. Colgrove (age 63), has served as Senior Vice President and President of Consumer Products since January 
2013, and served as Senior Vice President and President of Pulp and Paperboard from May 2011 to December 2012. 
Mr. Colgrove served as Vice President of Pulp and Paperboard from May 2009 to May 2011. He was employed by 
Kimberly-Clark Corporation from 1984 to 2009, in various manufacturing management positions, including as Senior 
Director-North America Product Supply with responsibility for seven North American tissue facilities from September 
2006 to April 2009. 

Danny G. Johansen (age 64) has served as Senior Vice President and President of Pulp and Paperboard since January 
2013. From December 2008 through December 2012, he served as Vice President, Sales and Marketing, for Pulp and 
Paperboard.  Prior to December 2008, Mr. Johansen was employed by Potlatch Corporation for nearly 36 years.  From 
2002 to December 2008, he served as the Director of Sales, Idaho Pulp and Paperboard division, for Potlatch.

Jackson O. Lynch (age 46) served as Senior Vice President of Human Resources from April 2013 to December 31, 
2014. Before joining our company, Mr. Lynch served as Vice President of Human Resources for Nestlé USA’s Direct 
Store Delivery division from March 2010 to February 2013. From June 2007 to March 2010, he served as National 
Director of Human Resources for Nestlé USA's Dreyer's Ice Cream division. Prior to June 2007, Mr. Lynch held various 
senior human resources roles with PepsiCo, Inc. 

7

ITEM 1A.
Risk Factors

Our  business, financial  condition,  results  of  operations  and  liquidity  are  subject  to  various  risks  and  uncertainties, 
including those described below, and as a result, the trading price of our common stock could decline.

Increases in tissue supply could adversely affect our operating results and financial condition.

Over the past few years, several new or refurbished TAD paper machines have been completed or announced by our 
competitors, including private label competitors, that will result in a substantial increase in the supply of TAD tissue in 
the North American market. Additionally, several new or refurbished conventional tissue machines have been installed 
or announced, including as a result of foreign competitors increasing their presence and operations in North America. 
The increase in supply of TAD products, as well as the effects of that increased supply in displacing existing conventional 
tissue product sales, and the increase in conventional tissue production could each have a material adverse effect on 
the price of TAD tissue products and on the market demand and price for conventional tissue products, which will 
continue to represent a majority of our total production for the foreseeable future.

The loss of, or a significant reduction in, orders from, or changes in prices in regards to, any of our large 
customers could adversely affect our operating results and financial condition.

We  derive  a  substantial  amount  of  revenues  from  a  concentrated  group  of  customers.  For  example,  in  2014  our 
Consumer Products segment derived approximately 33% of its net sales and we derived approximately 20% of our 
total net sales from three customers. If we lose any of these customers or a substantial portion of their business or if 
the terms of our relationship with any of them becomes less favorable to us, our net sales would decline, which would 
harm our business, results of operations and financial condition. We have experienced increased price and promotion 
competition for our consumer products customers, particularly in regards to TAD products, and this competition has 
decreased our gross margins and adversely affected our financial condition. Some of our customers have the capability 
to produce the parent rolls or products themselves that they purchase from us. Our Pulp and Paperboard segment 
sells its products to a large number of customers, although certain customers have historically purchased a significant 
amount of our pulp or paperboard products.

We do not have long-term contracts with many of our customers, including some of our largest customers, that ensure 
a continuing level of business from them. In addition, our agreements with our customers are not exclusive and generally 
do not contain minimum volume purchase commitments. Our relationship with our large customers will depend on our 
ability to continue to meet their needs for quality products and services at competitive prices. If we lose one or more 
of these customers or if we experience a significant decline in the level of purchases by any of them, we may not be 
able to quickly replace the lost business volume and our operating results and business could be harmed. In addition, 
our focus on these large accounts could affect our ability to serve our smaller accounts, particularly when product 
supply is tight and we are not able to fully satisfy orders for these smaller accounts.

Disruptions  in  our  transportation  services  or  increases  in  our  transportation  costs  could  have  a  material 
adverse effect on our business.

Shipments of products and raw materials may be delayed or disrupted due to weather conditions, labor shortages or 
strikes, regulatory actions or other events. If any transportation providers are unavailable or fail to deliver our products 
in a timely manner, we may incur increased costs. If any transportation providers are unavailable or fail to deliver raw 
materials to us in a timely manner, we may be unable to manufacture products on a timely basis. In 2014, there was 
a general disruption in the availability of truck and rail transportation due to a number of factors, including the escalating 
shortage of qualified truck drivers, severe weather in many parts of the U.S. and large scale railroad maintenance 
projects. In addition, our sales in the fourth quarter of 2014 were negatively impacted by labor slowdowns at West 
Coast shipping ports. The combination of these factors contributed to a decrease in available transportation capacity, 
which had a direct negative impact on our costs and ability to service customers. Any failure of a third-party transportation 
provider to deliver raw materials or products in a timely manner could harm our reputation, negatively affect our customer 
relationships and have a material adverse effect on our business, financial condition, results of operations and cash 
flows.

8

Our business, particularly our consumer products business, is dependent on transportation services to deliver our 
products to our customers and to deliver raw materials to us. In 2014, our transportation costs were 11.2% of our cost 
of sales. The costs of these transportation services are influenced by fuel prices, which are affected by geopolitical 
and economic events. We have not been in the past, and may not be in the future, able to pass along part or all of any 
fuel price increases to customers. If we are unable to increase our prices as a result of increased fuel costs charged 
to us by transportation providers, our gross margins may be materially adversely affected.

We incur significant expenses to maintain our manufacturing equipment and any interruption in the operations 
of our facilities may harm our operating performance.

We regularly incur significant expenses to maintain our manufacturing equipment and facilities. The machines and 
equipment that we use to produce our products are complex, have many parts and some are run on a continuous 
basis. We must perform routine maintenance on our equipment and will have to periodically replace a variety of parts 
such as motors, pumps, pipes and electrical parts. In addition, our pulp and paperboard facilities require periodic 
shutdowns to perform major maintenance. These scheduled shutdowns of facilities result in decreased sales and 
increased costs in the periods in which a shutdown occurs and could result in unexpected operational issues in future 
periods as a result of changes to equipment and operational and mechanical processes made during the shutdown 
period. We have two major maintenance shutdowns scheduled in 2015 - one during the first quarter at our Lewiston, 
Idaho pulp and paperboard facility and one during the second quarter at our Cypress Bend, Arkansas facility.

Unexpected production disruptions could cause us to shut down or curtail operations at any of our facilities. For example, 
we have had ongoing operational issues with the recovery furnace at our Cypress Bend, Arkansas facility associated 
with a 2013 upgrade project and certain of our facilities have had to curtail operations as the result of an electrical 
malfunction  and  a  fire  in  previous  years.  Disruptions  could  occur  due  to  any  number  of  circumstances,  including 
prolonged power outages, mechanical or process failures, shortages of raw materials, natural catastrophes, disruptions 
in  the  availability  of  transportation,  labor  disputes,  terrorism,  changes  in  or  non-compliance  with  environmental  or 
safety laws and the lack of availability of services from any of our facilities' key suppliers. Any facility shutdowns may 
be followed by prolonged startup periods, regardless of the reason for the shutdown. Those startup periods could 
range from several days to several weeks, depending on the reason for the shutdown and other factors. Any prolonged 
disruption in operations at any of our facilities could cause significant lost production, which would have a material 
adverse effect on our business, financial condition, results of operations and cash flows.

We  depend  on  external  sources  of  wood  pulp,  which  subjects  our  business  and  results  of  operations  to 
potentially significant fluctuations in the price of market pulp.

Our Consumer Products segment sources a significant portion of its wood pulp requirements from external suppliers. 
In 2014, it sourced approximately 74% of its pulp requirements externally. Approximately 17.3% of our cost of sales 
in 2014 consisted of purchased pulp costs. Although the sale of our specialty business and mills will decrease our 
dependence on the purchase of external pulp by approximately 45%, we still remain dependent on external sources 
of wood pulp. This increases our exposure to fluctuations in prices for wood pulp, which in turn could have a material 
adverse effect on our financial results, operations and cash flows.

Pulp prices can, and have, changed significantly from one period to the next. The volatility of pulp prices can adversely 
affect our earnings if we are unable to pass cost increases on to our customers or if the timing of any price increases 
for our products significantly trails the increases in pulp prices. We have not hedged these risks.

Changes in the cost and availability of wood fiber used in production of our products may adversely affect 
our results of operations and cash flow.

Wood fiber is the principal raw material used to create wood pulp, which in turn is used to manufacture our pulp and 
paperboard products and consumer products. In 2014, our wood fiber costs were 8.9% of our cost of sales. Much of 
the wood fiber we use in our pulp manufacturing process in Lewiston, Idaho, is the by-product of sawmill operations. 
As a result, the price of these residual wood fibers is affected by operating levels in the lumber industry. The significant 
reduction in home building over the past six years resulted in the closure or curtailment of operations at many sawmills. 
The price of wood fiber is expected to remain volatile until the housing market recovers and sawmill operations increase. 
Additionally, the supply and price of wood fiber can be negatively affected by weather and other events. For example, 
our Arkansas pulp and paperboard facility relies on whole log chips for a significant portion of its wood fiber, and in 
2014 this facility experienced increases in the costs for that wood fiber due to extremely wet weather conditions in the 
Southeastern U.S. that limited accessibility and availability.

9

The effects on market prices for wood fiber resulting from various governmental programs involving tax credits or 
payments related to biomass and other renewable energy projects are uncertain and could result in a reduction in the 
supply of wood fiber available for our pulp and paperboard manufacturing operations. If we and our pulp suppliers are 
unable to obtain wood fiber at favorable prices or at all, our costs will increase and financial results, operations and 
cash flows may be materially adversely affected.

Our business and financial performance may be harmed by future labor disruptions.

As  of  December 31,  2014,  52%  of  our  full-time  employees  are  represented  by  unions  under  collective  bargaining 
agreements. As these agreements expire, we may not be able to negotiate extensions or replacement agreements 
on terms acceptable to us. Two collective bargaining agreements that expired in 2014 are currently being renegotiated. 
Any failure to reach an agreement with one of the unions may result in strikes, lockouts or other labor actions. Any 
such labor actions, including work slowdowns in the future or stoppages, could have a material adverse effect on our 
operations and financial results.

The cost of chemicals and energy needed for our manufacturing processes significantly affects our results 
of operations and cash flows.

We use a variety of chemicals in our manufacturing processes, including petroleum-based polyethylene and certain 
petroleum-based  latex  chemicals.  In  2014,  our  chemical  costs  were  12.1%  of  our  cost  of  sales.  Prices  for  these 
chemicals have been and are expected to remain volatile. In addition, chemical suppliers that use petroleum-based 
products in the manufacture of their chemicals may, due to supply shortages and cost increases, ration the amount 
of chemicals available to us, and therefore we may not be able to obtain at favorable prices the chemicals we need 
to operate our business, if we are able to obtain them at all.

Our  manufacturing  operations  utilize  large  amounts  of  electricity  and  natural  gas  and  our  energy  requirements, 
particularly natural gas, have increased significantly as a result of operations at our North Carolina facility. In 2014, 
our energy costs were 8.2%  of our cost of sales. Energy prices have fluctuated widely over the past decade, which 
in turn affects our cost of sales. We purchase on the open market a substantial portion of the natural gas necessary 
to produce our products, and, as a result, the price and other terms of those purchases are subject to change based 
on factors such as worldwide supply and demand, geopolitical events, government regulation, and natural disasters. 
Our energy costs in future periods will depend principally on our ability to produce a substantial portion of our electricity 
needs internally, on changes in market prices for natural gas and on reducing energy usage.

Any significant energy shortage or significant increase in our energy costs in circumstances where we cannot raise 
the price of our products could have a material adverse effect on our business, financial condition, results of operations 
and cash flows. Any disruption in the supply of energy could also affect our ability to meet customer demand in a timely 
manner and could harm our reputation.

We are subject to significant environmental regulation and environmental compliance expenditures, which 
could increase our costs and subject us to liabilities.

We are subject to various federal, state and foreign environmental laws and regulations concerning, among other 
things,  water  discharges,  air  emissions,  hazardous  material  and  waste  management  and  environmental  cleanup. 
Environmental  laws  and  regulations  continue  to  evolve  and  we  may  become  subject  to  increasingly  stringent 
environmental standards in the future, particularly under air quality and water quality laws and standards related to 
climate change issues, such as reporting of greenhouse gas emissions. Increased regulatory activity at the state, 
federal and international level is possible regarding climate change as well as other emerging environmental issues 
associated with our manufacturing sites, such as water quality standards based on elevated fish consumption rates. 
Compliance with regulations that implement new public policy in these areas might require significant expenditures 
on our part or even the curtailment of certain of our manufacturing operations.

We are required to comply with environmental laws and the terms and conditions of multiple environmental permits. 
In particular, the pulp and paper industry in the United States is subject to several performance based rules associated 
with effluent and air emissions as a result of certain of its manufacturing processes. Federal, state and local laws and 
regulations require us to routinely obtain authorizations from and comply with the evolving standards of the appropriate 
governmental  authorities,  which  have  considerable  discretion  over  the  terms  of  permits.  Failure  to  comply  with 
environmental laws and permit requirements could result in civil or criminal fines or penalties or enforcement actions, 
including regulatory or judicial orders enjoining or curtailing our operations or requiring us to take corrective measures, 
install pollution control equipment, or take other remedial actions, such as product recalls or labeling changes. We 
also may be required to make additional expenditures, which could be significant, relating to environmental matters 
on an ongoing basis.

10

In 2012, we were notified that the U.S. Environmental Protection Agency, or EPA, submitted a civil referral to the U.S. 
Department of Justice, or DOJ, alleging violations of the Clean Air Act stemming from an EPA investigation at our 
Lewiston, Idaho pulp facility. Prior to the filing of any formal action, we and the DOJ agreed to discuss the resolution 
of the allegations, and the parties entered into an agreement to toll the statute of limitations. The tolling agreement 
expires on April 30, 2015, unless further extended by the parties. Discussions with the DOJ and EPA are ongoing. 
However, this matter could result in civil penalties or enforcement actions, including regulatory or judicial orders enjoining 
or curtailing our operations or requiring us to take corrective measures, install pollution control equipment, or take 
other remedial actions.

The recovery boiler at our Cypress Bend, Arkansas facility has been experiencing ongoing operational and related 
environmental compliance issues associated with a 2013 upgrade project. A capital project to address these issues 
is scheduled for April 2015. We expect to enter into a consent administrative order with the State of Arkansas in 2015 
to resolve compliance issues associated with the recovery boiler. Penalties, if any, associated with this settlement have 
not been proposed by the State. The total cost of the corrective action is expected to be approximately $5 million.

We own properties, conduct or have conducted operations at properties, and have assumed indemnity obligations for 
properties or operations where hazardous materials have been or were used for many years, including during periods 
before careful management of these materials was required or generally believed to be necessary. Consequently, we 
will continue to be subject to risks under environmental laws that impose liability for historical releases of hazardous 
substances. 

There can be no assurance that future environmental permits will be granted or that we will be able to maintain and 
renew existing permits, and the failure to do so could have a material adverse effect on our results of operations, 
financial condition and cash flows.

United States and global economic conditions could have adverse effects on the demand for our products 
and financial results.

U.S. and global economic conditions have negatively affected and may continue to negatively affect our business and 
financial results. Recessed global economic conditions and a strong U.S. dollar can affect our business in a number 
of  ways,  including  causing  declines  in  global  demand  for  consumer  tissue  and  paperboard,  which  increases  the 
likelihood or the pace of foreign manufacturers entering into or increasing sales into the U.S. market.

Increased competition and supply from foreign manufacturers could have adverse effects on the demand for 
our products and financial results.

Foreign manufacturers, particularly in Asia, are currently increasing, and are expected to continue to increase, their 
paper production capabilities, particularly of paperboard. This, in turn, may result in increased competition in the North 
American paper markets from direct sales by foreign competitors into these markets and/or increased competition in 
the U.S. as domestic manufacturers seek increased U.S. sales to offset displaced overseas sales caused by increased 
sales by Asian suppliers into those markets. An increased supply of Asian paper products could cause us to lower our 
prices or lose sales to competitors, either of which could have a material adverse effect on our business, financial 
condition, results of operations and cash flows.

Larger competitors have operational and other advantages over our operations.

The markets for our products are highly competitive, and companies that have substantially greater financial resources 
compete with us in each market. Some of our competitors have advantages over us, including lower raw material and 
labor costs and better access to the inputs of our products.

Our consumer products business faces competition from companies that produce the same type of products that we 
produce or that produce alternative products that customers may use instead of our products. Our consumer products 
business  competes  with  the  branded  tissue  products  producers,  such  as  Procter  &  Gamble,  and  branded  label 
producers who manufacture branded and private label products, such as Georgia-Pacific and Kimberly-Clark. These 
companies are far larger than us, have more sales, marketing and research and development resources than we do, 
and enjoy significant cost advantages due to economies of scale. For example, in 2014 the net sales of our Consumer 
Products' segment was negatively impacted in part as a result of increased promotional activity for branded tissue 
products. In addition, because of their size and resources, these companies may foresee market trends more accurately 
than we do and develop new technologies that render our products less attractive or obsolete.

11

Our ability to successfully compete in the pulp and paperboard industry is influenced by a number of factors, including 
manufacturing capacity, general economic conditions and the availability and demand for paperboard substitutes. Our 
pulp and paperboard business competes with International Paper, MeadWestvaco, Georgia-Pacific, RockTenn and 
international producers, most of whom are much larger than us. Any increase in manufacturing capacity by any of 
these or other producers could result in overcapacity in the pulp and paperboard industry, which could cause downward 
pressure on pricing. For example, several new, large paperboard manufacturing facilities in China have recently been, 
or soon will be, completed, the output of which is expected to increase paperboard supplies on the international market. 
In addition, customers could choose to use types of paperboard that we do not produce or could rely on alternative 
materials, such as plastic, for their products. An increased supply of any of these products could cause us to lower 
our prices or lose sales to competitors, either of which could have a material adverse effect on our business, financial 
condition, results of operations and cash flows.

The  consolidation  of  paperboard  converting  businesses,  including  through  the  acquisition  and  integration  of  such 
converting business by larger competitors of ours, could result in a loss of customers and sales on the part of our pulp 
and paperboard business, which does not include paperboard converting facilities or capabilities. A loss of paperboard 
customers or sales as a result of consolidations and integrations could have a material adverse effect on our business, 
financial condition, results of operations and cash flows.

Competitors' branded products and private label products could have an adverse effect on our financial results.

Our consumer products compete with well-known, branded products, as well as other private label products. Inherent 
risks  include  whether  our  products  will  receive  direct  and  retail  customer  acceptance,  new  product  offerings  by 
competitors, the effects of consolidation within retailer and distribution channels, and price competition from companies 
that may have greater financial resources than we do. If we are unable to offer our existing customers, or new customers, 
tissue products comparable to branded products or private label TAD products in terms of quality and/or price, we may 
lose business or we may not be able to grow our existing business and be forced to sell lower-margin products, all of 
which could negatively affect our financial condition and results of operations.

Our  company-sponsored  pension  plans  are  currently  underfunded,  and  we  are  required  to  make  cash 
payments to the plans, reducing cash available for our business.

We have company-sponsored pension plans covering certain of our salaried and hourly employees. The volatility in 
the value of equity and fixed income investments held by these plans, coupled with a low interest rate environment 
resulting in higher liability valuations, has caused these plans to be underfunded as the projected benefit obligation 
has exceeded the aggregate fair value of plan assets by varying year-end amounts since 2008. At December 31, 2014, 
and 2013, our company sponsored pension plans were underfunded in the aggregate by $16.9 million and $6.8 million, 
respectively. As a result of underfunding, we may be required to make contributions to our qualified pension plans. In 
2014, we contributed $17.0 million to these pension plans. We may be required to make increased annual contributions 
to our pension plans in future years, which would reduce the cash available for business and other needs.

We may be required to pay material amounts under multiemployer pension plans.

We contribute to two multiemployer pension plans. The amount of our annual contributions to each of these plans is 
negotiated with the plan and the bargaining unit representing our employees covered by the plan. In 2014, we contributed 
approximately $6 million to these plans, and in future years we may be required to make increased annual contributions, 
which would reduce the cash available for business and other needs. In addition, in the event of a partial or complete 
withdrawal by us from any multiemployer plan that is underfunded, we would be liable for a proportionate share of 
such  multiemployer  plan's  unfunded  vested  benefits,  referred  to  as  a  withdrawal  liability. A  withdrawal  liability  is 
considered a contingent liability. In the event that any other contributing employer withdraws from any multiemployer 
plan that is underfunded, and such employer cannot satisfy its obligations under the multiemployer plan at the time of 
withdrawal, then the proportionate share of the plan’s unfunded vested benefits that would be allocable to us and to 
the other remaining contributing employers, would increase and there could be an increase to our required annual 
contributions.  In  renegotiations  of  collective  bargaining  agreements  with  labor  unions  that  participate  in  these 
multiemployer plans, we may decide to discontinue participation in these plans.

12

One of the multiemployer pension plans to which we contribute, the PACE Industry Union-Management Pension Fund, 
or PIUMPF, was certified to be in “critical status” for the plan year beginning January 1, 2010, and continued to be in 
critical status for the plan year beginning January 1, 2014. In 2013, two large employers withdrew from PIUMPF. Further 
withdrawals by other contributing employers could cause a “mass withdrawal” from, or effectively a termination of, 
PIUMPF or alternatively we could elect to withdraw.  Although we have no current intention to withdraw from PIUMPF, 
if  we  were  to  withdraw,  either  completely  or  partially,  we  would  incur  a  withdrawal  liability  based  on  our  share  of 
PIUMPF’s unfunded vested benefits. Based on information as of December 31, 2013 provided by PIUMPF and reviewed 
by our actuarial consultant, we estimate that, as of December 31, 2014, the payments that we would be required to 
make to PIUMPF in the event of our complete withdrawal would be approximately $5.7 million per year on a pre-tax 
basis. These payments would continue for 20 years, unless we were deemed to be included in a “mass withdrawal” 
from PIUMPF, in which case these payments would continue in perpetuity.  However, we are not able to determine 
the exact amount of our withdrawal liability because the amount could be higher or lower depending on the nature and 
timing  of  any  triggering  event,  the  funded  status  of  the  plan  and  our  level  of  contributions  to  the  plan  prior  to  the 
triggering event.  These withdrawal liability payments would be in addition to pension contributions to any new pension 
plan adopted or contributed to by us to replace PIUMPF, all of which would reduce the cash available for business and 
other needs. Adverse changes to pension laws and regulations could increase the likelihood and amount of our liabilities 
arising under PIUMPF. 

Our pension and health care costs are subject to numerous factors that could cause these costs to change.

In addition to our pension plans, we provide health care benefits to certain of our current and former U.S. salaried and 
hourly employees. There is a risk of increased costs due to the Affordable Care Act’s individual mandate and required 
coverage. Our health care costs vary with changes in health care costs generally, which have significantly exceeded 
general economic inflation rates for many years. Our pension costs are dependent upon numerous factors resulting 
from actual plan experience and assumptions about future investment returns. Pension plan assets are primarily made 
up of equity and fixed income investments. Fluctuations in actual equity market returns as well as changes in general 
interest rates may result in increased pension costs in future periods. Likewise, changes in assumptions regarding 
current discount rates, expected rates of return on plan assets and mortality rates could also increase pension costs. 
Significant changes in any of these factors may adversely impact our cash flows, financial condition and results of 
operations.

We  rely  on  information  technology  in  critical  areas  of  our  operations,  and  a  disruption  relating  to  such 
technology could harm our financial condition.

We use information technology, or IT, systems in various aspects of our operations, including enterprise resource 
planning, or ERP, management of inventories and customer sales. Some of these systems have been in place for long 
periods of time. We have different legacy IT systems that we are continuing to integrate, including the implementation 
of  a  single  company-wide  ERP  system.  If  one  of  these  systems  or  the  ERP  implementation  was  to  fail  or  cause 
operational or reporting interruptions, or if we decide to change these systems or hire outside parties to provide these 
systems,  we  may  suffer  disruptions,  which  could  have  a  material  adverse  effect  on  our  results  of  operations  and 
financial condition. In addition, we may underestimate the costs and expenses of developing and implementing new 
systems.

We face cyber-security risks.

Our business operations rely upon secure information technology systems for data capture, processing, storage and 
reporting.  Despite  careful  security  and  controls  design,  implementation  and  updating,  our  information  technology 
systems  could  become  subject  to  cyber-attacks.  Network,  system,  application  and  data  breaches  could  result  in 
operational disruptions or information misappropriation, which could result in lost sales, business delays, negative 
publicity and could have a material adverse effect on our business, results of operations and financial condition.

Cyclical  industry  conditions  have  in  the  past  affected  and  may  continue  to  adversely  affect  the  operating 
results and cash flows of our pulp and paperboard business.

Our pulp and paperboard business has historically been affected by cyclical market conditions. We may be unable to 
sustain pricing in the face of weaker demand, and weaker demand may in turn cause us to take production downtime. 
In addition to lost revenue from lower shipment volumes, production downtime causes unabsorbed fixed manufacturing 
costs due to lower production levels. Our results of operations and cash flows may be materially adversely affected 
in a period of prolonged and significant market weakness. We are not able to predict market conditions or our ability 
to sustain pricing and production levels during periods of weak demand.

13

We rely on a limited number of third-party suppliers for certain raw materials required for the production of 
our products.

Our dependence on a limited number of third-party suppliers, and the challenges we may face in obtaining adequate 
supplies of raw materials, involve several risks, including limited control over pricing, availability, quality, and delivery 
schedules. We cannot be certain that our current suppliers will continue to provide us with the quantities of these raw 
materials that we require or will continue to satisfy our anticipated specifications and quality requirements. Any supply 
interruption in limited raw materials could materially harm our ability to manufacture our products until a new source 
of supply, if any, could be identified and qualified. Although we believe there are other suppliers of these raw materials, 
we may be unable to find a sufficient alternative supply channel in a reasonable time or on commercially reasonable 
terms. Any performance failure on the part of our suppliers could interrupt production of our products, which would 
have a material adverse effect on our business.

Our efforts to increase operational efficiencies may not be fully achieved.

Our near term strategy of increasing operational efficiencies and cost effectiveness may not be fully achieved. The 
capital projects we invest in may not achieve expected operational or financial results in the timeframes we anticipate, 
or at all. Such delays or failures could materially affect our business, cash flows and financial condition.  

Additional expansion of our business through construction of new facilities or acquisitions may not proceed 
as anticipated.

In the future, we may build other converting and papermaking facilities, pursue acquisitions of existing facilities, or 
both. We may be unable to identify future suitable building locations or acquisition targets. In addition, we may be 
unable to achieve anticipated benefits or cost savings from construction projects or acquisitions in the timeframe we 
anticipate, or at all. Any inability by us to integrate and manage any new or acquired facilities or businesses in a timely 
and efficient manner, any inability to achieve anticipated cost savings or other anticipated benefits from these projects 
or acquisitions in the time frame we anticipate or any unanticipated required increases in promotional or capital spending 
could adversely affect our business, financial condition, results of operations or liquidity. Large construction projects 
or acquisitions can result in a decrease in our cash and short-term investments, an increase in our indebtedness, or 
both, and also may limit our ability to access additional capital when needed and divert management's attention from 
other business concerns.

To service our substantial indebtedness, we must generate significant cash flows. Our ability to generate cash 
depends on many factors beyond our control.

As of December 31, 2014, we had $575 million of outstanding indebtedness, and we could incur substantial additional 
indebtedness in the future. Our ability to make payments on and to refinance our indebtedness, including our outstanding 
notes, and to fund planned capital expenditures, will depend on our ability to generate cash in the future. This, to a 
certain extent, is subject to general economic, financial, competitive, legislative, regulatory and other factors that are 
beyond our control.

We cannot assure you that our business will generate sufficient cash flow from operations or that future borrowings 
will be available to us under our senior secured revolving credit facility in an amount sufficient to enable us to pay our 
indebtedness, including the notes, or to fund our other liquidity needs. We cannot assure you that we will be able to 
refinance any of our indebtedness, including our senior secured revolving credit facility and our existing notes, on 
commercially reasonable terms or at all.

14

The indentures for our outstanding notes that we issued in 2013 and the credit agreement governing our 
senior secured revolving credit facility, contain various covenants that limit our discretion in the operation of 
our business.

The indentures governing our outstanding notes that we issued in 2013 and the credit agreement governing our senior 
secured revolving credit facility, contain various provisions that limit our discretion in the operation of our business by 
restricting our ability to:

undergo a change in control;

sell assets;

pay dividends and make other distributions;

make investments and other restricted payments;

redeem or repurchase our capital stock;

incur additional debt and issue preferred stock;

create liens;

consolidate, merge, or sell substantially all of our assets;

enter into certain transactions with our affiliates;

engage in new lines of business; and

enter into sale and lease-back transactions.

These restrictions on our ability to operate our business at our discretion could seriously harm our business by, among 
other things, limiting our ability to take advantage of financing, merger and acquisition and other corporate opportunities. 
In addition, our senior secured revolving credit facility requires, among other things, that we maintain a minimum fixed 
charge coverage ratio of at least 1.0-to-1.0 when availability falls below $50 million or an event of default exists. Events 
beyond our control could affect our ability to meet this financial test, and we cannot assure you that we will meet it.

Our  failure  to  comply  with  the  covenants  contained  in  our  senior  secured  revolving  credit  facility  or  the 
indentures governing our outstanding notes, including as a result of events beyond our control, could result 
in an event of default that could cause repayment of the debt to be accelerated.

If we are not able to comply with the covenants and other requirements contained in the indentures governing our 
outstanding notes, our senior secured revolving credit facility or our other debt instruments, an event of default under 
the relevant debt instrument could occur. If an event of default does occur, it could trigger a default under our other 
debt instruments, prohibit us from accessing additional borrowings, and permit the holders of the defaulted debt to 
declare amounts outstanding with respect to that debt to be immediately due and payable. Our assets and cash flow 
may not be sufficient to fully repay borrowings under our outstanding debt instruments. In addition, we may not be 
able to refinance or restructure the payments on the applicable debt. Even if we were able to secure additional financing, 
it may not be available on favorable terms.

15

Certain provisions of our certificate of incorporation and bylaws and Delaware law may make it difficult for 
stockholders  to  change  the  composition  of  our  Board  of  Directors  and  may  discourage  hostile  takeover 
attempts that some of our stockholders may consider to be beneficial. 

Certain provisions of our certificate of incorporation and bylaws and Delaware law may have the effect of delaying or 
preventing changes in control if our Board of Directors determines that such changes in control are not in the best 
interests of the company and our stockholders. The provisions in our certificate of incorporation and bylaws include, 
among other things, the following: 

a classified Board of Directors with three-year staggered terms; 

the ability of our Board of Directors to issue shares of preferred stock and to determine the price and other 
terms, including preferences and voting rights, of those shares without stockholder approval; 

stockholder action can only be taken at a special or regular meeting and not by written consent; 

advance  notice  procedures  for  nominating  candidates  to  our  Board  of  Directors  or  presenting  matters  at 
stockholder meetings; 

removal of directors only for cause; 

allowing only our Board of Directors to fill vacancies on our Board of Directors; and 

supermajority voting requirements to amend our bylaws and certain provisions of our certificate of incorporation. 

While these provisions have the effect of encouraging persons seeking to acquire control of the company to negotiate 
with our Board of Directors, they could enable the Board of Directors to hinder or frustrate a transaction that some, or 
a majority, of the stockholders might believe to be in their best interests and, in that case, may prevent or discourage 
attempts to remove and replace incumbent directors. We are also subject to Delaware laws that could have similar 
effects. One of these laws prohibits us from engaging in a business combination with a significant stockholder unless 
specific conditions are met. 

ITEM 1B.
Unresolved Staff Comments

None.

16

 
ITEM 2.
Properties

FACILITIES

We own and operate facilities located throughout the United States and one in Canada. The following table lists each of our 
facilities and its location, use, and 2014 capacity and production:  

  USE

  LEASED OR OWNED   CAPACITY

PRODUCTION1

CONSUMER PRODUCTS
Tissue manufacturing
facilities:

East Hartford, Connecticut2   Tissue
Gouverneur, New York2
  Tissue
  Tissue
Ladysmith, Wisconsin
  TAD tissue
Las Vegas, Nevada
  Tissue
Lewiston, Idaho
Menominee, Michigan2
  Machine-glazed tissue
  Tissue
Neenah, Wisconsin
Shelby, North Carolina3
  TAD tissue
St. Catharines, Ontario2
  TAD tissue
  Machine-glazed tissue
  Tissue
  Machine-glazed tissue

Wiggins, Mississippi2

Owned
Owned
Owned
Owned
Owned
Owned
Owned
Owned/Leased
Owned

Owned

Tissue converting facilities:
Central Islip, New York3, 4
Elwood, Illinois3
Las Vegas, Nevada
Lewiston, Idaho
Menominee, Michigan2
Neenah, Wisconsin
Oklahoma City, Oklahoma3
Shelby, North Carolina3

  Tissue converting
  Tissue converting
  Tissue converting
  Tissue converting
  Machine-glazed tissue converting  
  Tissue converting
  Tissue converting
  Tissue converting

Leased
Owned/Leased
Owned
Owned
Owned
Owned
Owned/Leased
Owned/Leased

36,000 tons
39,000 tons
56,000 tons
38,000 tons
  185,000 tons
36,000 tons
84,000 tons
70,000 tons
20,000 tons
24,000 tons
29,000 tons
35,000 tons
  652,000 tons

— tons
76,000 tons
61,000 tons
90,000 tons
27,000 tons
  106,000 tons
29,000 tons
73,000 tons
  462,000 tons

30,000 tons
37,000 tons
53,000 tons
37,000 tons
177,000 tons
34,000 tons
80,000 tons
65,000 tons
18,000 tons
22,000 tons
28,000 tons
34,000 tons
615,000 tons

4,000 tons
53,000 tons
55,000 tons
73,000 tons
8,000 tons
67,000 tons
23,000 tons
50,000 tons
333,000 tons

PULP AND PAPERBOARD  
Pulp Mills:

Cypress Bend, Arkansas
Lewiston, Idaho

  Pulp
  Pulp

Bleached Paperboard Mills:
Cypress Bend, Arkansas
Lewiston, Idaho

  Paperboard
  Paperboard

CORPORATE

Owned
Owned

Owned
Owned

  316,000 tons
  540,000 tons
  856,000 tons

302,000 tons
533,000 tons
835,000 tons

  347,000 tons
  465,000 tons
  812,000 tons

327,000 tons
464,000 tons
791,000 tons

Alpharetta, Georgia
Spokane, Washington

  Operations and administration
  Corporate headquarters

Owned/Leased
Leased

N/A
N/A

N/A
N/A

1  
2 

3  

4 

Production amounts are approximations for full year 2014. 
On December 30, 2014, we sold our specialty business and mills, which consisted predominantly of machine-glazed tissue and also included parent rolls and 
other specialty tissue products.
The buildings located at these facilities are leased by Clearwater Paper or a subsidiary, and the operating equipment located within the building is owned by 
Clearwater Paper or a subsidiary. 
On February 17, 2014, we announced the permanent and immediate closure of our Long Island, New York, tissue converting and distribution facility. As of December 
31, 2014, all converting lines have been relocated and installed at our other facilities. As a result, the capacity from our Long Island facility has been reallocated 
accordingly. 

In addition to the manufacturing facilities listed in this table, we lease a chip shipment facility in Columbia City, Oregon and own a 
chipping producing facility in Clarkston, Washington.

17

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 3.
Legal Proceedings

On August 13, 2012, we were notified that the U.S. Environmental Protection Agency, or EPA, submitted a civil referral 
to the U.S. Department of Justice, or DOJ, alleging violations of the Clean Air Act stemming from an EPA investigation 
that included an inspection of our Lewiston, Idaho pulp facility in July 2009 and a subsequent information request 
dated February 24, 2011. On July 19, 2013, the EPA issued to us an additional information request. Prior to the filing 
of any formal action, we and the DOJ agreed to discuss the resolution of the allegations. On October 21, 2013, the 
parties entered into a new agreement to toll the statute of limitations. The tolling period commenced as of September 
14, 2012 and expires on April 30, 2015, unless further extended by the parties. Discussions with the DOJ and EPA 
are ongoing. 

On October 13, 2014, we were sent a pre-enforcement notice from the Arkansas Department of Environmental Quality, 
or ADEQ,  in  connection  with  an  inspection  of  our  Cypress  Bend, Arkansas  facility.  The  notice  sought  additional 
information in regards to air emission limits applicable to the recovery boiler at the facility. In November 2014, we 
reviewed with ADEQ scheduled work to be done to address operational issues with the recovery boiler and identified 
previously unreported air emission exceedances to ADEQ. We expect to enter into a consent administrative order with 
the State of Arkansas in 2015 to resolve the compliance issues associated with the recovery boiler. Penalties, if any, 
associated with this settlement have not been proposed by the State.

In addition to the matters discussed above, we may from time to time be involved in claims, proceedings and litigation 
arising from our business and property ownership. We believe, based on currently available information, that the results 
of such proceedings, in the aggregate, will not have a material adverse effect on our financial condition.

ITEM 4.
Mine Safety Disclosures

Not applicable.

18

Part II

ITEM 5.
Market for Registrant’s Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities

MARKET FOR OUR COMMON STOCK

Our common stock is traded on the New York Stock Exchange. The following table sets forth, for each period indicated, 
the high and low sales prices of our common stock during our two most recent years.

Year Ended December 31, 2014:

Fourth Quarter
Third Quarter
Second Quarter
First Quarter

Year Ended December 31, 2013:

Fourth Quarter
Third Quarter
Second Quarter
First Quarter

HOLDERS

Common Stock Price

High

Low

$ 71.58 $ 60.20
59.48
59.07
49.88

72.94
67.20
68.30

$ 53.91 $ 47.15
45.13
44.64
38.94

50.40
52.47
53.01

On February 20, 2015, the last reported sale price for our common stock on the New York Stock Exchange was $63.97 
per share. As of February 20, 2015, there were approximately 970 registered holders of our common stock.

DIVIDENDS

We have not paid any cash dividends and do not anticipate paying a cash dividend in 2015. We will continue to review 
whether payment of a cash dividend on our common stock in the future best serves the company and our stockholders. 
The declaration and amount of any dividends, however, will be determined by our Board of Directors and will depend 
on our earnings, our compliance with the terms of our notes and revolving credit facility that contain certain restrictions 
on our ability to pay dividends, and any other factors that our Board of Directors believes are relevant.

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

Please see Part III, Item 12 of this report for information relating to our equity compensation plans.

ISSUER PURCHASES OF EQUITY SECURITIES

On December 15, 2014, we announced that our Board of Directors had approved a new stock repurchase program 
authorizing the repurchase of up to $100 million of our common stock. The repurchase program authorizes purchases 
of  our  common  stock  from  time  to  time  through  open  market  purchases,  negotiated  transactions  or  other  means, 
including accelerated stock repurchases and 10b5-1 trading plans in accordance with applicable securities laws and 
other restrictions. We have no obligation to repurchase stock under this program and may suspend or terminate the 
program at any time.

On February 5, 2014, we announced that our Board of Directors had approved a stock repurchase program authorizing 
the repurchase of up to $100 million of our common stock. We completed this program during the third quarter of 2014. 
In total, we repurchased 1,574,748 shares of our outstanding common stock at an average price of $63.50 per share 
under this program.

On January 17, 2013, we announced that our Board of Directors had approved a stock repurchase program authorizing 
the repurchase of up to $100 million of our common stock, which was completed in the fourth quarter of 2013. Under 
this program, we repurchased 1,039,513 shares of our outstanding common stock under an accelerated stock buyback 
agreement  with  a  major  financial  institution  at  an  average  repurchase  price  of  $48.10  per  share.  We  also  made 
repurchases of 1,030,657 shares of our outstanding common stock on the open market at a total cost of $50 million, 
representing an an average price of $48.51 per share, under this program.

19

 
  
ITEM 6.
Selected Financial Data

All of the data listed below has been derived from our audited financial statements. Our historical financial and other 
data is not necessarily indicative of our future performance. In addition, all amounts below for 2010 reflect the acquisition 
of  Cellu  Tissue  on  December 27,  2010,  including  four  days  of  Cellu  Tissue’s  operating  results  and  incurrence  of 
acquisition related expenses. Amounts for 2011 forward are reflective of the sale of our Lewiston, Idaho sawmill in 
November 2011. Amounts for 2014 reflect the sale of our specialty business and mills on December 30, 2014.

Earnings per share and common shares outstanding data have been retroactively adjusted to reflect our two-for-one 
stock split that was effected in the form of a stock dividend distributed on August 26, 2011 to shareholders of record 
on August 12, 2011.

(In thousands, except net
(loss) earnings per share amounts)
Net sales

Income from operations
Net (loss) earnings1
Working capital2
Long-term debt, net of current portion

Stockholders’ equity
Capital expenditures3
Property, plant and equipment, net

2014

2013

2012

2011

2010

$

1,967,139

$

1,889,830

$

1,874,304

$

1,927,973

$

1,372,965

79,811

(2,315)

302,836

575,000

497,537

99,600

810,987

99,328

106,955

375,975

650,000

605,094

86,508

884,698

145,387

64,131

293,733

523,933

540,894

207,115

877,377

115,445

39,674

390,839

523,694

484,904

137,743

735,566

98,767

73,800

394,346

538,314

468,349

47,033

654,456

Total assets

1,585,928

1,744,825

1,633,456

1,571,318

1,545,336

Net (loss) earnings per basic common
  share

Average basic common shares
  outstanding

Net (loss) earnings per diluted common
  share

$

$

Average diluted common shares
  outstanding

(0.11) $

4.84

$

2.75

$

1.73

$

3.22

20,130

22,081

23,299

22,914

22,947

(0.11) $

4.80

$

2.72

$

1.66

$

3.12

20,130

22,264

23,614

23,952

23,670

1 

Income from operations for the year ended December 31, 2013, includes the reversal of uncertain tax positions. For additional discussion, 
see Note 8, "Income Taxes," in the notes to the consolidated financial statements.

2  Working capital is defined as our current assets less our current liabilities, as presented on our Consolidated Balance Sheets. 
3 

Capital expenditures in 2012, 2011 and 2010 primarily include expenditures related to our through-air-dried tissue expansion project at our 
Shelby, North Carolina, and Las Vegas, Nevada, manufacturing and converting facilities. 

20

ITEM 7.
Management’s Discussion and Analysis of Financial Condition and Results
of Operations

The following discussion and analysis should be read in conjunction with our audited consolidated financial statements 
and notes thereto that appear elsewhere in this report. This discussion contains forward-looking statements reflecting 
our current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed 
in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk 
Factors” and elsewhere in this report.

Unless the context otherwise requires or unless otherwise indicates, references in this report to “Clearwater Paper 
Corporation,” “we,” “our,” “the company” and “us” refer to Clearwater Paper Corporation and its subsidiaries. 

OVERVIEW

2014 Events

Mill Divestitures and Facility Closures

On December 30, 2014, we sold our specialty business and mills to a private buyer for $113.5 million, before related 
expenses and adjustments. The specialty business and mills sold consisted predominantly of machine-glazed tissue 
and also included parent rolls and other specialty tissue products such as absorbent materials and dark-hued napkins. 
The sale included five facilities located at East Hartford, Connecticut; Menominee, Michigan; Gouverneur, New York; 
St. Catharines, Ontario; and Wiggins, Mississippi. 

On February 17, 2014, we announced the permanent and immediate closure of our Long Island, New York, tissue 
converting and distribution facility. As of December 31, 2014, we have incurred $18.8 million of costs associated with 
the closure and the relocation of related converting lines to other of our converting facilities. The cost savings benefits 
resulting from the Long Island facility consolidation and optimization, which are incremental to our previously announced 
cost savings programs, are expected to be approximately $12 million in 2015 and on an annual basis thereafter. 

On March 6, 2013, we announced the permanent closure of our Thomaston, Georgia converting and distribution facility.  
The  shutdown  occurred  gradually  as  converting  lines  were  relocated  and  installed  at  our  other  facilities,  with  all 
operations at Thomaston ceasing at the end of 2013 and the closure being finalized in 2014. We incurred $7.2 million 
of costs associated with this closure, of which $1.3 million was incurred during 2014.

Capital Allocation

On December 15, 2014, we announced that our Board of Directors had approved a new stock repurchase program 
authorizing the repurchase of up to $100 million of our common stock. The repurchase program authorizes purchases 
of  our  common  stock  from  time  to  time  through  open  market  purchases,  negotiated  transactions  or  other  means, 
including accelerated stock repurchases and 10b5-1 trading plans in accordance with applicable securities laws and 
other restrictions. We have no obligation to repurchase stock under this program and may suspend or terminate the 
program at any time.

On July 29, 2014, we issued $300 million of aggregate principal amount senior notes, which we refer to as the 2014 
Notes. The 2014 Notes mature on February 1, 2025, have an interest rate of 5.375% and were issued at their face 
value. All of the net proceeds from the issuance, as well as company funds and short-term borrowings from our senior 
secured revolving credit facility, were used to redeem all of our $375 million aggregate principal amount of 7.125% 
senior notes due 2018, which we refer to as the 2010 Notes.

On February 5, 2014, we announced that our Board of Directors had approved a stock repurchase program authorizing 
the repurchase of up to $100 million of our common stock. We completed this program during the third quarter of 2014. 
In total, we repurchased 1,574,748 shares of our outstanding common stock at an average price of $63.50 per share 
under this program.

21

Business

We  are  a  leading  producer  of  private  label  tissue  and  premium  bleached  paperboard  products.  Our  products  are 
primarily wood pulp based and manufactured in the U.S.

Our business is organized into two reporting segments:

•  Our Consumer Products segment manufactures and sells a complete line of at-home tissue products in each 
tissue category, including bathroom tissue, paper towels, napkins and facial tissue. We also manufacture 
away-from-home  tissue,  or AFH,  and  parent  rolls  for  external  sales.  Our  integrated  manufacturing  and 
converting operations and geographic footprint enable us to deliver a broad range of cost-competitive products 
with brand equivalent quality to our consumer products customers. In 2014, our Consumer Products segment 
had net sales of $1.2 billion, representing approximately 60% of our total net sales.

•  Our Pulp and Paperboard segment manufactures and markets bleached paperboard for the high-end segment 
of the packaging industry and is a leading producer of solid bleach sulfate paperboard. This segment also 
produces hardwood and softwood pulp, which is primarily used as the basis for our paperboard products, 
and slush pulp, which it supplies to our Consumer Products segment. In 2014, our Pulp and Paperboard 
segment had net sales of $783.8 million, representing approximately 40% of our total net sales. 

Developments and Trends in our Business

Net Sales

Prices  for  our  consumer  tissue  products  are  affected  by  competitive  conditions  and  the  prices  of  branded  tissue 
products. Tissue has historically been one of the strongest segments of the paper and forest products industry due to 
its steady demand growth. In recent years, the industry has seen an increase in TAD tissue products as industry 
participants have added or improved TAD production capacity. Our Consumer Products segment competes based on 
product quality, customer service and price. We deliver customer-focused business solutions by assisting in managing 
product assortment, category management, and pricing and promotion optimization.

Our pulp and paperboard business is affected by macro-economic conditions around the world and has historically 
experienced cyclical market conditions.  As a result, historical prices for our products and sales volumes have been 
volatile.  Product  pricing  is  significantly  affected  by  the  relationship  between  supply  and  demand  for  our  products. 
Product supply in the industry is influenced primarily by fluctuations in available manufacturing production, which tends 
to increase during periods when prices remain strong. In addition, currency exchange rates affect U.S. supplies of 
paperboard,  as  non-U.S.  manufacturers  are  attracted  to  the  U.S.  market  when  the  dollar  is  relatively  strong.  Our 
paperboard business, through exports denominated in U.S. dollars, benefited significantly from general weakness in 
the U.S. dollar over the past few years. Paperboard pricing increased when comparing 2014 to 2013. 

The markets for our products are highly competitive. Our business is capital intensive, which leads to high fixed costs, 
large capital outlays and generally results in continued production as long as prices are sufficient to cover variable 
costs.  These  conditions  have  contributed  to  substantial  price  competition,  particularly  during  periods  of  reduced 
demand. Some of our competitors have lower production costs and greater buying power and, as a result, may be 
less adversely affected than we are by price decreases.

Net sales consist of sales of consumer tissue and paperboard, net of discounts, returns and allowances and any sales 
taxes collected.

22

Operating Costs

Prices for our principal operating cost items are variable and directly affect our results of operations. For example, as 
economic conditions improve, we normally would expect at least some upward pressure on these operating costs. 
Competitive market conditions can limit our ability to pass cost increases through to our customers.

(Dollars in thousands)
Purchased pulp
Chemicals
Transportation1
Chips, sawdust and logs
Energy
Packaging supplies
Maintenance and repairs2
Depreciation

2014

2013

2012

Years Ended December 31,

Cost
$ 295,889
206,054
191,774
151,331
139,756
103,769

84,309
80,094
$1,252,976

Percentage of
Cost of Sales

Cost

Percentage of
Cost of Sales

Cost

17.3% $ 294,911
191,473
12.1
180,188
11.2
139,456
8.9
126,687
8.2
103,286
6.1

4.9
4.6

97,006
80,758
73.3% $1,213,765

17.6% $ 242,921
183,606
11.5
171,114
10.8
162,904
8.3
109,592
7.6
86,282
6.2

5.8
4.8

98,217
69,880
72.6% $1,124,516

Percentage of
Cost of Sales
15.1%
11.5
10.6
10.1
6.8
5.4

6.1
4.3
69.9%

1  
2 

Includes internal and external transportation costs. 
Excluding related labor costs. 

Purchased pulp. We purchase a significant amount of the pulp needed to manufacture our consumer products, and 
to a lesser extent our paperboard, from external suppliers. For 2014, total purchased pulp costs were 17.3% of our 
cost of sales. Total purchased pulp costs increased slightly in 2014 due to increased paperboard and TAD tissue 
production, as well as inflated pulp pricing. These costs were largely offset by a reduction in the purchases of outside 
pulp in 2014 compared to 2013, during which we offset reductions in internal pulp production with purchases of outside 
pulp as a result of planned major maintenance performed, and the related machine downtime, at our Idaho and Arkansas 
pulp and paperboard facilities. We expect our purchased pulp costs to decrease in 2015 as a result of the sale of our 
specialty business and mills.

Chemicals. We consume a substantial amount of chemicals in the production of pulp and paperboard, as well as in 
the production of TAD tissue. The chemicals we generally use include polyethylene, caustic, starch, sodium chlorate, 
latex and paper processing chemicals. A portion of the chemicals used in our manufacturing processes, particularly 
in the pulp-making process, are petroleum-based and are impacted by petroleum prices. 

Our chemical costs increased $14.6 million compared to 2013, due primarily to increased production and higher pricing 
for polyethylene, as well as other tissue and paperboard processing chemicals. Chemical consumption and the related 
costs for 2014 also increased compared to 2013 due to operational issues at our Arkansas facility involving both the 
pulp mill and paper machine. The paper machine issues were resolved and did not impact the second half of 2014. 
These increases were partially offset by the absence of prior year chemical costs related to facilities closed during the 
year. The Arkansas facility operational issues are discussed further under "Discussion of Business Segments."

Transportation. Fuel prices largely impact transportation costs related to delivery of raw materials to our manufacturing 
facilities, internal inventory transfers and delivery of our finished products to customers. Changing fuel prices particularly 
affect our margins for consumer products because we supply customers throughout the U.S. and transport unconverted 
parent rolls from our tissue mills to our tissue converting facilities. Transportation costs for 2014 increased $11.6 million 
compared to 2013 due primarily to higher overall costs associated with increased paperboard and non-retail tissue 
shipments. Transportation costs also increased as a result of higher carrier costs, primarily attributable to tighter carrier 
supply resulting from a shortage of qualified drivers throughout 2014, as well as a result of extreme weather conditions 
in the Midwest and Northeast during the first quarter of 2014. These higher costs were partially offset by the absence 
of regional internal inventory distribution costs that occurred during the first quarter of 2013 as a result of reduced 
inventory levels during our TAD transition. The reduced inventory levels required multiple shifts in regional distributions 
for our tissue product lines, and as a result we incurred an overall increase of internal tons shipped during that period.

23

 
 
Chips, sawdust and logs. We purchase chips, sawdust and logs that we use to manufacture pulp. We source residual 
wood  fiber  under  both  long-term  and  short-term  supply  agreements,  as  well  as  in  the  spot  market.  Overall  costs 
increased by $11.9 million for chips, sawdust and logs for 2014 compared to 2013. The increases were primarily due 
to higher overall paperboard production associated with increased paperboard shipment volumes, as well as higher 
chip pricing at our Arkansas pulp and paperboard facility due to supply constraints resulting from wet weather conditions. 
Costs for 2014 were also impacted by operational issues at our Arkansas facility involving both the pulp mill and paper 
machine. These overall costs were partially offset by decreased pricing at our Idaho facility during 2014.

Energy. We use energy in the form of electricity, hog fuel, steam and natural gas to operate our mills. Energy prices 
have fluctuated widely over the past decade. We have taken steps, and intend to continue to take steps, to reduce 
our exposure to volatile energy prices through conservation. In addition, cogeneration facilities that produce steam 
and electricity at our Lewiston, Idaho manufacturing site help to lower our energy costs. TAD tissue production involves 
increased  natural  gas  usage  compared  to  conventional  tissue  manufacturing  and,  as  a  result,  our  natural  gas 
requirements have increased with the ramp up of our North Carolina TAD paper machine. 

Energy costs for 2014, were $13.1 million higher than 2013 due to higher electrical and natural gas pricing, as well as 
increased natural gas consumption. Energy costs for 2014 were also negatively impacted by higher electricity costs 
during 2014 as a result of increased production at our pulp and paperboard facilities, as well as the extremely cold 
weather conditions in the Midwest and Northeast during the first quarter of 2014. In addition, our energy costs were 
also impacted by a second quarter operational issue at our Arkansas facility involving both the pulp mill and paper 
machine.

To help mitigate our exposure to changes in natural gas prices we have used firm-price contracts to supply a portion 
of our natural gas requirements. As of December 31, 2014, these contracts covered approximately 57% of our expected 
average  monthly  natural  gas  requirements  for  2015,  which  includes  approximately  67%  of  the  expected  average 
monthly requirements for the first quarter. Our energy costs in future periods will depend principally on our ability to 
produce a substantial portion of our electricity needs internally, on changes in market prices for natural gas and on 
our ability to reduce our energy usage through conservation.

Packaging supplies. As a significant producer of private label consumer tissue products, we package to order for retail 
chains,  wholesalers  and  cooperative  buying  organizations.  Under  our  agreements  with  those  customers,  we  are 
responsible for the expenses related to the unique packaging of our products for direct retail sale to their consumers. 
For 2014, packaging costs remained relatively flat, increasing by only $0.5 million compared to 2013, due primarily to 
increased pricing for poly wrapping and corrugated cardboard, which was partially offset by decreased packaging 
costs during the first half of 2014 as we relocated the converting lines from our recently closed Long Island facility.

Maintenance and repairs. We regularly incur significant costs to maintain our manufacturing equipment. We perform 
routine maintenance on our machines and periodically replace a variety of parts such as motors, pumps, pipes and 
electrical parts.

Major equipment maintenance and repairs in our Pulp and Paperboard segment also require maintenance shutdowns 
approximately every 18 months to 24 months at both our Idaho and Arkansas facilities, which increase costs and may 
reduce  net  sales  in  the  quarters  in  which  the  major  maintenance  shutdowns  occur.  We  did  not  have  any  major 
maintenance outages during 2014, compared to 2013 during which we incurred four days of planned machine downtime 
in the first quarter of 2013 at a cost of $5.0 million at our Arkansas facility, and eleven days of planned machine downtime 
in the third quarter of 2013 at a cost of $17.5 million for planned major maintenance at our Idaho facility. We expect 
our 2015 planned major maintenance costs to be between approximately $21 million and $23 million, which consists 
of approximately $17 million at our Idaho facility during the first half of 2015 and approximately $6 million at our Arkansas 
facility during the second quarter. In addition, the planned major maintenances is expected to result in eleven days of 
paper machine downtime at our Idaho facility during the first quarter and five days of paper machine downtime at our 
Arkansas facility during the second quarter. 

In addition to ongoing maintenance and repair costs, we make capital expenditures to increase our operating capacity 
and efficiency, improve safety at our facilities and comply with environmental laws. We spent $99.6 million and $86.4 
million, respectively, on capital expenditures during 2014 and 2013. We expect our total estimated capital expenditures 
for 2015 to be approximately $155 million, which includes $85 million of strategic capital spending on projects that we 
expect to provide a positive return on investment, plus an additional $70 million of capital spending on essential and 
general replacement projects. 

Depreciation. We record substantially all of our depreciation expense associated with our plant and equipment in "Cost 
of sales" on our Consolidated Statements of Operations. Depreciation expense for 2014 decreased slightly compared 
to 2013 primarily as a result of the Thomaston and Long Island facilities closures. 

24

Other. Other costs not included in the above table primarily consist of wage and benefit expenses and miscellaneous 
operating costs. Although period cut-offs and inventory levels can impact cost of sales amounts, we would expect this 
impact to be relatively steady as a percentage of costs on a period-over-period basis. We experienced lower benefit 
expenses in 2014 compared to 2013, primarily as a result of lower pension and medical related costs and the Thomaston 
and Long Island facilities closures. 

Selling, general and administrative expenses

Selling, general and administrative expenses primarily consist of compensation and associated costs for sales and 
administrative personnel, as well as commission expenses related to sales of our products. Our total selling, general 
and administrative costs were $130.1 million in 2014 compared to $119.1 million in 2013. The higher expense for 2014 
was primarily a result of higher information technology systems and incentive-based compensation expenses.

Interest expense

Interest expense is mostly comprised of interest on our 2013 Notes and 2014 Notes and short-term borrowings from 
our revolving credit facility. In 2014, we also incurred interest expense through a portion of the third quarter on our 
2010 notes that were paid off in that quarter. Interest expense also includes amortization of deferred issuance costs 
associated with all of our notes and our revolving credit facility. As a result of the issuance of the 2014 Notes at an 
interest rate lower than that of our 2010 Notes, we expect overall interest expense to be lower in 2015.

Income taxes

Income taxes are based on reported earnings and tax rates in jurisdictions in which our operations occur and offices 
are located, adjusted for available credits, changes in valuation allowances and differences in reported earnings and 
taxable income using current law and enacted tax rates.

The following table details our tax provision and effective tax rates for the years ended December 31, 2014, 2013 and 
2012:

(Dollars in thousands)

Income tax provision (benefit)

Effective tax rate

2014

2013

2012

$

18,556

$ (68,721)

$

47,460

114.3%

(179.7)%

42.5%

Our provision for income taxes for 2014 was unfavorably impacted primarily by a non-recurring tax provision of 65.0% 
related  to  losses  on  divested  assets  recorded  in  our  Consolidated  Statement  of  Operations  that  did  not  have  a 
corresponding  tax  benefit. Additionally,  the  rate  was  unfavorably  impacted  by  changes  in  valuation  allowances  of 
14.4%.  In  2013,  our  provision  for  income  taxes  was  favorably  impacted  primarily  by  non-recurring  tax  benefits  of 
180.9% related to the release of an uncertain tax position and 32.7% related to federal credits and net operating losses. 

The estimated annual effective tax rate for 2015 is expected to be approximately 37%.

25

RESULTS OF OPERATIONS

Our business is organized into two reporting segments: Consumer Products and Pulp and Paperboard. Intersegment 
costs for pulp transferred from our Pulp and Paperboard segment to our Consumer Products segment are recorded 
at cost, and thus no intersegment sales or cost of sales for these transfers are included in our segments' results. Our 
financial and other data are not necessarily indicative of our future performance. 

YEAR ENDED DECEMBER 31, 2014 COMPARED TO YEAR ENDED DECEMBER 31, 2013 

The following table sets forth data included in our Consolidated Statements of Operations as a percentage of net sales.

(Dollars in thousands)
Net sales
Costs and expenses:

Cost of sales
Selling, general and administrative expenses
Loss on divested assets
Impairment of assets

Total operating costs and expenses
Income from operations
Interest expense, net
Debt retirement costs
Earnings before income taxes
Income tax (provision) benefit
Net (loss) earnings

Years Ended December 31,

2014

2013

$ 1,967,139

100.0% $ 1,889,830

100.0%

(1,708,840)
(130,102)
(40,159)
(8,227)
(1,887,328)
79,811
(39,150)
(24,420)
16,241
(18,556)
(2,315)

$

86.9
6.6
2.0
0.4
95.9
4.1
2.0
1.2
0.8
0.9
0.1% $

(1,671,371)
(119,131)
—
—
(1,790,502)
99,328
(44,036)
(17,058)
38,234
68,721
106,955

88.4
6.3
—
—
94.7
5.3
2.3
0.9
2.0
3.6
5.7%

Net sales—Net sales for 2014 increased by $77.3 million, or 4.1%, compared to 2013, due primarily to higher average 
net selling prices and shipments for paperboard, increased sales of higher priced TAD tissue products and increased 
average net selling prices and shipments for non-retail tissue. These items are discussed below under “Discussion of 
Business Segments.”

Cost of sales—Cost of sales was 86.9% of net sales for 2014 and 88.4% of net sales for 2013. The decrease as a 
percentage of net sales was primarily a result of higher net sales, including sales of higher margin products, during 
2014. Our overall cost of sales during 2014 increased $37.5 million, or 2.2%, when compared to 2013, due primarily 
to $20.1 million of costs recorded in 2014 related to the closure of our Thomaston and Long Island facilities, compared 
to  $6.0  million  of  costs  related  to  the  closure  of  our Thomaston  facility  in  2013,  higher  incremental  costs  in  2014 
associated with the extreme cold weather conditions in the Midwest and Northeast during the first quarter, and higher 
costs  related  to  operational  issues  during  2014  at  our Arkansas  pulp  and  paperboard  facility.  These  unfavorable 
comparisons were partially offset by the absence of $22.5 million of total major maintenance costs that were incurred 
at our pulp and paperboard facilities in 2013.

Selling, general and administrative expenses—Selling, general and administrative expenses increased $11.0 million 
during  2014  compared  to  2013,  primarily  due  to  higher  information  technology  systems  and  incentive-based 
compensation expenses in 2014.

Loss  on  divested  assets—On  December  30,  2014,  we  sold  our  specialty  business  and  mills  for  net  proceeds  of 
approximately $108 million. In total, $40.2 million was recorded as a loss on divested assets, which include losses on 
$105.7 million of net assets sold, write-offs of $20.4 million and $4.9 million, respectively, of goodwill and intangible 
assets  associated  with  the  specialty  business  and  mills,  and  other  expenses  related  to  the  sale,  net  of  proceeds 
received.

Impairment of assets—During 2014, as a result of the permanent closure of our Long Island facility, we assessed both 
our intangible and long-lived assets for recoverability. As a result of this assessment, we recorded non-cash impairment 
losses during 2014 for intangible and long-lived assets in the amounts of $5.1 million. In addition, we determined during 
the  fourth  quarter  of  2014  that  a  customer  relationship  intangible  asset  associated  with  the  Pulp  and  Paperboard 
segment's wood chipping facility was fully impaired, and as a result we recorded an additional $3.1 million non-cash 
impairment loss.

26

 
Interest expense—Interest expense decreased $4.9 million during 2014, compared to 2013. The decrease was primarily 
attributable to reduced interest rates on our debt as a result of the third quarter 2014 refinancing of the 2010 Notes 
and the issuance of the lower interest bearing 2014 Notes, partially offset by short-term borrowings from our credit 
facility.

Debt retirement costs—Debt retirement costs for 2014 consist of a one-time $24.4 million charge in connection with 
the redemption of the 2010 Notes on August 28, 2014. These costs were comprised of cash charges of $19.8 million, 
which consisted of a "make-whole" premium of $17.6 million plus unpaid interest of $2.2 million, and a non-cash charge 
of $4.6 million related to the write-off of deferred issuance costs. Debt retirement costs of $17.1 million for 2013 include 
a  one-time  charge  in  connection  with  the  redemption  of  the  2009  Notes  on  February  22,  2013,  consisting  of  an 
approximate  $14  million  “make  whole”  premium  plus  accrued  and  unpaid  interest  and  a  non-cash  charge  of 
approximately $3 million related to the write-off of deferred issuance costs and unamortized discounts. 

Income tax provision—We recorded an income tax provision of $18.6 million in 2014, compared to a benefit of $68.7 
million in 2013. The tax rate determined in conformity with accounting principles generally accepted in the U.S., which 
we refer to as GAAP, for 2014 was a provision of 114.3%, compared to a benefit of 179.7% for 2013. The increase in 
the rate in 2014 was primarily the result of adjustments for losses on divested assets. The lower rate in 2013 was the 
result of the net impact of reporting discrete items, primarily relating to an additional benefit realized from a release of 
uncertain tax positions. During 2014 and 2013, there were a number of items that were included in the calculation of 
our income tax provision that we do not believe were indicative of our core operating performance. Excluding these 
items, the adjusted tax rate for 2014 would have been 36.1%, compared to an adjusted 33.3% in 2013. The following 
table details these items:

Non-GAAP Adjusted Income Tax Provision

(In thousands)

Income tax (provision) benefit

Special items, tax impact:

Debt retirement costs

Costs associated with Long Island facility closure

Costs/loss associated with optimization and sale of specialty business and mills

Directors' equity-based compensation expense

Loss on impairment of Clearwater Fiber intangible asset

Discrete tax item related to state tax rate changes

Costs associated with Thomaston facility closure

Discrete tax items related to settlement of uncertain tax positions

Discrete tax items related to tax credit conversions

Discrete tax items related to additional Cellulosic Biofuel Producer Credits

Years Ended December 31,

2014

2013

$ (18,556) $ 68,721

(8,643)

(6,677)

(3,774)

(1,625)

(1,054)

1,388

(448)

—

—

—

(6,277)

—

—

(1,399)

—

—

(2,033)

(67,457)

(9,832)

(3,495)

Adjusted income tax provision

$ (39,389) $ (21,772)

27

DISCUSSION OF BUSINESS SEGMENTS

Consumer Products

(Dollars in thousands - except per ton amounts)
Net sales
Operating (loss) income
Percent of net sales

Shipments (short tons)

Non-retail
Retail

Total tissue tons

Converted products cases (in thousands)

Sales price (per short ton)

Non-retail
Retail

Total tissue

Years Ended December 31,

2014
$ 1,183,385
(6,028)

2013
$ 1,149,692
52,799

(0.5)%

4.6%

233,943
293,907
527,850
55,501

231,243
295,529
526,772
55,135

$

$

1,504
2,822
2,238

$

$

1,470
2,740
2,183

Net sales for our Consumer Products segment increased by $33.7 million, or 2.9%, for 2014, compared to 2013. The 
higher net sales were due to increases of 3.0% and 2.3%, respectively, in retail and non-retail average net selling 
prices, as well as an increase in non-retail tissue shipments. The higher average net selling prices for retail tissue were 
driven primarily by increased sales of higher-priced TAD tissue products. These increases were partially offset by a 
decrease in conventional tissue shipments and lower pricing for conventional retail tissue. 

The segment reported reported a $6.0 million operating loss for 2014, compared to operating income of $52.8 million 
in 2013. The decline was primarily driven by a $40.2 million loss on the sale of our specialty business and mills. In 
addition, the segment's operating income was impacted by $20.1 million of costs related to the closure of our Thomaston 
and Long Island facilities, compared to $6.0 million of costs related to the closure of our Thomaston facility in 2013, 
as well as other incremental costs associated with extreme cold weather conditions in the Midwest and Northeast 
during the first quarter of 2014, which negatively impacted our energy and transportation costs. These impacts were 
partially offset by lower depreciation and wage and benefit expenses due to the facility closures.

Pulp and Paperboard

(Dollars in thousands - except per ton amounts)
Net sales
Operating income

Percent of net sales

Paperboard shipments (short tons)
Paperboard sales price (per short ton)

Years Ended December 31,

2014
$ 783,754
144,171

2013
$ 740,138
95,781

18.4%

12.9%

774,665
1,009

$

765,052
958

$

Net sales for our Pulp and Paperboard segment increased by $43.6 million, or 5.9%, for 2014, compared to 2013. This 
increase was primarily attributable to a 5.3% increase in average net selling prices for paperboard due to increased 
demand  resulting  from  positive  market  conditions  and  an  improved  sales  mix.  In  addition,  paperboard  shipments 
increased 1.3%, as a result of higher market demand and backlogs during 2014.

Operating income for the segment increased $48.4 million, or 50.5%, during 2014 compared to 2013, primarily due to 
the improved paperboard pricing and volume, the absence of $22.5 million of major maintenance costs incurred in the 
2013 period and lower overall benefit expenses. These improvements were partially offset by increased energy and 
transportation costs associated with extreme cold weather conditions in the Midwest and Northeast during the first 
quarter  of  2014,  as  well  as  operational  issues  at  our Arkansas  facility  that  caused  elevated  levels  of  energy  and 
chemicals and lower throughputs. 

28

  
  
YEAR ENDED DECEMBER 31, 2013 COMPARED TO YEAR ENDED DECEMBER 31, 2012 

The following table sets forth data included in our Consolidated Statements of Operations as a percentage of net sales.

(Dollars in thousands)
Net sales
Costs and expenses:

Cost of sales
Selling, general and administrative expenses

Total operating costs and expenses
Income from operations
Interest expense, net
Debt retirement costs
Earnings before income taxes
Income tax benefit (provision)
Net earnings

Years Ended December 31,

2013

2012

$ 1,889,830

100.0% $ 1,874,304

100.0%

(1,671,371)
(119,131)
(1,790,502)
99,328
(44,036)
(17,058)
38,234
68,721
106,955

$

88.4
6.3
94.7
5.3
2.3
0.9
2.0
3.6
5.7% $

(1,607,872)
(121,045)
(1,728,917)
145,387
(33,796)
—
111,591
(47,460)
64,131

85.8
6.5
92.2
7.8
1.8
—
6.0
2.5
3.4%

Net sales—Net sales for 2013 increased by $15.5 million, or 0.8%, compared to 2012, due to increased shipments of 
paperboard and higher net selling prices for retail tissue, which were favorably affected by a larger proportion of higher-
priced TAD product sales. These favorable comparisons were partially offset by lower non-retail shipments, as well 
as lower external pulp shipments as we continued to increase our consumption of  our internally produced pulp within 
our Consumer Products segment. These items are discussed further below under “Discussion of Business Segments.”

Cost of sales—Cost of sales increased 2.6 percentage points in 2013 to 88.4% of net sales, compared to 85.8% of 
net sales in 2012. The increase was primarily a result of $15.7 million in TAD transition costs incurred during the 2013 
period, an increase in depreciation expense of $10.7 million related to our North Carolina TAD machine, $6.0 million 
of costs related to the Thomaston, Georgia facility closure, $2.9 million of incremental costs associated with an electrical 
disruption  and  operational  issues  with  maintenance  and  repairs  on  the  recovery  boiler  at  our Arkansas  pulp  and 
paperboard facility, and higher energy, employee and packaging costs.

Selling, general and administrative expenses—Selling, general and administrative expenses decreased $1.9 million, 
or 1.6%, during 2013 when compared to 2012, due to a decrease in profit-dependent compensation accruals and 
lower legal expense, which was higher in 2012 due to the First Quality/Metso Paper litigation. These decreases were 
partially  offset  by  a  $4.1  million  mark-to-market  expense  adjustment  related  to  our  directors'  common  stock  units 
compared to $1.4 million of such expense in 2012.

Interest expense—Interest expense increased $10.2 million during 2013, compared to the same period of 2012. The 
increase was  attributable to the absence of capitalized interest during the current year, compared to $12.6 million of 
capitalized interest associated with our TAD tissue expansion project in 2012. The increase in interest expense was 
partially offset by the benefit of refinancing the 2009 Notes with proceeds from the issuance of the 2013 Notes, which 
carry a significantly lower interest rate.

Debt retirement costs—Debt retirement costs include a one-time charge in connection with the complete redemption 
of the 2009 Notes on February 22, 2013. Total costs of $17.1 million include cash charges of approximately $14 million 
related to a “make whole” premium plus accrued and unpaid interest and a non-cash charge of approximately $3 
million related to the write-off of deferred issuance costs and unamortized discounts. 

29

 
Income tax provision—We recorded an income tax benefit of $68.7 million in 2013, compared to a provision of $47.5 
million in 2012. The GAAP rate for 2013 was a benefit of 179.7%, compared to a provision of 42.5% for 2012. The 
lower rate was the result of the net impact of reporting discrete items, primarily relating to an additional benefit realized 
from a release of uncertain tax positions. During 2013 and 2012, there were a number of items that were included in 
the calculation of our income tax provision that we do not believe were indicative of our core operating performance. 
Excluding these items, the adjusted tax rate for 2013 would have been 33.3%, compared to an adjusted 36.8% in 
2012. The following table details these items:

Non-GAAP Adjusted Income Tax Provision

(In thousands)

Income tax benefit (provision)

Special items, tax impact:

Discrete tax items related to settlement of uncertain tax positions

Discrete tax items related to tax credit conversions

Debt retirement costs

Discrete tax items related to additional Cellulosic Biofuel Producer Credits

Costs associated with Thomaston facility closure

Directors' equity-based compensation expense

Loss on sale of foam assets

Expense associated with Metso litigation

Years Ended December 31,

2013

2012

$ 68,721 $ (47,460)

(67,457)

(9,832)

(6,277)

(3,495)

(2,033)

(1,399)

—

—

—

6,398

—

—

—

(609)

(356)

(709)

Adjusted income tax provision

$ (21,772) $ (42,736)

30

DISCUSSION OF BUSINESS SEGMENTS

Consumer Products

(Dollars in thousands - except per ton amounts)
Net sales
Operating income

Percent of net sales

Shipments (short tons)

Non-retail
Retail

Total tissue tons

Converted products cases (in thousands)

Sales price (per short ton)

Non-retail
Retail

Total tissue

Years Ended December 31,

2013
$ 1,149,692
52,799

2012
$ 1,134,556
93,347

4.6%

8.2%

231,243
295,529
526,772
55,135

237,655
293,672
531,327
53,675

$

$

1,470
2,740
2,183

$

$

1,466
2,674
2,134

Our Consumer Products segment reported an increase in net sales of $15.1 million, or 1.3%, for 2013, compared to 
2012. The higher net sales were due primarily to a 2.5% increase in retail tissue net selling prices, largely attributable 
to a higher proportion of higher-priced TAD product sales, and a 2.7% increase in converted retail tissue case shipments, 
softened by a 2.7% decrease in non-retail shipments. 

Segment operating income for 2013 decreased by $40.5 million compared to the same period in 2012, primarily driven 
by TAD transition costs of $15.7 million, an increase in depreciation expense of $10.7 million related to our North 
Carolina TAD machine, and higher energy and employee costs also largely related to the ramp up of the North Carolina 
facility. In addition, operating income was unfavorably affected by $6.0 million of costs associated with the closure of 
our Thomaston, Georgia facility, as well as increased packaging costs due to increased pricing for poly wrapping and 
corrugated cardboard. The TAD transition costs consisted primarily of increased transportation, manufacturing and 
outside purchased paper costs associated with the increased conventional tissue sales we took on to help offset the 
displacement of conventional tissue sales expected by the ramp up of our new Ultra TAD bathroom tissue product in 
2013. 

Pulp and Paperboard

(Dollars in thousands - except per ton amounts)
Net sales
Operating income

Percent of net sales

Paperboard shipments (short tons)
Paperboard sales price (per short ton)

Years Ended December 31,

2013
$ 740,138
95,781

2012
$ 739,748
103,910

12.9%

14.0%

765,052
958

$

760,919
956

$

Net  sales  for  our  Pulp  and  Paperboard  segment  in  2013  were  relatively  flat  when  compared  to  2012.  While  both 
shipments and net selling pricing for our paperboard increased slightly, these gains were partially offset by a continued 
decrease in net sales of external pulp, which was a direct result of our increased utilization of internally produced pulp 
in our Consumer Products segment.

Operating income for the segment decreased $8.1 million during 2013, compared to 2012. The lower operating income 
was primarily due to incremental costs of $2.9 million associated with an electrical disruption and operational issues 
with  maintenance  and  repairs  on  the  recovery  boiler  at  our Arkansas  pulp  and  paperboard  facility,  an  increase  of 
approximately 25% in average market pricing for natural gas, and higher employee, transportation and chemical costs.

31

  
  
EARNINGS BEFORE INTEREST, TAX, DEPRECIATION AND AMORTIZATION (EBITDA) AND ADJUSTED EBITDA

We use earnings before interest (including debt retirement costs), tax, depreciation and amortization, or EBITDA, and 
EBITDA adjusted for certain items, or Adjusted EBITDA, as supplemental performance measures that are not required 
by, or presented in accordance with GAAP. EBITDA and Adjusted EBITDA should not be considered as alternatives 
to  net  earnings,  operating  income  or  any  other  performance  measure  derived  in  accordance  with  GAAP,  or  as 
alternatives to cash flows from operating activities or a measure of our liquidity or profitability.

EBITDA and Adjusted EBITDA have important limitations as analytical tools, and should not be considered in isolation, 
or as a substitute for any of our results as reported under GAAP. Some of these limitations are:

EBITDA and Adjusted EBITDA do not reflect our cash expenditures for capital assets; 

EBITDA  and Adjusted  EBITDA  do  not  reflect  changes  in,  or  cash  requirements  for,  our  working  capital 
requirements; 

EBITDA and Adjusted EBITDA do not include cash pension payments; 

EBITDA and Adjusted EBITDA exclude certain tax payments that may represent a reduction in cash available 
to us;

EBITDA and Adjusted EBITDA do not reflect the interest expense, or the cash requirements necessary to 
service interest or principal payments on our debt; 

although depreciation and amortization are non-cash charges, the assets being depreciated and amortized 
will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect cash requirements 
for such replacements; and 

other companies, including other companies in our industry, may calculate these measures differently than 
we do, limiting their usefulness as a comparative measure. 

We present EBITDA, Adjusted EBITDA and Adjusted income tax provisions because we believe they assist investors 
and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we 
do not believe are indicative of our core operating performance. In addition, we use EBITDA and Adjusted EBITDA: 
(i) as factors in evaluating management’s performance when determining incentive compensation, (ii) to evaluate the 
effectiveness of our business strategies and (iii) because our credit agreement and the indentures governing the 2013 
Notes and 2014 Notes use measures similar to EBITDA to measure our compliance with certain covenants.

The following table provides our EBITDA and Adjusted EBITDA for the periods presented, as well as a reconciliation 
to net earnings: 

Years Ended December 31,

(In thousands)
Net (loss) earnings
Interest expense, net 1
Income tax provision (benefit)
Depreciation and amortization expense

EBITDA

Directors' equity-based compensation expense
Costs associated with Thomaston facility closure
Costs associated with Long Island facility closure
Costs/loss associated with optimization and sale of the specialty mills
Loss on impairment of Clearwater Fiber intangible asset
Expenses associated with Metso Litigation
Loss on sale of foam assets

Adjusted EBITDA

$

2013

2012

2014
(2,315) $ 106,955 $ 64,131
33,796
61,094
63,570
47,460
(68,721)
18,556
79,333
90,272
90,145
$ 169,956 $ 189,600 $ 224,720
1,369
—
—
—
—
2,019
1,014
$ 238,511 $ 199,661 $ 229,122

4,606
1,257
18,813
40,801
3,078
—
—

4,084
5,977
—
—
—
—
—

1 

Interest expense, net for the years ended December 31, 2014 and 2013 includes debt retirement costs of $24.4 million and $17.1 million, 
respectively.

32

LIQUIDITY AND CAPITAL RESOURCES

The following table presents information regarding our cash flows for the years ended December 31, 2014, 2013 and 
2012.

Cash Flows Summary 

(In thousands)
Net cash flows from operating activities
Net cash flows from investing activities
Net cash flows from financing activities

Years Ended December 31,

2014
139,100 $

$

35,687
(171,131)

2013
136,357 $
(140,593)
15,332

2012
198,693
(177,004)
(17,549)

Operating Activities—Net cash flows from operating activities for 2014 increased by $2.7 million compared to 2013. 
The slight improvement was largely due to higher earnings, after adjusting for noncash related items, which increased 
$5.9 million compared to 2013, as well as a $2.8 million decrease in cash flows used for working capital. The decrease 
in cash flows used for working capital were driven primarily by a year-end increase in inventories beyond our normal 
cyclical amounts, which resulted from labor slowdowns at West Coast shipping ports, partially offset by a decrease in 
accounts receivable due primarily to the timing of sales collections, and slightly higher accounts payable and accrued 
liabilities driven by process improvements to our capital management. These improvements were partially offset by a 
$1.9 million increase in contributions to our qualified pension plans in 2014 compared to 2013.

Net cash flows from operating activities for 2013 decreased $62.3 million compared to 2012 due primarily to $15.0 
million of cash used in working capital during the year, compared to $61.3 million of cash flows generated from working 
capital in 2012. The decrease in working capital was primarily attributable to a build-up in inventory to support our TAD 
tissue program, partially offset by higher accounts payable and accrued liabilities and increased accrued interest due 
to the timing of interest payments on our 2013 Notes. In addition, operating cash flows decreased due to lower net 
earnings, after adjusting for noncash related items. Included in our noncash adjustments to net earnings was a $75.3 
million reduction of tax reserves largely related to our decision to release certain tax reserves based on the Internal 
Revenue Service's ruling on the taxability of the Alternative Fuel Mixture Tax Credit. These decreases were partially 
offset by a $21.2 million favorable change in cash flows from taxes receivable, an absence of excess tax benefits used 
in 2013 compared to $15.8 million for 2012, which was a result of performance shares for the 2011-2013 performance 
period not being paid or issued because the requisite market condition performance measure was not met, and a $5.6 
million decrease in contributions to our qualified pension plans in 2013 compared to 2012. 

Investing Activities—Net cash flows from investing activities increased $176.3 million in 2014, compared to 2013. The 
primary increase in cash flows from investing activities was largely due to $107.7 million of net cash proceeds from 
divested assets, which relates to the sale of our specialty business and mills. Investing cash flows also increased due 
to $20.0 million of cash provided by the conversion of short-term investments into cash during 2014, as compared to 
$50.0 million of cash converted into short-term investments in 2013. Cash spent for plant and equipment was $93.0 
million in 2014, compared to $90.6 million in 2013.

Net cash flows used for investing activities decreased $36.4 million in 2013 compared to 2012. The decrease in cash 
used for investing activities was largely due to a $113.2 million decrease in capital spending for plant and equipment 
in 2013 compared to 2012. The lower capital spending was due to the substantial completion in 2012 of our North 
Carolina TAD tissue facility. The decrease in cash used for investing activities was partially offset by $50.0 million of 
cash converted into short-term investments in 2013, compared to $35.0 million provided by the conversion of short-
term investments into cash during 2012.

Financing Activities—Net cash flows used for financing activities were $171.1 million for 2014, and were largely driven 
by the completion of our 2014 $100 million stock repurchase program, as well as a $75.0 million decrease in long-
term debt associated with the issuance of the 2014 Notes and retirement of the 2010 Notes. 

Net cash flows from financing activities were $15.3 million in 2013, compared to $17.5 million of cash flows used in 
financing activities in 2012. Cash flows from financing activities during 2013 were the result of the issuance of the 2013 
Notes,  partially  offset  by  the  retirement  of  the  2009  Notes  and  $100.0  million  associated  with  repurchases  of  our 
outstanding common stock pursuant to our 2013 $100 million stock repurchase program, which was completed in 
October 2013.

33

 
Capital Resources

Due to the competitive and cyclical nature of the markets in which we operate, as well as an uncertain economic 
environment, there is uncertainty regarding the amount of cash flows we will generate during the next twelve months. 
However, we believe that our cash flows from operations, cash on hand, short-term investments and available borrowing 
capacity under our credit facility will be adequate to fund debt service requirements and provide cash required to 
support our ongoing operations, capital expenditures, stock repurchase program and working capital needs for the 
next twelve months.

We may choose to refinance all or a portion of our indebtedness on or before maturity. We cannot be certain that we 
will be able to refinance any of our indebtedness on commercially reasonable terms or at all. As of December 31, 2014, 
our short-term investments were not restricted and were largely invested in demand deposits.

At  December 31,  2014,  our  financial  position  included  debt  of  $575.0  million,  compared  to  $650.0  million  at 
December 31, 2013. Stockholders’ equity at December 31, 2014 was $497.5 million, compared to the December 31, 
2013 balance of $605.1 million. Our total debt to total capitalization, excluding accumulated other comprehensive loss, 
was 50.3% at December 31, 2014, compared to 49.5% at December 31, 2013. 

On July 29, 2014 we issued the 2014 Notes, of which we received net proceeds of approximately $298 million after 
deducting offering expenses. We used proceeds from the issuance along with company funds and a draw from our 
senior secured revolving credit facility during the third quarter of 2014 to redeem all of the 2010 Notes. During the 
fourth quarter of 2014, we utilized proceeds from the sale of our specialty business and mills to pay off the remaining 
credit facility balance.  

In 2013, we issued the 2013 Notes, of which we received net proceeds of approximately $271 million after deducting 
offering expenses. We used approximately $166 million of the net proceeds to redeem all of our outstanding 2009 
Notes,  and  used  approximately  $100  million  of  the  remaining  net  proceeds  to  purchase  shares  of  the  company's 
common stock pursuant to our $100 million stock repurchase program authorized in January 2013.

Debt Arrangements

Issuance of $300 Million Senior Notes Due 2025 and Redemption of $375 Million Senior Notes Due 2018

On July 29, 2014, we issued the 2014 Notes, which mature on February 1, 2025, have an interest rate of 5.375% and 
were issued at their face value. The issuance of these notes generated net proceeds of approximately $298 million 
after deducting offering expenses. We redeemed all of our 2010 Notes using the net proceeds from the 2014 Notes 
along with company funds and a draw from our senior secured revolving credit facility during the third quarter of 2014. 

The 2010 Notes had a maturity date of November 1, 2018, and an interest rate of 7.125%. On August 28, 2014, we 
redeemed all of the 2010 Notes at a redemption price equal to 100% of the principal amount of $375 million and a 
“make whole” premium of $17.6 million plus accrued and unpaid interest of $8.7 million, for an aggregate amount of 
$401.3 million.

The 2014 Notes are guaranteed by all of our direct and indirect domestic subsidiaries. The 2014 Notes will also be 
guaranteed by each of our future direct and indirect domestic subsidiaries that do not constitute an immaterial subsidiary 
under the indenture governing the 2014 Notes. The 2014 Notes are equal in right of payment with all other existing 
and future unsecured senior indebtedness and are senior in right of payment to any future subordinated indebtedness. 
The 2014 Notes are effectively subordinated to all of our existing and future secured indebtedness, including borrowings 
under our secured revolving credit facility, which is secured by certain of our accounts receivable, inventory and cash. 
The terms of the 2014 Notes limit our ability and the ability of any restricted subsidiaries to incur certain liens, engage 
in sale and leaseback transactions and consolidate, merge with, or convey, transfer or lease substantially all of our or 
their assets to another person.

We may, on any one or more occasions, redeem all or a part of the 2014 Notes, upon not less than 30 days nor more 
than 60 days notice, at a redemption price equal to 100% of the principal amount of the 2014 Notes redeemed, plus 
the applicable premium as of, and accrued and unpaid interest, if any, to the date of redemption. Unless we default in 
the payment of the redemption price, interest will cease to accrue on the 2014 Notes or portions thereof called for 
redemption on the applicable redemption date. In addition, we may be required to make an offer to purchase the 2014 
Notes upon the sale of certain assets and upon a change of control.

Our 2015 expected debt service obligation related to the 2014 Notes, consisting of cash payments for interest, is $16.2 
million.

34

$275 Million Senior Notes Due 2023

In June 2009, we issued the 2009 Notes, in the aggregate principal amount of $150 million. The 2009 Notes, which 
were due on June 15, 2016 and had an interest rate of 10.625%, were issued at a price equal to 98.792% of their face 
value.

On  February 22,  2013,  we  exercised  our  option  to  redeem  all  of  the  2009  Notes  at  a  redemption  price  equal  to 
approximately $166 million, which consisted of 100% of the principal amount, plus an approximate $13 million “make 
whole” premium and accrued and unpaid interest of approximately $3 million. Proceeds to fund the redemption of our 
2009 Notes were made available through the sale of the 2013 Notes. The 2013 Notes mature on February 1, 2023, 
have an interest rate of 4.5% and were issued at their face value. 

The 2013 Notes are guaranteed by our existing and future direct and indirect domestic subsidiaries, are equal in right 
of payment with all other existing and future unsecured senior indebtedness, and are senior in right of payment to any 
future subordinated indebtedness. The 2013 Notes are effectively subordinated to all of our existing and future secured 
indebtedness,  including  borrowings  under  our  secured  revolving  credit  facility,  which  is  secured  by  certain  of  our 
accounts receivable, inventory and cash. The terms of the 2013 Notes limit our ability and the ability of any restricted 
subsidiaries to borrow money; pay dividends; redeem or repurchase capital stock; make investments; sell assets; 
create restrictions on the payment of dividends or other amounts to us from any restricted subsidiaries; enter into 
transactions with affiliates; enter into sale and lease back transactions; create liens; and consolidate, merge or sell all 
or substantially all of our assets.

Prior to February 1, 2016, we may redeem up to 35% of the 2013 Notes at a redemption price equal to 104.5% of the 
principal amount plus accrued and unpaid interest with the proceeds from one or more qualified equity offerings.  We 
have the option to redeem all or a portion of the 2013 Notes at any time before February 1, 2018 at a redemption price 
equal to 100% of the principal amount plus accrued and unpaid interest and a “make whole” premium.  On or after 
February 1, 2018, we may redeem all or a portion of the 2013 Notes at specified redemption prices plus accrued and 
unpaid interest. In addition, we may be required to make an offer to purchase the 2013 Notes upon the sale of certain 
assets and upon a change of control.

Our 2015 expected debt service obligation related to the 2013 Notes, consisting of cash payments for interest, is $12.4 
million.

Revolving Credit Facility

In  November 2008,  we  entered  into  a  $125  million  senior  secured  revolving  credit  facility  with  certain  financial 
institutions. The amount available to us under the revolving credit facility is based on the lesser of 85% of our eligible 
accounts receivable plus approximately 65% of our eligible inventory, or $125 million. The revolving credit facility has 
been subsequently amended and expires on September 30, 2016.

As of December 31, 2014, there were no borrowings outstanding under the credit facility, but $7.8 million of the credit 
facility was being used to support outstanding standby letters of credit. Loans under the credit facility bear interest (i) 
for LIBOR loans, LIBOR plus between 1.75% and 2.25%  and (ii) for base rate loans, a per annum rate equal to the 
greater of (a) the prime rate for such day; (b) the federal funds effective rate for such day, plus 0.50%; or (c) LIBOR 
for a 30-day interest period as determined on such day, plus between 1.25% and 1.75%. The percentage margin on 
all loans is based on our fixed charge coverage ratio for the most recent four quarters. As of December 31, 2014, we 
would have been permitted to draw $117.2 million under the credit facility at LIBOR plus 1.75%, or base rate plus 
1.25%.

A  minimum  fixed  charge  coverage  ratio  is  the  only  financial  covenant  requirement  under  our  credit  facility  and  is 
triggered when there are any commitments or obligations outstanding and availability falls below 12.5% or an event 
of default exists, at which time the minimum fixed charge coverage ratio must be at least 1.0-to-1.0. As of December 31, 
2014, the fixed charge coverage ratio for the most recent four quarters was 1.1-to-1.0.

Our obligations under the revolving credit facility are secured by certain of our accounts receivable, inventory and 
cash. The terms of the credit facility contain various provisions that limit our discretion in the operations of our business 
by restricting our ability to, among other things, pay dividends; redeem or repurchase capital stock; create, incur or 
guarantee  certain  debt;  incur  liens  on  certain  properties;  make  capital  expenditures;  enter  into  certain  affiliate 
transactions; enter into certain hedging arrangements; and consolidate with or merge with another entity. The revolving 
credit facility contains usual and customary affirmative and negative covenants and usual and customary events of 
default.

35

CONTRACTUAL OBLIGATIONS

The following table summarizes our contractual obligations as of December 31, 2014. Portions of the amounts shown 
are reflected in our financial statements and accompanying notes, as required by GAAP. See the footnotes following 
the table for information regarding the amounts presented and for references to relevant financial statement notes that 
include a detailed discussion of the item.

Payments Due by Period

(In thousands)
Long-term debt1
Interest on long-term debt1
Capital leases2
Operating leases2
Purchase obligations3
Other obligations4,5
Total

$

Total
575,000 $
274,591
45,289
53,303
358,469
244,705
$ 1,551,357 $

Less
Than 1 Year

1-3 Years

3-5 Years

— $

— $

— $

28,590
2,530
14,588
270,787
122,333
438,828 $

57,000
5,199
21,568
82,354
27,473

193,594 $

57,000
5,367
9,644
5,328
16,261
93,600 $

More Than
5 Years
575,000
132,001
32,193
7,503
—
78,638
825,335

1  

2  

3  

4   

5  

Included above are the principal and interest payments that were due on our 2013 and 2014 Notes, which were outstanding as of December 
31, 2014. For more information regarding specific terms of our long-term debt, see the discussion under the heading “Debt Arrangements,” 
and Note 10, “Debt,” in the notes to the consolidated financial statements. 

These amounts represent our minimum capital lease payments, including amounts representing interest, and our minimum operating lease 
payments. See Note 17, “Commitments and Contingencies,” in the notes to the consolidated financial statements. 

Purchase obligations consist primarily of contracts for the purchase of raw materials (primarily pulp) from third parties, trade accounts payable 
as of December 31, 2014, and contracts with natural gas and electricity providers. 

Included  in  other  obligations  are  accrued  liabilities  and  accounts  payable  (other  than  trade  accounts  payable)  as  of  December 31,  2014, 
liabilities associated with supplemental pension and deferred compensation arrangements, and estimated payments on qualified pension and 
postretirement employee benefit plans. Since pension contributions are determined by factors that are subject to change each year, estimated 
payments on qualified pension plans included above are only for years 1-5 and are based on current estimates of minimum required contributions. 

Total excludes $2.7 million of unrecognized tax benefits due to the uncertainty of timing of payment. See Note 8, “Income Taxes,” in the notes 
to the consolidated financial statements. 

OFF-BALANCE SHEET ARRANGEMENTS

We have no off-balance sheet arrangements that have had, or are reasonably likely to have, a material current or 
future effect on our financial conditions or consolidated financial statements.

ENVIRONMENTAL

Our operating facilities are subject to rigorous federal and state environmental regulation governing air emissions, 
wastewater  discharges,  and  solid  and  hazardous  waste  management.  Our  goal  is  continuous  compliance  with  all 
environmental regulations and we regularly monitor our activities to ensure compliance with all pertinent rules and 
requirements. Compliance with environmental regulations is a significant factor in our business and requires periodic 
capital expenditures as well as additional operating costs as rules change.

The  new  federal  standard  for  hazardous  air  pollutants  from  boiler  and  process  heaters  was  finalized  by  the  U.S. 
Environmental Protection Agency, or EPA, and became effective in 2013. Our Lewiston, Idaho facility will require a 
significant capital expenditure to comply with this rule. Total cost estimates for the required compliance expenditure 
is expected to be between approximately $5 million and $7 million, with approximately $2 million of that amount to be 
incurred in 2015 and the remainder split between 2016 and 2017. We expect no technical issues with meeting the 
new rule.

Concern over climate change, including the impact of global warming, may lead to future regulations. We believe there 
are no U.S. rules currently proposed that would have a material impact on our operations.

In 2012, we received notification of alleged Clean Air Act violations at our Lewiston facility. We have entered into a 
tolling agreement and are negotiating with the U.S. Department of Justice and EPA to resolve these alleged violations. 
These negotiations have continued into 2015.

36

 
The recovery boiler at our Cypress Bend, Arkansas facility has been experiencing ongoing operational and related 
environmental compliance issues associated with a 2013 upgrade project. A capital project to correct these issues is 
slated for April 2015 and is expected to cost approximately $5 million. We expect to enter into a consent administrative 
order with the State of Arkansas in 2015 to resolve the compliance issues associated with the recovery boiler. Penalties, 
if any, associated with this settlement have not been proposed by the State.

Our facilities are currently in substantial compliance with applicable environmental laws and regulations. We cannot 
be certain, however, that situations that may give rise to material environmental liabilities will not be discovered or that 
the enactment of new environmental laws or regulations or changes in existing laws or regulations will not require 
significant expenditures by us.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The  preparation  of  financial  statements  in  accordance  with  GAAP  requires  our  management  to  select  and  apply 
accounting  policies  that  best  provide  the  framework  to  report  the  results  of  operations  and  financial  position. The 
selection and application of those policies requires management to make difficult, subjective and complex judgments 
concerning reported amounts of revenue and expenses during the reporting period and the reported amounts of assets 
and liabilities at the date of the financial statements. As a result, it is possible that materially different amounts would 
be reported under different conditions or using different assumptions.

See  Note  3,  “Recently Adopted  and  Prospective Accounting  Standards”  to  the  consolidated  financial  statements 
included in Item 8 of this Annual Report on Form 10-K for additional information regarding recently adopted and new 
accounting pronouncements.

Goodwill. Our acquisitions are accounted for using the purchase method of accounting as prescribed by applicable 
accounting guidance. In accordance with the accounting guidance, we revalued the assets and liabilities acquired at 
their respective fair values on the acquisition date. Changes in assumptions and estimates during the allocation period 
affecting the acquisition date fair value of acquired assets and liabilities would result in changes to the recorded values, 
resulting in an offsetting change to the goodwill balance associated with the business acquired. Significant changes 
in assumptions and estimates subsequent to completing the allocation of purchase price to the assets and liabilities 
acquired, as well as differences in actual results versus estimates, could have a material impact on our earnings.

Goodwill from an acquisition represents the excess of the cost of a business acquired over the net of the amounts 
assigned to assets acquired, including identifiable intangible assets and liabilities assumed. As a result of our Cellu 
Tissue acquisition, we recorded  $229.5 million of goodwill on our Consolidated Balance Sheet as of December 31, 
2010, which was all assigned to our Consumer Products reporting unit. As a result of our December 30, 2014 sale of 
our specialty business and mills, a portion of goodwill was allocated to the divested mills and included in our loss on 
divested assets on our Consolidated Statement of Operations. As of December 31, 2014, we had $209.1 million of 
goodwill included on our Consolidated Balance Sheet. Goodwill is not amortized but tested for impairment annually 
each November 1st and at any time when events suggest impairment may have occurred. When required, our goodwill 
impairment test is performed by comparing the fair value of the Consumer Products reporting unit to its carrying value. 
We incorporate assumptions involving future growth rates, discount rates and tax rates in projecting the future cash 
flows. In the event the carrying value exceeds the fair value of the reporting unit, an impairment loss would be recognized 
to the extent the carrying amount of the reporting unit’s goodwill exceeds its implied fair value.

Long-lived assets. A significant portion of our total assets are invested in our manufacturing facilities. Also, the cyclical 
patterns of our businesses cause cash flows to fluctuate by varying degrees from period to period. As a result, long-
lived assets are a material component of our financial position, with the potential for material change in valuation if 
assets are determined to be impaired. Accounting guidance requires that long-lived assets be reviewed for impairment 
whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not 
be recoverable, as measured by its undiscounted estimated future cash flows.

We use our operational budgets to estimate future cash flows. Budgets are inherently uncertain estimates of future 
performance due to the fact that all inputs, including net sales, costs and capital spending, are subject to frequent 
change for many different reasons. Because of the number of variables involved, the interrelationship between the 
variables and the long-term nature of the impairment measurement, sensitivity analysis of individual variables is not 
practical.  Budget  estimates  are  adjusted  periodically  to  reflect  changing  business  conditions,  and  operations  are 
reviewed, as appropriate, for impairment using the most current data available.

We believe we have adequate support for the carrying value of all of our long-lived assets based on anticipated cash 
flows that will result from our estimates of future demand, pricing, and production costs, assuming certain levels of 
capital expenditures.

37

Pension and postretirement employee benefits. The determination of pension plan expense and the requirements 
for funding our pension plans are based on a number of actuarial assumptions. Three critical assumptions are the 
discount  rate  applied  to  pension  plan  obligations,  the  rate  of  return  on  plan  assets  and  mortality  rates.  For  other 
postretirement employee benefit, or OPEB, plans, which provide certain health care and life insurance benefits to 
qualified retired employees, critical assumptions in determining OPEB expense are the discount rate applied to benefit 
obligations, the assumed health care cost trend rates used in the calculation of benefit obligations and mortality rates.

Note 13, "Savings, Pension and Other Postretirement Employee Benefit Plans," to our consolidated financial statements 
includes information for the three years ended December 31, 2014, 2013 and 2012, on the components of pension 
and OPEB expense and the underlying actuarial assumptions used to calculate periodic expense, as well as the funded 
status for our pension and OPEB plans as of December 31, 2014 and 2013.

The discount rate used in the determination of pension benefit obligations and pension expense is determined based 
on a review of long-term high-grade bonds and management’s expectations. At December 31, 2014, we calculated 
obligations using a 4.25% discount rate. The discount rates used at December 31, 2013 and 2012 were 5.20% and 
4.15%, respectively. To determine the expected long-term rate of return on pension assets, we employ a process that 
analyzes historical long-term returns for various investment categories, as measured by appropriate indices. These 
indices are weighted based upon the extent to which plan assets are invested in the particular categories in arriving 
at  our  determination  of  a  composite  expected  return.  The  long-term  rates  of  return  used  for  the  years  ended 
December 31, 2014, 2013 and 2012 were 7.50%, 7.50% and 8.00%, respectively.

Total periodic pension plan expense in 2014 was $6.3 million. An increase in the discount rate or the rate of expected 
return  on  plan  assets,  all  other  assumptions  remaining  the  same,  would  decrease  pension  plan  expense,  and 
conversely, a decrease in either of these measures would increase plan expense. As an indication of the sensitivity 
that pension expense has to the discount rate assumption, a 25 basis point change in the discount rate would affect 
annual plan expense by approximately $0.5 million. A 25 basis point change in the assumption for expected return on 
plan assets would affect annual plan expense by approximately $0.7 million. The actual rates of return on plan assets 
may vary significantly from the assumptions used because of unanticipated changes in financial markets.

Our company-sponsored pension plans were underfunded by a net $16.9 million at December 31, 2014 and $6.8 
million at December 31, 2013. As a result of being underfunded, we may be required to make contributions to our 
qualified pension plans. In 2014, we contributed $17.0 million to these pension plans. We also contributed $0.5 million 
to our non-qualified pension plan in 2014. Our cash contributions in 2015 are estimated to be approximately $12 million.

For our OPEB plans, expense for 2014 was $2.6 million. We do not anticipate funding our OPEB plans in 2015 except 
to  pay  benefit  costs  as  incurred  during  the  year  by  plan  participants. The  discount  rates  used  to  calculate  OPEB 
obligations, which was determined using the same methodology we used for our pension plans, were 4.15%, 5.05% 
and 4.05% at December 31, 2014, 2013 and 2012, respectively. The assumed health care cost trend rate used to 
calculate OPEB obligations and expense was 6.30% in 2014, grading to a range of 4.30% to 4.50% over approximately 
70 years.

As an indication of the sensitivity that OPEB expense has to the discount rate assumption, a 25 basis point change 
in the discount rate would affect plan expense by approximately $0.1 million. A 1% change in the assumption for health 
care cost trend rates would have affected 2014 plan expense by approximately $0.4 million to $0.5 million and the 
total postretirement employee obligation by approximately $8.7 million to $10.3 million. The actual rates of health care 
cost increases may vary significantly from the assumption used because of unanticipated changes in health care costs.

Periodic pension and OPEB expenses are included in “Cost of sales” and “Selling, general and administrative expenses” 
in the Consolidated Statements of Operations. The expense is allocated to all business segments. In accordance with 
current accounting guidance governing defined benefit pension and other postretirement plans, at December 31, 2014 
and 2013, long-term assets are recorded for overfunded plans and liabilities are recorded for underfunded plans. The 
funded status of a benefit plan is measured as the difference between plan assets at fair value and the projected 
benefit obligation. For underfunded plans, the estimated liability to be payable in the next twelve months is recorded 
as a current liability, with the remaining portion recorded as a long-term liability.

Effective December 15, 2010, the salaried pension plan was closed to new entrants and after December 31, 2011, it 
was frozen and ceased accruing further benefits.

38

Income taxes. The conclusion that deferred tax assets are realizable is subject to certain assessments, projections 
and judgments made by management. In assessing whether deferred tax assets are realizable, the standard we use 
is whether it is more likely than not that some or all of the deferred tax assets will not be realized. The ultimate realization 
of deferred tax assets depends on the generation of future taxable income during the periods in which those temporary 
differences  are  deductible.  We  consider  the  scheduled  reversal  of  deferred  tax  liabilities  (including  the  impact  of 
available carryforward periods), projected taxable income, and amounts of taxable income we would have generated 
historically if we had been a stand-alone company in making this assessment. In order to fully realize the deferred tax 
asset, we will need to generate future taxable income before the expiration of the deferred tax assets governed by the 
tax code.

Based on existing deferred tax liabilities and projected taxable income over the periods for which the deferred tax 
assets are deductible, we believe that it is more likely than not that we will realize the benefits of these future deductible 
differences, excluding items for which we have already recorded a valuation allowance. The amount of the deferred 
tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income 
during the carryforward period are reduced.

We have tax jurisdictions located in many areas of the United States and are subject to audit in these jurisdictions. 
Tax  audits  by  their  nature  are  often  complex  and  can  require  several  years  to  resolve.  In  the  preparation  of  our 
consolidated financial statements, management exercises judgment in estimating the potential exposure to unresolved 
tax matters and applies the guidance pursuant to uncertain tax positions which employs a more likely than not criteria 
approach for recording tax benefits related to uncertain tax positions. While actual results could vary, in management's 
judgment, we have adequate tax accruals with respect to the ultimate outcome of such unresolved tax matters.

ITEM 7A.
Quantitative and Qualitative Disclosures About Market Risks

Interest Rate Risk

Our exposure to market risks on financial instruments includes interest rate risk on our secured revolving credit facility. 
As of December 31, 2014, there were no borrowings outstanding under our revolving credit facility. The interest rates 
applied to borrowings under the credit facility are adjusted often and therefore react quickly to any movement in the 
general trend of market interest rates. For example, a one percentage point increase or decrease in interest rates, 
based on assumed outstanding credit facility borrowings of $10.0 million, would have a $0.1 million annual effect on 
interest expense. We currently do not attempt to mitigate the effects of short-term interest rate fluctuations on our 
credit facility borrowings through the use of derivative financial instruments.

Commodity Risk

We are exposed to market risk for changes in natural gas commodity pricing, which we have, from time-to-time, partially 
mitigated through the use of firm price contracts for a portion of the natural gas requirements of our manufacturing 
facilities. As of December 31, 2014, these contracts covered approximately 57% of the expected average monthly 
requirements for 2015, including approximately 67% of the expected average monthly requirements for the first quarter.

Foreign Currency Risk

We have minimal foreign currency exchange risk. Virtually all of our international sales are denominated in U.S. dollars. 

Quantitative Information about Market Risks

(Dollars in thousands)
Long-term debt:
Fixed rate
Average interest rate

Fair value at December 31,
2014

2015

2016

2017

2018

2019

Thereafter

Total      

Expected Maturity Date

$ — $ — $ — $ — $

—%

—%

—%

—%

— $ 575,000
—%

4.957%

$ 575,000

4.957%

$ 558,000

39

 
ITEM 8.
Financial Statements and Supplementary Data

Index to Consolidated Financial Statements

Consolidated Statements of Operations for the years ended December 31, 2014, 2013 and 2012

Consolidated Statements of Comprehensive (Loss) Income for the years ended December 31, 2014,
  2013 and 2012

Consolidated Balance Sheets at December 31, 2014 and 2013

Consolidated Statements of Cash Flows for the years ended December 31, 2014, 2013 and 2012

Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2014, 2013
  and 2012

Notes to Consolidated Financial Statements

Reports of Independent Registered Public Accounting Firm

Financial Statement Schedules:

All schedules have been omitted because the required information is not present or is not present in 
amounts sufficient to require submission of the schedule, or because the information required is included 
in the consolidated financial statements, including the notes thereto.

PAGE
NUMBER

41

42

43

44

45

46-81

82-83

40

  
CLEARWATER PAPER CORPORATION
Consolidated Statements of Operations
(Dollars in thousands – except per-share amounts) 

Net sales

Costs and expenses:

Cost of sales

Selling, general and administrative expenses

Loss on divested assets

Impairment of assets

Total operating costs and expenses

Income from operations

Interest expense, net

Debt retirement costs

Earnings before income taxes

Income tax (provision) benefit

Net (loss) earnings

Net (loss) earnings per common share:

Basic

Diluted

The accompanying notes are an integral part of these consolidated financial statements.

For The Years Ended December 31,

2014

2013

2012

$ 1,967,139 $ 1,889,830 $ 1,874,304

(1,708,840)

(1,671,371)

(1,607,872)

(130,102)

(119,131)

(121,045)

(40,159)

(8,227)

—

—

—

—

(1,887,328)

(1,790,502)

(1,728,917)

79,811

(39,150)

(24,420)

16,241

(18,556)

99,328

(44,036)

(17,058)

38,234

68,721

145,387

(33,796)

—

111,591

(47,460)

(2,315) $

106,955 $

64,131

(0.11) $

4.84 $

(0.11)

4.80

2.75

2.72

$

$

41

 
  
CLEARWATER PAPER CORPORATION
Consolidated Statements of Comprehensive (Loss) Income
(In thousands)

Net (loss) earnings

Other comprehensive (loss) income, net of tax:

Defined benefit pension and other postretirement employee benefits:

Net (loss) gain arising during the period, net of tax
  of $(15,103), $32,346, and $(6,359)

Curtailments, net of tax of $ - , $298, and $188
Prior service credit (cost) arising during the period, net of
  tax of $3,278, $(1,976), and $2,079

Amortization of actuarial loss included in net periodic cost,
  net of tax of $3,836, $5,742, and $4,761

Amortization of prior service credit included in net
  periodic cost, net of tax of $(772), $(64), and $(806)

For The Years Ended December 31,

2014

2013

2012

$

(2,315) $

106,955 $

64,131

(23,523)

—

51,262

471

(9,780)

289

5,106

(3,130)

3,199

5,975

9,098

7,324

(1,202)

(101)

(1,240)

Amortization of deferred taxes related to actuarial gain on other
  postretirement employee benefit obligations

Foreign currency translation amounts reclassified from accumulated
  other comprehensive loss

—

874

—

—

Other comprehensive (loss) income, net of tax

(12,770)

57,600

(220)

—

(428)

Comprehensive (loss) income

$

(15,085) $

164,555 $

63,703

The accompanying notes are an integral part of these consolidated financial statements.

42

 
  
CLEARWATER PAPER CORPORATION
Consolidated Balance Sheets
(Dollars in thousands – except share data)

ASSETS

Current assets:

Cash

Restricted cash

Short-term investments

Receivables, net

Taxes receivable

Inventories

Deferred tax assets

Prepaid expenses

Total current assets

Property, plant and equipment, net

Goodwill

Intangible assets, net

Pension assets

Other assets, net

TOTAL ASSETS

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable and accrued liabilities

Current liability for pensions and other postretirement employee benefits

Total current liabilities

Long-term debt

Liability for pensions and other postretirement employee benefits

Other long-term obligations

Accrued taxes
Deferred tax liabilities
Stockholders’ equity:

Preferred stock, par value $0.0001 per share, 5,000,000 authorized shares,
  no shares issued
Common stock, par value $0.0001 per share, 100,000,000 authorized
  shares-24,056,057 and 24,007,581 shares issued
Additional paid-in capital
Retained earnings
Treasury stock, at cost, common shares–4,498,388 and 2,923,640
  shares repurchased

Accumulated other comprehensive loss, net of tax

Total stockholders’ equity

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

The accompanying notes are an integral part of these consolidated financial statements.

43

At December 31,

2014

2013

$

27,331 $

23,675

1,500

50,000

133,914

1,255

286,626

21,760

4,191

526,577

810,987

209,087

24,956

4,738

9,583

1,500

70,000

158,874

10,503

267,788

37,538

5,523

575,401

884,698

229,533

40,778

4,488

9,927

$1,585,928 $1,744,825

$ 215,826 $ 190,648

7,915

223,741

575,000

118,464

56,856

2,696

8,778

199,426

650,000

109,807

52,942

2,658

111,634

124,898

—

2

—

2

334,074

464,324

326,546

466,639

(230,000)

(130,000)

(70,863)

(58,093)

497,537

605,094

$1,585,928 $1,744,825

 
 
  
CLEARWATER PAPER CORPORATION
Consolidated Statements of Cash Flows
(In thousands)

CASH FLOWS FROM OPERATING ACTIVITIES

Net (loss) earnings
Adjustments to reconcile net (loss) earnings to net cash flows from
  operating activities:

Depreciation and amortization
Equity-based compensation expense
Impairment of assets
Deferred tax provision
Employee benefit plans
Deferred issuance costs and discounts on long-term debt
Loss on divestiture of assets
Disposal of plant and equipment, net
Non-cash adjustments to unrecognized taxes

Changes in working capital, net
Change in taxes receivable, net
Excess tax benefits from equity-based payment arrangements
Change in non-current accrued taxes, net
Funding of qualified pension plans
Other, net
Net cash flows from operating activities
CASH FLOWS FROM INVESTING ACTIVITIES

Change in short-term investments, net
Additions to plant and equipment
Net proceeds from divested assets
Proceeds from sale of assets
Cash paid for acquisitions, net of cash acquired
Net cash flows from investing activities
CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from long-term debt
Repayment of long-term debt
Purchase of treasury stock
Payments for long-term debt issuance costs
Payment of tax withholdings on equity-based payment arrangements
Excess tax benefits from equity-based payment arrangements
Other, net
Net cash flows from financing activities
Increase in cash
Cash at beginning of period
Cash at end of period
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

Cash paid for interest, net of amounts capitalized
Cash paid for income taxes
Cash received from income tax refunds
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING ACTIVITIES:

Changes in accrued plant and equipment
Property acquired under capital lease

The accompanying notes are an integral part of these consolidated financial statements.

44

$

$

$

For The Years Ended December 31,

2014

2013

2012

$

(2,315) $

106,955

$

64,131

90,145
12,790
8,227
13,813
2,115
6,141
29,059
959
38
(12,248)
9,248
(864)
290
(16,955)
(1,343)
139,100

20,000
(93,028)
107,740
975
—
35,687

300,000
(375,000)
(100,000)
(3,002)
(1,523)
864
7,530
(171,131)
3,656
23,675
27,331

34,418
6,851
11,867

6,187
385

$

$

$

90,272
10,960
—
5,629
10,131
4,964
—
1,493
(75,308)
(15,022)
10,325
—
569
(15,050)
439
136,357

(50,000)
(90,593)
—
—
—
(140,593)

275,000
(150,000)
(100,000)
(4,837)
(4,831)
—
—
15,332
11,096
12,579
23,675

36,147
3,256
1,577

$

$

79,333
9,703
—
12,870
9,366
2,010
—
2,003
3,275
61,281
(10,828)
(15,837)
960
(20,627)
1,053
198,693

35,001
(203,776)
—
1,035
(9,264)
(177,004)

—
—
(18,650)
(2)
(13,234)
15,837
(1,500)
(17,549)
4,140
8,439
12,579

30,086
18,719
2,220

(4,085) $
—

3,339
—

 
  
CLEARWATER PAPER CORPORATION
Consolidated Statements of Stockholders’ Equity
(In thousands)

Common Stock

Shares

Amount

Additional
Paid-In
Capital

Retained
Earnings

Treasury Stock

Shares

Amount

Accumulated
Other
Comprehensive
(Loss) Income

Total
Stockholders'
Equity

Balance, December 31,
2011

23,102

$

Net earnings

Performance share and
  restricted stock unit
  awards

Pension and OPEB, net
  of tax of $(137)

Amortization of
  deferred taxes related
  to actuarial gain on
  other postretirement
  employee benefit
  obligations

Purchase of treasury
  stock

—

739

—

—

—

Balance, December 31,
2012

23,841

$

Net earnings

Performance share and
  restricted stock unit
  awards

Pension and OPEB, net
  of tax of $36,346

Purchase of treasury
  stock

—

167

—

—

Balance, December 31,
2013

24,008

$

—

48

—

—

Net (loss) earnings

Performance share and
  restricted stock unit
  awards

Pension and OPEB, net
  of tax of $8,761

Purchase of treasury
  stock

Foreign currency 
  translation amounts
  reclassified from
  accumulated other
  comprehensive loss

Balance, December 31,
2014

2

—

—

—

—

—

2

—

—

—

—

2

—

—

—

—

$ 315,964

$

295,553

(333) $

(11,350) $

(115,265) $

484,904

—

64,131

10,937

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

64,131

10,937

(208)

(208)

(220)

(220)

(520)

(18,650)

—

(18,650)

$ 326,901

$

359,684

(853) $

(30,000) $

(115,693) $

540,894

—

106,955

(355)

—

—

—

—

—

—

—

—

—

—

—

—

—

106,955

(355)

57,600

57,600

(2,071)

(100,000)

—

(100,000)

$ 326,546

$

466,639

(2,924) $ (130,000) $

(58,093) $

605,094

—

(2,315)

—

—

—

—

—

—

—

—

(2,315)

7,528

(13,644)

(13,644)

(1,574)

(100,000)

—

(100,000)

—

—

—

7,528

—

—

—

—

—

—

—

—

874

874

24,056

$

2

$ 334,074

$

464,324

(4,498) $ (230,000) $

(70,863) $

497,537

The accompanying notes are an integral part of these consolidated financial statements.

45

 
 
 
CLEARWATER PAPER CORPORATION
Notes to Consolidated Financial Statements

NOTE 1 Nature of Operations and Basis of Presentation

Clearwater  Paper  manufactures  quality  consumer  tissue,  away-from-home  tissue,  parent  roll  tissue,  bleached 
paperboard and pulp at manufacturing facilities across the nation. The company is a premier supplier of private label 
tissue to major retailers and wholesale distributors, including grocery, drug, mass merchants and discount stores. In 
addition, the company produces bleached paperboard used by quality-conscious printers and packaging converters. 
Clearwater Paper's employees build shareholder value by developing strong customer partnerships through quality 
and service.

Unless the context otherwise requires or unless otherwise indicated, references in this report to “Clearwater Paper 
Corporation,” “we,” “our,” “the company” and “us” refer to Clearwater Paper Corporation and its subsidiaries.

On December 28, 2012, we acquired the assets of a wood chipping facility located in Clarkston, Washington, near our 
Lewiston, Idaho facility, in an effort to bolster our wood fiber position and obtain cost savings. The total consideration 
associated with the acquisition was approximately $11 million, which included $1.5 million of contingent consideration 
paid in cash by the company based on certain performance and indemnity guarantees. We allocated the purchase 
price to the tangible and amortizable intangible assets acquired based on their estimated fair values at the date of 
acquisition, resulting in the recognition of approximately $6 million in equipment, $4 million in intangible assets for 
customer relationships and a $1 million intangible asset for a non-compete agreement with the former owners. No 
goodwill was recorded.

On March 6, 2013, we announced the planned permanent closure of our Thomaston, Georgia converting and distribution 
facility. The shutdown occurred gradually as converting lines were relocated and installed at our other facilities, with 
all operations at Thomaston having ceased as of the end of 2013. We incurred $7.2 million of costs associated with 
the closure, of which $1.3 million was incurred in 2014. 

On February 17, 2014, we announced the permanent and immediate closure of our Long Island, New York, tissue 
converting and distribution facility. In 2014, we incurred $18.8 million of costs associated with the closure.

On December 30, 2014, we sold our specialty business and mills to a private buyer for $108 million in cash, net of 
sale  related  expenses  and  adjustments.  The  specialty  business  and  mills'  production  consisted  predominantly  of 
machine-glazed tissue and also included parent rolls and other specialty tissue products such as absorbent materials 
and  dark-hued  napkins.  The  sale  included  five  of  our  former  subsidiaries  with  facilities  located  at  East  Hartford, 
Connecticut; Menominee, Michigan; Gouverneur, New York; St. Catharines, Ontario; and Wiggins, Mississippi. 

These consolidated financial statements include the financial condition and results of operations of Clearwater Paper 
Corporation and its wholly-owned subsidiaries. All intercompany transactions and balances between operations within 
the company have been eliminated.

NOTE 2 Summary of Significant Accounting Policies

SIGNIFICANT ESTIMATES

The preparation of financial statements in conformity with accounting principles generally accepted in the U.S., which 
we refer to in this report as GAAP, requires management to make estimates and assumptions that affect the reported 
amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements 
and the reported amounts of net sales and expenses during the reporting period. Significant areas requiring the use 
of estimates and measurement of uncertainty include determination of net realizable value for deferred tax assets, 
uncertain  income  tax  positions,  assessment  of  impairment  of  long-lived  assets  and  goodwill,  assessment  of 
environmental matters, allocation of purchase price and fair value estimates for business combinations, equity-based 
compensation and pension and postretirement obligation assumptions. Actual results could differ from those estimates 
and assumptions.

46

SHORT-TERM INVESTMENTS AND RESTRICTED CASH

Our short-term investments are invested primarily in demand deposits, which have very short maturity periods, and 
therefore earn an interest rate commensurate with low-risk instruments. We do not attempt to hedge our exposure to 
interest rate risk for our short-term investments. Our restricted cash in which the underlying instrument has a term of 
greater than twelve months from the balance sheet date is classified as non-current and is included in “Other assets, 
net” on our Consolidated Balance Sheet. As of December 31, 2014, we had $1.5 million of restricted cash classified 
as current and $2.3 million of restricted cash classified as non-current on our Consolidated Balance Sheet. As of 
December 31, 2013, substantially all restricted cash balances were classified as current and included in "Restricted 
cash" on our Consolidated Balance Sheet.

TRADE ACCOUNTS RECEIVABLE

Trade  accounts  receivable  are  stated  at  the  amount  we  expect  to  collect. Trade  accounts  receivable  do  not  bear 
interest. The allowance for doubtful accounts is our best estimate of the losses we expect will result from the inability 
of our customers to make required payments. We generally determine the allowance based on a combination of actual 
historical write-off experience and an analysis of specific customer accounts. As of December 31, 2014 and 2013, we 
had allowances for doubtful accounts of $1.4 million and $1.9 million, respectively, which decreased primarily as a 
result  of  the  sale  of  our  specialty  business  and  mills.  Bad  debt  expense,  net,  charged  to  selling,  general  and 
administrative expenses during 2014, 2013 and 2012 was $0.1 million, $1.5 million and $0.2 million, respectively. All 
other activity impacting the allowance for doubtful accounts was immaterial for all periods.

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment are stated at cost, including assets acquired under capital lease obligations and any 
interest costs capitalized, less accumulated depreciation. Depreciation of buildings, equipment and other depreciable 
assets is determined using the straight-line method. Estimated useful lives generally range from 10 to 40 years for 
land improvements; 10 to 40 years for buildings and improvements; 5 to 25 years for machinery and equipment; and 
2 to 15 years for office and other equipment. Assets we acquire through business combinations have estimated lives 
that are typically shorter than the assets we construct or buy new. 

We  review  the  carrying  value  of  our  property,  plant  and  equipment  for  impairment  when  events  or  changes  in 
circumstances indicate that the carrying amount of those assets may not be recoverable. An impairment of property, 
plant and equipment exists when the carrying value is not considered to be recoverable through future undiscounted 
cash flows from operations and the carrying value of the assets exceeds the estimated fair value. During the first 
quarter of 2014, we permanently closed our Consumer Products segment's Long Island converting and distribution 
facility. As a result of this closure, we impaired certain plant and equipment. In addition, as a result of the December 
30, 2014 sale of our specialty business and mills, certain property, plant and equipment associated with the divested 
mills were written off and included in our loss on divested assets. See Note 4, "Asset Divestiture" and Note 6, "Property, 
Plant and Equipment"  for further discussion.

INTANGIBLE ASSETS

We use estimates in determining and assigning the fair value of the useful lives of intangible assets, the amount and 
timing of related future cash flows and fair values of the related operations. Our intangible assets have definite lives 
and are amortized over their estimated useful lives. We assess our intangible assets for impairment annually and when 
events or changes in circumstances indicate that the carrying amount may not be recoverable.

We recorded intangible assets as a result of our acquisition of Cellu Tissue Holdings, Inc., or Cellu Tissue, on December 
27, 2010. We also recorded intangible assets as a result of our December 2012 acquisition of a wood chipping facility.  
During the first quarter of 2014, we permanently closed our Consumer Products segment's Long Island converting 
and distribution facility. As a result of this closure, we impaired certain intangible assets. In addition, during the fourth 
quarter  of  2014  we  determined  that  a  customer  relationship  intangible  asset  related  to  our  Pulp  and  Paperboard 
segment's wood chipping facility was fully impaired. Also, as a result of the December 30, 2014, sale of our specialty 
business and mills, certain intangible assets associated with the divested mills were written off and included in our 
loss on divested assets. See Note 4, "Asset Divestiture" and Note 7, "Goodwill and Intangible Assets"  for further 
discussion.

47

GOODWILL

Goodwill from an acquisition represents the excess of the cost of a business acquired over the net of the amounts 
assigned  to  assets  acquired,  including  identifiable  intangible  assets  and  liabilities  assumed.  We  use  estimates  in 
determining and assigning the fair value of goodwill, including the amount and timing of related future cash flows and 
fair values of the related operations. Goodwill is not amortized but is tested for impairment annually as of November 1, 
as well as any time when events suggest impairment may have occurred. In the event the carrying value of the reporting 
unit in which our goodwill is assigned exceeds the estimated fair value of that reporting unit, an impairment loss would 
be recognized to the extent the carrying amount of the reporting unit exceeds its implied fair value.

As a result of our acquisition of Cellu Tissue in December 2010, we recorded $229.5 million of goodwill as included 
on  our  Consolidated  Balance  Sheet  as  of  December 31,  2013.  All  of  the  recorded  goodwill  was  assigned  to  our 
Consumer Products segment and reporting unit.  As a result of the December 30, 2014, sale of our specialty business 
and mills, a certain portion of goodwill was allocated to the divested mills and included in our loss on divested assets, 
see Note 4, "Asset Divestiture" and Note 7, "Goodwill and Intangible Assets"  for further discussion. As of December 31, 
2014, we had $209.1 million of goodwill included on our Consolidated Balance Sheet. 

PENSION AND OTHER POSTRETIREMENT EMPLOYEE BENEFITS 

The determination of pension plan expense and the requirements for funding our pension plans are based on a number 
of actuarial assumptions. Three critical assumptions are the discount rate applied to pension plan obligations, the rate 
of return on plan assets and mortality rates. For other postretirement employee benefit, or OPEB, plans, which provide 
certain health care and life insurance benefits to qualified retired employees, critical assumptions in determining OPEB 
expense are the discount rate applied to benefit obligations, the assumed health care cost trend rates used in the 
calculation  of  benefit  obligations  and  mortality  rates. We  also  participate  in  multiemployer  defined  benefit  pension 
plans. We make contributions to these multiemployer plans, as well as make contributions to a trust fund established 
to provide retiree medical benefits for a portion of these employees.

The discount rate used in the determination of pension benefit obligations and pension expense is determined based 
on a review of long-term high-grade bonds and management's expectations. To determine the expected long-term 
rate of return on pension assets, we employ a process that analyzes historical long-term returns for various investment 
categories, as measured by appropriate indices. These indices are weighted based upon the extent to which plan 
assets are invested in the particular categories in arriving at our determination of a composite expected return. 

An increase in the discount rate or the rate of expected return on plan assets, all other assumptions remaining the 
same, would decrease pension plan expense, and conversely, a decrease in either of these measures would increase 
plan expense. The actual rates of return on plan assets may vary significantly from the assumptions used because of 
unanticipated changes in financial markets. 

The estimated net loss and prior service cost (credit) for the defined benefit pension and OPEB plans is amortized 
from accumulated other comprehensive loss into net periodic cost (benefit) in accordance with current accounting 
guidance.

Periodic pension and OPEB expenses are included in “Cost of sales” and “Selling, general and administrative expenses” 
in the Consolidated Statements of Operations. The expense is allocated to all business segments. In accordance with 
current accounting guidance governing defined benefit pension and other postretirement plans, at December 31, 2014 
and  2013,  long-term  assets  are  recorded  for  overfunded  single-employer  plans  and  liabilities  are  recorded  for 
underfunded single-employer plans. The funded status of a benefit plan is measured as the difference between plan 
assets at fair value and the projected benefit obligation. For underfunded single-employer plans, the estimated liability 
to be payable in the next twelve months is recorded as a current liability, with the remaining portion recorded as a long-
term liability.

INCOME TAXES

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized 
for  the  future  tax  consequences  attributable  to  differences  between  the  consolidated  financial  statement  carrying 
amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. 
Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the 
years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets 
and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

48

The  determination  of  our  provision  for  income  taxes  requires  significant  judgment,  the  use  of  estimates,  and  the 
interpretation and application of complex tax laws. Significant judgment is required in assessing the timing and amounts 
of deductible and taxable items and the probability of sustaining uncertain tax positions. The benefits of uncertain tax 
positions are recorded in our consolidated financial statements only after determining a more-likely-than-not probability 
that the uncertain tax positions will withstand challenge, if any, from tax authorities. When facts and circumstances 
change,  we  reassess  these  probabilities  and  record  any  changes  in  the  consolidated  financial  statements  as 
appropriate.

REVENUE RECOGNITION

We recognize net sales when there is persuasive evidence of a sales agreement, the price to the customer is fixed 
and determinable, collection is reasonably assured, and title and the risk of loss passes to the customer. Shipping 
terms generally indicate when title and the risk of loss have passed. Revenue is recognized at shipment for sales when 
shipping terms are free on board, or FOB, shipping point. For sales where shipping terms are FOB destination, revenue 
is recognized when the goods are received by the customer. Revenue from both domestic and foreign sales of our 
products can involve shipping terms of either FOB shipping point or FOB destination or other shipping terms, depending 
upon the sales agreement with the customer.

We did not have any single customer that accounted for 10% or more of our total net sales in either 2014 or 2012. In 
2013, we had one customer in the Consumer Products segment, the Kroger Company, that accounted for approximately 
$204 million, or 10.8%, of our total company net sales.  

We provide for trade promotions, customer cash discounts, customer returns and other deductions as reductions to 
net sales in the same period as the related revenues are recognized. Provisions for these items are determined based 
on historical experience or specific customer arrangements.

Revenue is recognized net of any sales taxes collected. Sales taxes, when collected, are recorded as a current liability 
and remitted to the appropriate governmental entities.

ENVIRONMENTAL

As part of our corporate policy, we have an ongoing process to monitor, report on and comply with environmental 
requirements. Based on this ongoing process, accruals for environmental liabilities that are not within the scope of 
specific authoritative guidance related to accounting for asset retirement obligations or conditional asset retirement 
obligations are established in accordance with guidance related to accounting for contingencies. We estimate our 
environmental liabilities based on various assumptions and judgments, the specific nature of which varies in light of 
the  particular  facts  and  circumstances  surrounding  each  environmental  liability.  These  estimates  typically  reflect 
assumptions and judgments as to the probable nature, magnitude and timing of required investigation, remediation 
and  monitoring  activities  and  the  probable  cost  of  these  activities.  Currently,  we  are  not  aware  of  any  material 
environmental  liabilities  and  have  accrued  only  for  specific  costs  related  to  environmental  matters  that  we  have 
determined  are  probable  and  for  which  an  amount  can  be  reasonably  estimated.  Fees  for  professional  services 
associated with environmental and legal issues are expensed as incurred.

STOCKHOLDERS’ EQUITY

On December 15, 2014, we announced that our Board of Directors had approved a new stock repurchase program 
authorizing the repurchase of up to $100 million of our common stock. The repurchase program authorizes purchases 
of  our  common  stock  from  time  to  time  through  open  market  purchases,  negotiated  transactions  or  other  means, 
including accelerated stock repurchases and 10b5-1 trading plans in accordance with applicable securities laws and 
other restrictions. We have no obligation to repurchase stock under this program and may suspend or terminate the 
program at any time.

On February 5, 2014, we announced that our Board of Directors had approved a stock repurchase program authorizing 
the repurchase of up to $100 million of our common stock. We completed this program during the third quarter of 2014. 
In total, we repurchased 1,574,748 shares of our outstanding common stock at an average price of $63.50 per share 
under this program.

On January 17, 2013, we announced that our Board of Directors had approved a stock repurchase program authorizing 
the repurchase of up to $100 million of our common stock, which was completed in 2013. Under this program, we 
repurchased 1,039,513 shares of our outstanding common stock under an accelerated stock buyback agreement with 
a major financial institution at an average repurchase price of $48.10 per share. We also made repurchases of 1,030,657 
shares of our outstanding common stock on the open market at a total cost of $50 million, representing an an average 
price of $48.51 per share, under this program. 

49

DERIVATIVES

We had no activity during the years ended December 31, 2014, 2013 and 2012 that required hedge or derivative 
accounting treatment. However, to partially mitigate our exposure to market risk for changes in utility commodity pricing, 
we use firm price contracts to supply a portion of the natural gas requirements for our manufacturing facilities. As of 
December 31, 2014, these contracts covered approximately 57% of the expected average monthly requirements for 
2015, including approximately 67% of the expected average monthly requirements for the first quarter. For the years 
ended December 31, 2014, 2013 and 2012, approximately 58%, 16% and 29%, respectively, of our natural gas volumes 
were supplied through firm price contracts. These contracts qualify for treatment as “normal purchases or normal sales” 
under authoritative guidance and thus require no mark-to-market adjustment.

NOTE 3 Recently Adopted and Prospective Accounting Standards
In  May  2014,  the  Financial Accounting  Standards  Board,  or  FASB,  issued Accounting  Standard  Update,  or ASU, 
2014-09, Revenue from Contracts with Customers. The core principle of the new standard is for companies to recognize 
revenue in a manner that depicts the transfer of goods or services to customers in amounts that reflect the consideration, 
or payment, to which the company expects to be entitled in exchange for those goods or services. The standard will 
also  result  in  enhanced  disclosures  about  revenue,  provide  guidance  for  transactions  that  were  not  previously 
addressed comprehensively, such as service revenue and contract modifications, and clarify guidance for multiple-
element arrangements. This standard is effective for fiscal years and interim periods within those years beginning after 
December  15,  2016,  with  early  adoption  prohibited. The  standard  may  be  applied  under  either  a  retrospective  or 
cumulative effect adoption method. We are currently evaluating the impact this guidance will have on our consolidated 
financial statements.

In April 2014, the FASB issued ASU 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of 
Components  of  an  Entity,  which  amends  and  raises  the  threshold  of  a  disposal  transaction  that  qualifies  as  a 
discontinued  operation,  as  well  as  requires  additional  disclosures  about  discontinued  operations  and  disposals  of 
individually  significant  components  that  do  not  qualify  as  discontinued  operations.  This  standard  is  effective 
prospectively for all disposals of components that occur within annual periods beginning on or after December 15, 
2014, and interim periods within those years, with early adoption permitted. We adopted this guidance in 2014; see 
Note 4, "Asset Divestiture."

In July 2013, the FASB issued ASU 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating 
Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, which provides guidance on financial 
statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a 
tax credit carryforward exists. This ASU only changes existing presentation requirements but does not require new 
recurring disclosures and is prospective for annual and interim reporting periods beginning after December 15, 2013. 
This guidance did not impact our consolidated financial statements.

We reviewed all other new accounting pronouncements issued in the period and concluded that they are not applicable 
to our business.

NOTE 4 Asset Divestiture
Specialty Business and Mills Divestiture

On December 30, 2014, we simultaneously announced and completed the sale of our specialty business and mills, 
which includes our former Menominee, Michigan; St. Catharines, Ontario; East Hartford, Connecticut; Gouverneur, 
New York; and Wiggins, Mississippi manufacturing, converting and distribution sites from our Consumer Products 
reporting segment for net proceeds of approximately $108 million. We assessed the sale of our specialty business 
and  mills  under  the  relevant  authoritative  accounting  guidance  related  to  discontinued  operations  reporting  and 
concluded that this divestiture of assets does not qualify for discontinued operations reporting as the divestiture does 
not constitute a disposal of a component of our Consumer Products reporting segment. Furthermore, we concluded 
during our assessment that the sale of our specialty business and mills does not represent either a strategic shift in 
the Consumer Products segment, nor does it represent a major impact on our operations and financial results. Rather, 
consistent with our long-term corporate strategy, the sale of the specialty business and mills is intended to sharpen 
our Consumer Products segment's focus on its core retail businesses by investing net proceeds from the sale into 
capital projects within our Consumer Products segment. 

50

In total, $40.2 million was recorded as "Loss on divested assets" and included as a component of operating income 
within  our  Consolidated  Statement  of  Operations,  as  well  as  a  component  of  our  Consumer  Products  segment's 
operating income as disclosed in Note 18, “Segment Information.” Among other charges, the loss on divested assets 
included a $20.4 million write-off of goodwill, which was originally recorded in connection with the Cellu Tissue acquisition 
and was allocated to the sale of the specialty business and mills. Consistent with authoritative guidance, the goodwill 
was allocated to our divested assets by estimating the fair value of the specialty business compared to the estimated 
fair value of the Consumer Products reporting unit, which was then used to estimate the percentage of goodwill to 
allocate  to  the  sale  of  this  business.  In  addition,  "Loss  on  divested  assets"  within  our  Consolidated  Statement  of 
Operations included a $4.9 million intangible asset write-off related to certain identifiable customer relationship and 
trade name and trademark intangibles associated with the divested mills. Both the goodwill and intangible asset charges 
are discussed further in Note 7, “Goodwill and Intangible Assets." 

In total, $105.7 million of assets were sold, consisting primarily of $86.7 million of property, plant and equipment and 
$18.0 million of inventory. As part of the sales transaction, we also agreed to certain brokerage and service arrangements 
totaling approximately $6.0 million to be recognized over the next five years. Furthermore, as a result of this sale we 
have recorded restricted cash balances totaling $3.8 million on our December 31, 2014 Consolidated Balance Sheet, 
which include contingencies related to certain indemnity and working capital guarantees.

NOTE 5 Inventories 

(In thousands)
Pulp, paperboard and tissue products
Materials and supplies
Logs, pulpwood, chips and sawdust

December 31,
2014
188,760 $

$

74,916
22,950

$

286,626 $

December 31,
2013
182,715
69,836
15,237
267,788

At December 31, 2014, our inventories are stated at the lower of market or current average cost using the average 
cost method. 

NOTE 6 Property, Plant and Equipment

(In thousands)
Machinery and equipment
Buildings and improvements
Land improvements
Office and other equipment
Land
Construction in progress

Less accumulated depreciation and amortization

December 31,
2014

December 31,
2013

311,468
46,652
21,832
7,221
43,668

$ 1,830,245 $ 1,937,914
304,971
54,277
11,951
11,827
40,204
$ 2,261,086 $ 2,361,144
(1,476,446)
884,698

810,987 $

(1,450,099)

$

The December 31, 2014 and 2013 buildings and improvements and machinery and equipment combined balances 
include $24.6 million and $24.1 million, respectively, associated with capital leases.

Depreciation expense, including amounts associated with capital leases, totaled $83.6 million, $83.3 million and $74.6 
million in 2014, 2013 and 2012, respectively. We did not capitalize any interest during 2014 and 2013. For 2012 we 
capitalized $12.6 million of interest expense associated with our TAD tissue expansion project, which included the 
construction of our new tissue manufacturing and converting facilities in Shelby, North Carolina, and upgrades to our 
tissue manufacturing facility in Las Vegas, Nevada.

51

Consistent with authoritative guidance, we assess the carrying amount of long-lived assets with definite lives that are 
held-for-use and evaluate them for recoverability whenever events or changes in circumstances indicate that we may 
be unable to recover the carrying amount of the assets. During the first quarter of 2014, we permanently closed our 
Long Island converting and distribution facility. As a result of this closure, we considered an outside third party's appraisal 
in  assessing  the  recoverability  of  the  facility's  long-lived  plant  and  equipment  based  on  available  market  data  for 
comparable assets sold through private party transactions. Based on this assessment, we determined the carrying 
amounts of certain long-lived plant and equipment related to the Long Island facility exceeded their fair value. As a 
result, we recorded $3.8 million of non-cash impairment charges to our accompanying Consolidated Statement of 
Operations in the year ended December 31, 2014. In addition, on December 30, 2014 we completed the sale of our 
specialty business and mills, which included $86.7 million of net property, plant and equipment. This event did not 
impact the recoverability of our remaining long-lived assets. For additional discussion regarding the sale of our specialty 
business and mills, see Note 4, "Asset Divestiture." There were no other such events or changes in circumstances 
that impacted our remaining long-lived assets.

NOTE 7 Goodwill and Intangible Assets
The carrying amount of goodwill is reviewed at least annually for impairment as of November 1. The first step of the 
goodwill impairment test, used to identify potential impairment, compares the fair value of a reporting unit with its carrying 
amount, including goodwill. If the carrying amount of a reporting unit is greater than zero and its estimated fair value 
exceeds  its  carrying  amount,  goodwill  of  the  reporting  unit  is  not  considered  impaired.  For  the  purpose  of  goodwill 
impairment testing, we identify two reporting units, Consumer Products and Pulp and Paperboard, the same as our two 
reportable operating segments (see Note 18, "Segment Information"). All of the recorded goodwill is assigned to our 
Consumer Products reporting unit.

As of November 1, 2014 and 2013, we performed calculations of both a discounted cash flow and market-based valuation 
model for our Consumer Products reporting unit. The assumptions used in these models allowed us to evaluate the 
estimated fair value of our reporting unit. The determination of these assumptions required significant estimates on our 
part. Due to the inherent uncertainty involved in making such estimates, actual results could differ from those assumptions. 
However, we evaluated the merits of each significant assumption, both individually and in the aggregate, used to determine 
the estimated fair value of our reporting unit for reasonableness. Upon completion of this exercise, we concluded that the 
estimated fair value of the Consumer Products reporting unit exceeded its carrying amount. We determined that no further 
testing was necessary and did not record any impairment loss on our goodwill for the years ended December 31, 2014 
and 2013.

On December 30, 2014, we simultaneously announced and completed the sale of our Consumer Products reporting 
unit's specialty business and mills. We considered the sale to be highly probable during our annual goodwill review 
and as such included its impact in estimating the fair value of the Consumer Products reporting unit, concluding that 
this event did not require additional impairment testing. However, consistent with authoritative guidance we allocated 
a portion of our goodwill to the specialty business and mills sold. As a result, we recorded a $20.4 million write-off of 
goodwill, which was originally recorded in connection with the Cellu Tissue acquisition and was allocated to the sale 
of  the  specialty  mills  business.  In  addition,  certain  of  our  customer  relationships  and  trade  name  and  trademarks 
intangible assets were associated with our divested specialty business and mills, and as a result we recorded a $4.9 
million write-off of these assets. These charges are included in "Loss on divested assets" within our accompanying 
Consolidated Statement of Operations. For additional discussion regarding the sale of our specialty business and 
mills, see Note 4, "Asset Divestiture."   

Intangible asset amounts represent the acquisition date fair values of identifiable intangible assets acquired. The fair 
values of the intangible assets were determined by using the income approach, discounting projected future cash flows 
based on management’s expectations of the current and future operating environment. The rates used to discount projected 
future cash flows reflected a weighted average cost of capital based on our industry, capital structure and risk premiums 
including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over their 
useful lives, which have historically ranged from 2.5 to 10 years. Authoritative guidance requires that the carrying amount 
of a long-lived asset with a definite life that is held-for-use be evaluated for recoverability whenever events or changes 
in circumstances indicate that the entity may be unable to recover the asset’s carrying amount. 

During the first quarter of 2014, we permanently closed our Consumer Products segment's Long Island converting 
and distribution facility. As a result of this closure, we performed an assessment of the recoverability of our intangible 
assets associated with this facility. It was determined that the carrying amounts of certain trade names and trademarks 
related to the Long Island facility were exceeding their fair value. As a result, we recorded a $1.3 million non-cash 
impairment  charge  in  our  accompanying  Consolidated  Statement  of  Operations.  Fully  amortized  non-compete 
agreements related to the Long Island facility were also disposed during the facility closure. 

52

During the fourth quarter of 2014, we evaluated the recoverability of our remaining intangible assets under the income 
approach and noted that a customer relationship intangible asset relating to our Pulp and Paperboard segment's wood 
chipping facility was fully impaired. As a result, we recorded an additional non-cash impairment charge of $3.1 million 
in our accompanying Consolidated Statement of Operations. 

During 2013, we permanently closed our Thomaston converting and distribution facility and finalized this closure in 
2014. This closure did not require an assessment of recoverability on our assets as all converting lines were relocated 
and installed at our other facilities. There were no other such events or changes in circumstances that required us to 
assess whether our definite-lived intangible assets were impaired for the years ended December 31, 2014 and 2013. We 
do not have any indefinite-lived intangible assets recorded from acquisitions.

Intangible assets at the balance sheet dates are comprised of the following:

(Dollars in thousands, lives in years)
Customer relationships

Trade names and trademarks

Non-compete agreements

Total intangible assets

(Dollars in thousands, lives in years)
Customer relationships

Trade names and trademarks

Non-compete agreements

Total intangible assets

December 31, 2014

Useful
Life

Historical
Cost

Accumulated
Amortization

Net
Balance

9.0

$

41,001

$

(18,223) $

10.0

5.0

3,286

1,189

(1,314)

(983)

$

45,476

$

(20,520) $

22,778

1,972

206

24,956

December 31, 2013

Useful
Life

Historical
Cost

Accumulated
Amortization

Net
Balance

9.0

$

53,957

$

(17,234) $

10.0

2.5 - 5.0

5,300

1,674

(1,590)

(1,329)

$

60,931

$

(20,153) $

36,723

3,710

345

40,778

As of December 31, 2014, estimated future amortization expense related to intangible assets is as follows (in thousands):

Years ending December 31,
2015

2016

2017

2018

2019

Thereafter

Total

$

Amount

4,967

4,946

4,946

4,884

4,884

329

$

24,956

53

NOTE 8 Income Taxes

Earnings (loss) before income taxes is comprised of the following amounts in each tax jurisdiction:

(In thousands)
United States
Canada
Earnings before income taxes

The income tax provision (benefit) is comprised of the following:

(In thousands)
Current

Federal
State
Foreign

Deferred
Federal
State
Foreign

Income tax provision (benefit)

2014

2013

16,253 $
(12)
16,241 $

38,900 $
(666)
38,234 $

2012
111,278
313
111,591

2014

2013

2012

2,355 $
1,872
516
4,743

11,432
2,381
—
13,813
18,556 $

(75,119) $
506
263
(74,350)

10,177
(4,423)
(125)
5,629
(68,721) $

27,724
6,637
229
34,590

16,243
(3,180)
(193)
12,870
47,460

$

$

$

$

The income tax provision or benefit differs from the amount computed by applying the statutory federal income tax 
rate of 35.0% to earnings before income taxes due to the following:

(In thousands)
Computed expected tax provision

State and local taxes, net of federal income tax impact

$

Adjustment for state deferred tax rate

State investment tax credits

Federal credits and net operating losses

Federal manufacturing deduction

Uncertain tax positions

Loss on divested assets

State attribute true up
New York state attribute true up
Change in valuation allowances
U.S. tax provision on foreign operations
Other, net
Income tax provision (benefit)
Effective tax rate

2014

2013

2012

5,685

1,543

1,546

(1,039)

(485)

(674)

355

10,554

(2,874)

1,654

2,346

—

(55)

$

13,381

$

39,063

1,279

(762)

(2,263)

(10,234)

—

(69,144)

—

—

—

(1,334)

67

289

4,398

(742)

(9,077)

4,121

(3,288)

4,801

—

—

—

6,932

(33)

1,285

$

18,556

$ (68,721)

$

47,460

114.3%

(179.7)%

42.5%

As a result of the sale of our specialty business and mills, which included our Canadian subsidiary, we recognized a 
gain  due  to  a  basis  difference  of  approximately  $12.5  million  for  which  no  deferred  liability  had  been  previously 
recognized based upon our assertion to permanently reinvest in foreign operations. Additionally, as a result of the 
divestiture, there was a write-off of goodwill of approximately $20.4 million for which there was no tax basis. These 
items were offset by foreign tax credits generated through the sale.

54

During the year ended December 31, 2014, we recorded discrete expense for a reduction in our blended state tax rate 
as well as adjustments to New York state specific deferred items. These changes were due to amendments we made 
to our New York state return filings as a result of changes in New York state tax laws. In reviewing the changes in the 
tax laws, we identified that, in prior years, we had not applied the proper apportionment factor when certain New York 
state net operating loss carryforwards were generated, which resulted in a $2.9 million overstatement. We corrected 
this in the second quarter of 2014 by including the overstatement as a discrete item within state rate adjustments due 
to immateriality.

We have tax benefits relating to equity-based compensation that are being utilized to reduce our U.S. taxable income. 
As  of  December  31,  2014  and  December  31,  2013,  we  had  a  total  amount  of  excess  tax  benefits  that  were  not 
recognized on our Consolidated Balance Sheet of approximately $2.8 million and $2.3 million, respectively, that will 
be credited to additional paid-in capital when cash tax benefits are realized according to our “with-and-without” or 
“incremental” accounting policy method.  

The tax effects of significant temporary differences creating deferred tax assets and liabilities at December 31 were: 

(In thousands)
Deferred tax assets:

Employee benefits

Postretirement employee benefits

Incentive compensation

Inventories

Pensions

Federal and state credit carryforwards

Net operating losses

Other

Total deferred tax assets

Valuation allowance

Deferred tax assets, net of valuation allowance

Deferred tax liabilities:

Plant and equipment

Intangible assets

Total deferred tax liabilities

Net deferred tax liabilities

Net deferred tax assets and liabilities consist of:

(In thousands)
Current deferred tax assets
Current deferred tax liabilities

Net current deferred tax assets
Non-current deferred tax assets
Non-current deferred tax liabilities

Net non-current deferred tax liabilities

Net deferred tax liabilities

2014

2013

$

8,270 $

40,940

9,354

6,716

7,238

23,759

3,192

9,384

8,612

41,515

8,937

5,898

152

27,597

13,930

7,390

$

$

$

108,853 $

114,031

(15,969)

(13,622)

92,884 $

100,409

(178,531) $

(178,227)

(4,227)

(182,758)

$

(89,874) $

(9,542)

(187,769)
(87,360)  

2014

2013

$

21,760 $

37,538

—

21,760

71,124

—

37,538

62,871

(182,758)

(111,634)

(187,769)

(124,898)

$

(89,874) $

(87,360)

In the years ended December 31, 2014, 2013 and 2012, we recorded an expense of $1.5 million, and benefits of $0.7 
million  and  $0.7  million,  respectively,  reflecting  a  remeasurement  of  state  deferred  tax  assets  and  liabilities  using 
anticipated tax rates that will be in effect when the underlying assets and liabilities will reverse.

55

As of December 31, 2014, we had deferred tax assets arising from deductible temporary differences, tax losses and 
tax credits of approximately $108.9 million before the offset of certain deferred tax liabilities. With the exception of 
certain deferred tax assets related to federal foreign tax credits, state tax losses and state tax credits totaling $16.0 
million,  management  believes  it  is  more  likely  than  not  that  forecasted  income,  together  with  the  tax  effect  of  the 
deferred tax liabilities, will be sufficient to fully recover the remaining deferred tax assets.

During 2014, the valuation allowance for deferred tax assets increased by $2.4 million. We decreased the valuation 
allowances for state tax losses $0.6 million and increased the valuation allowances for state tax credits by $1.9 million. 
We  also  increased  the  valuation  allowance  relating  to  foreign  tax  credits  by  $1.1  million. These  three  items  were 
recorded as a deferred tax expense to the income tax provision.

During  2013,  the  valuation  allowance  for  deferred  tax  assets  decreased  by  a  net  $1.3  million.  We  decreased  the 
valuation allowances for state tax losses incurred by $1.2 million and decreased the valuation allowances for state tax 
credits by $0.4 million. Both of these items were recorded as current period deferred tax benefit. We also increased 
the valuation allowance relating to foreign tax credits by $0.3 million, which was recorded as a deferred tax expense 
to the income tax provision.

During the fourth quarter of 2012, the Internal Revenue Service, or IRS, commenced an audit of our tax returns for 
the tax years ending December 31, 2008 through December 31, 2012. The audit was finalized during the third quarter 
of 2014. As a result, we recognized an additional deferred tax asset of $1.5 million and an associated benefit to the 
rate.

During the second quarter of 2013, the IRS commenced an audit of our wholly owned subsidiary Cellu Tissue Holdings, 
Inc, or Cellu Tissue and its subsidiaries for the year ended December 27, 2010; the period immediately before our 
acquisition of Cellu Tissue. During the first quarter of 2014, we successfully closed the audit of Cellu Tissue.

Tax years subject to examination by major taxing jurisdictions are as follows: 

Jurisdiction
United States
Canada
Arkansas
California
Georgia
Idaho
Illinois
Wisconsin

Years
2009 - 2014
2011 - 2014
2011 - 2014
2010 - 2014
2010 - 2014
2011 - 2014
2008 - 2014
2010 - 2014  

Tax credits and losses subject to expiration by major taxing jurisdictions are as follows (dollars in thousands):

Jurisdiction
United States

Foreign tax credits
Cellulosic biofuel credits
Other federal tax credits

Connecticut tax losses
Georgia tax losses
Idaho tax credits
North Carolina tax credits
Oklahoma tax losses

Gross Values

Years

$

5,488
1,903
927
16,358
3,829
5,262
17,974
45,805

2016 - 2024
2015
2026 - 2033
2018 - 2033
2027 - 2033
2014 - 2027
2015 - 2017
2030 - 2033

56

    
    
    
    
    
    
    
    
    
A review of our uncertain income tax positions at December 31, 2014 and 2013 indicates that liabilities are required 
to be recorded for gross unrecognized tax benefits following authoritative accounting guidance. The following presents 
a roll forward of our unrecognized tax benefits and associated interest and penalties, as included in the Accrued taxes 
line item in non-current liabilities in our Consolidated Balance Sheets.

(In thousands)
Balance at January 1, 2013
Decrease in prior year tax positions
Decrease due to settlements
Increase in current year tax positions
Balance at December 31, 2013

Decrease in prior year tax positions

Increase in current year tax positions

Balance at December 31, 2014

Gross
Unrecognized
Tax Benefits,
Excluding
Interest and
Penalties

Interest
and
Penalties

72,004 $
(69,816)
(525)
469
2,132 $

(157)

431

$

$

$

Total Gross
Unrecognized
Tax Benefits
78,699
(75,213)
(1,302)
474
2,658

6,695 $
(5,397)
(777)
5
526 $

(301)

65

(458)

496

2,406 $

290 $

2,696

We have operations in many states within the U.S. and are subject, at times, to tax audits in these jurisdictions.  These 
tax audits by their nature are complex and can require multiple years to resolve. The final resolution of any such tax 
audits could result in either a reduction of our accruals or an increase in our income tax provision, both of which could 
have an impact on the results of operations in any given period. With a few exceptions, we are no longer subject to 
U.S. federal, state and local, or foreign income tax examinations by tax authorities for years prior to 2009. We regularly 
evaluate, assess and adjust these accruals in light of changing facts and circumstances, which could cause the effective 
tax rate to fluctuate from period to period. Although the timing of resolution of audits is not certain, we evaluate all audit 
issues in the aggregate, along with the expiration of applicable statutes of limitations, and estimate that it is reasonably 
possible  the  total  gross  unrecognized  tax  benefits  could  decrease  by  approximately  $1  million  within  the  next  12 
months.

In 2013, we recorded a total reduction to the reserve for uncertain tax positions materially related to tax positions 
concerning the Alternative Fuel Mixture Tax Credit, or AFMTC. The reduction, net of deferred tax assets associated 
with this position, totaled $69.1 million. The reduction was the result of a memorandum released by the IRS, which 
concluded that the AFMTC was not subject to taxation.

Unrecognized tax benefits net of related deferred tax assets at December 31, 2014, if recognized, would favorably 
impact our effective tax rate by decreasing our tax provision by $2.7 million. We reflect accrued interest related to tax 
obligations, as well as penalties, in our provision for income taxes. For the years ended December 31, 2014, 2013, 
and 2012 we accrued interest and no penalties of $0.1 million, $2.0 million and $1.9 million, respectively, in our income 
tax provision.

NOTE 9 Accounts Payable and Accrued Liabilities

(In thousands)
Trade accounts payable
Accrued wages, salaries and employee benefits
Accrued interest
Accrued discounts and allowances
Accrued utilities
Accrued taxes other than income taxes payable

Other

57

December 31,
2014

December 31,
2013

$

122,856 $

108,192

41,880

12,173

10,026

6,959

5,622

16,310

38,563

9,691

6,410

8,309

6,322

13,161

$

215,826 $

190,648

NOTE 10 Debt
ISSUANCE OF $300 MILLION SENIOR NOTES DUE 2025 AND REDEMPTION OF $375 MILLION SENIOR NOTES 
DUE 2018

On July 29, 2014 we issued $300 million aggregate principal amount of senior notes, which we refer to as the 2014 
Notes. The 2014 Notes mature on February 1, 2025, have an interest rate of 5.375% and were issued at their face 
value. The issuance of these notes generated net proceeds of approximately $298 million after deducting offering 
expenses. We redeemed all of our $375 million aggregate principal amount of senior notes issued on October 22, 
2010, which we refer to as the 2010 Notes, using the net proceeds from the 2014 Notes along with company funds 
and a $37 million draw from our senior secured revolving credit facility during the third quarter of 2014. 

The 2010 Notes had a maturity date of November 1, 2018, and an interest rate of 7.125%. On August 28, 2014, we 
redeemed all of the 2010 Notes at a redemption price equal to 100% of the principal amount of $375 million and a 
“make whole” premium of $17.6 million plus accrued and unpaid interest of $8.7 million, for an aggregate amount of 
$401.3 million. The make whole premium and a portion of the unpaid interest, as well as a $4.6 million non-cash charge 
relating to the unamortized deferred issuance costs associated with the 2010 Notes, were recorded as components 
of "Debt retirement costs" and included in our Consolidated Statement of Operations.  

The 2014 Notes are guaranteed by all of our direct and indirect domestic subsidiaries. The 2014 Notes will also be 
guaranteed by each of our future direct and indirect domestic subsidiaries that do not constitute an immaterial subsidiary 
under the indenture governing the 2014 Notes. The 2014 Notes are equal in right of payment with all other existing 
and future unsecured senior indebtedness and are senior in right of payment to any future subordinated indebtedness. 
The 2014 Notes are effectively subordinated to all of our existing and future secured indebtedness, including borrowings 
under our secured revolving credit facility, which is secured by certain of our accounts receivable, inventory and cash. 
The terms of the 2014 Notes limit our ability and the ability of any restricted subsidiaries to incur certain liens, engage 
in sale and leaseback transactions and consolidate, merge with, or convey, transfer or lease substantially all of our or 
their assets to another person.

We may, on any one or more occasions, redeem all or a part of the 2014 Notes, upon not less than 30 days nor more 
than 60 days notice, at a redemption price equal to 100% of the principal amount of the 2014 Notes redeemed, plus 
the applicable premium as of, and accrued and unpaid interest, if any, to the date of redemption. Unless we default in 
the payment of the redemption price, interest will cease to accrue on the 2014 Notes or portions thereof called for 
redemption on the applicable redemption date. In addition, we may be required to make an offer to purchase the 2014 
Notes upon the sale of certain assets and upon a change of control.

$275 MILLION SENIOR NOTES DUE 2023

In June 2009, we issued senior unsecured notes, which we refer to as the 2009 Notes, in the aggregate principal 
amount of $150 million. The 2009 Notes were due on June 15, 2016 and had an interest rate of 10.625%. The 2009 
Notes were issued at a price equal to 98.792% of their face value.

We had the option to redeem all or a portion of the 2009 Notes at any time prior to June 15, 2013 at a redemption 
price equal to 100% of the principal amount thereof plus a “make whole” premium and accrued and unpaid interest. 
On  February 22,  2013,  we  exercised  our  option  to  redeem  all  of  the  2009  Notes  at  a  redemption  price  equal  to 
approximately  $166  million,  which  consisted  of  100%  of  the  principal  amount,  plus  a  $12.6  million  “make  whole” 
premium and accrued and unpaid interest of approximately $3.0 million. The make whole premium and a portion of 
the unpaid interest, as well as an unamortized discount and deferred issuance costs associated with the 2009 Notes, 
were recorded as components of "Debt retirement costs" totaling $17.1 million in the first quarter of 2013, as included 
in the accompanying Consolidated Statement of Operations. Proceeds to fund the redemption of the 2009 Notes were 
made available through the sale of $275 million aggregate principal amount of senior notes on January 23, 2013, which 
we refer to as the 2013 Notes. The 2013 Notes mature on February 1, 2023, have an interest rate of 4.5% and were 
issued at their face value. The issuance of these notes generated net proceeds of approximately $271 million after 
deducting offering expenses.

58

The 2013 Notes are guaranteed by all of our direct and indirect domestic subsidiaries. The 2013 Notes will also be 
guaranteed by each of our future direct and indirect domestic subsidiaries that we do not designate as an unrestricted 
subsidiary under the indenture governing the 2013 Notes. The 2013 Notes are equal in right of payment with all other 
existing  and  future  unsecured  senior  indebtedness  and  are  senior  in  right  of  payment  to  any  future  subordinated 
indebtedness. The 2013 Notes are effectively subordinated to all of our existing and future secured indebtedness, 
including borrowings under our secured revolving credit facility, which is secured by certain of our accounts receivable, 
inventory and cash. The terms of the 2013 Notes limit our ability and the ability of any restricted subsidiaries to borrow 
money; pay dividends; redeem or repurchase capital stock; make investments; sell assets; create restrictions on the 
payment of dividends or other amounts to us from any restricted subsidiaries; enter into transactions with affiliates; 
enter into sale and lease back transactions; create liens; and consolidate, merge or sell all or substantially all of our 
assets.

Prior to February 1, 2016, we may redeem up to 35% of the 2013 Notes at a redemption price equal to 104.5% of the 
principal amount plus accrued and unpaid interest with the proceeds from one or more qualified equity offerings. We 
have the option to redeem all or a portion of the 2013 Notes at any time before February 1, 2018 at a redemption price 
equal to 100% of the principal amount plus accrued and unpaid interest and a “make whole” premium. On or after 
February 1, 2018, we may redeem all or a portion of the 2013 Notes at specified redemption prices plus accrued and 
unpaid interest. In addition, we may be required to make an offer to purchase the 2013 Notes upon the sale of certain 
assets and upon a change of control.

REVOLVING CREDIT FACILITY

On November 26, 2008, we entered into a $125 million senior secured revolving credit facility with certain financial 
institutions. The amount available to us under the revolving credit facility is based on the lesser of 85% of our eligible 
accounts receivable plus approximately 65% of our eligible inventory, or $125 million. The revolving credit facility has 
been subsequently amended and expires on September 30, 2016.

As of December 31, 2014, there were no borrowings outstanding under the credit facility, but $7.8 million of the credit 
facility was being used to support outstanding standby letters of credit. Loans under the credit facility bear interest (i) 
for LIBOR loans, LIBOR plus between 1.75% and 2.25% and (ii) for base rate loans, a per annum rate equal to the 
greater of (a) the prime rate for such day; (b) the federal funds effective rate for such day, plus 0.50%; or (c) LIBOR 
for a 30-day interest period as determined on such day, plus between 1.25% and 1.75%. The percentage margin on 
all loans is based on our fixed charge coverage ratio for the most recent four quarters. As of December 31, 2014, we 
would have been permitted to draw $117.2 million under the credit facility at LIBOR plus 1.75%, or base rate plus 
1.25%. 

A  minimum  fixed  charge  coverage  ratio  is  the  only  financial  covenant  requirement  under  our  credit  facility  and  is 
triggered when there are any commitments or obligations outstanding and availability falls below 12.5% or an event 
of default exists, at which time the minimum fixed charge coverage ratio must be at least 1.0-to-1.0. As of December 31, 
2014, the fixed charge coverage ratio for the most recent four quarters was 1.1-to-1.0.

Our obligations under the revolving credit facility are secured by certain of our accounts receivable, inventory and 
cash. The terms of the credit facility contain various provisions that limit our discretion in the operations of our business 
by restricting our ability to, among other things, pay dividends; redeem or repurchase capital stock; create, incur or 
guarantee  certain  debt;  incur  liens  on  certain  properties;  make  capital  expenditures;  enter  into  certain  affiliate 
transactions; enter into certain hedging arrangements; and consolidate with or merge with another entity. The revolving 
credit facility contains usual and customary affirmative and negative covenants and usual and customary events of 
default.

NOTE 11 Other Long-Term Obligations 

(In thousands)
Long-term lease obligations, net of current portion
Deferred compensation
Deferred proceeds
Other

$

December 31,
2014
24,805 $
14,609
12,360
5,082

56,856 $

December 31,
2013
24,815
14,149
11,205
2,773
52,942

$

59

NOTE 12 Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss at the balance sheet dates is comprised of the following:

(In thousands)

Balance at December 31, 2013

Other comprehensive income before reclassifications

Amounts reclassified from accumulated other comprehensive loss
Other comprehensive income, net of tax2
Balance at December 31, 2014

(In thousands)

Balance at December 31, 2012

Other comprehensive income before reclassifications

Amounts reclassified from accumulated other comprehensive loss
Other comprehensive income, net of tax2
Balance at December 31, 2013

Foreign 
Currency 
Translation 
Adjustments1

Pension and
Other Post
Retirement
Employee
Benefit Plan
Adjustments

Total

$

(874) $

(57,219) $

(58,093)

—

874

874

4,773

(18,417)

(13,644)

4,773

(17,543)

(12,770)

$

— $

(70,863) $

(70,863)

Foreign 
Currency 
Translation 
Adjustments1

Pension and
Other Post
Retirement
Employee
Benefit Plan
Adjustments

Total

$

(874) $ (114,819) $ (115,693)

—

—

—

9,468

48,132

57,600

9,468

48,132

57,600

$

(874) $

(57,219) $

(58,093)

1 

2 

This balance consists of unrealized foreign currency translation adjustments related to the operations of our former Canadian subsidiary before 
its functional currency was changed from Canadian dollars to U.S. dollars in 2012. As a result of the divestiture of our specialty business and 
mills, this balance was written-off and included in our net loss on divested assets. 

For the year ended December 31, 2014, net periodic costs associated with our pension and other postretirement employee benefit, or OPEB, 
plans included in other comprehensive loss and reclassified from accumulated other comprehensive loss, or AOCL, included $38.6 million of 
net loss on plan assets, $9.8 million of actuarial loss amortization, $8.4 million of prior service credit arising during the period and $2.0 million 
of prior service credit amortization, less total tax of $8.8 million. For the year ended December 31, 2013,  net periodic costs associated with 
our pension and OPEB plans included in other comprehensive income and reclassified from AOCL included $83.6 million of net gain on plan 
assets, $14.8 million of actuarial loss amortization, $5.1 million of prior service costs arising during the period, $0.2 million of prior service 
credit amortization and $0.8 million of curtailments, less total tax of $36.3 million. These accumulated other comprehensive loss components 
are included in the computation of net periodic pension and OPEB costs in Note 13, “Savings, Pension and Other Postretirement Employee 
Benefit Plans.”

60

NOTE 13 Savings, Pension and Other Postretirement Employee Benefit Plans
Certain of our employees are eligible to participate in defined contribution savings and defined benefit postretirement 
plans.  These  include  401(k)  savings  plans,  defined  benefit  pension  plans  including  company-sponsored  and 
multiemployer plans, and Other Postretirement Employee Benefit, or OPEB, plans, each of which is discussed below.

401(k) Savings Plans

Substantially all of our employees are eligible to participate in 401(k) savings plans, which include a company match 
component.  In 2014, 2013 and 2012, we made matching 401(k) contributions on behalf of employees of $17.4 million, 
$16.8 million and $14.9 million, respectively. 

Company-Sponsored Defined Benefit Pension Plans

A  majority  of  our  salaried  employees  and  a  portion  of  our  hourly  employees  are  covered  by  company-sponsored 
noncontributory defined benefit pension plans.

During  the  second  quarter  of  2013,  we  recorded  a  curtailment  loss  of  $0.8  million  in  net  periodic  cost,  and  a 
corresponding change in Other Comprehensive Income, net of tax, due to the freezing of pension benefits for certain 
employees at our Lewiston, Idaho pulp and paperboard facility, effective June 30, 2013. In the fourth quarter of 2012, 
we recorded a curtailment loss of  $0.5 million  in net periodic cost, and a corresponding change in Other Comprehensive 
Income, net of tax, as a result of certain hourly employees at our Cypress Bend, Arkansas pulp and paperboard facility 
electing to cease accruing further pension benefits effective December 31, 2012.  In exchange, beginning January 1, 
2013 and lasting for a certain number of years, these employees began receiving an enhanced employer contribution 
to one of our existing 401(k) savings plan in which they participate. 

Company-Sponsored OPEB Plans

We also provide benefits under company-sponsored defined benefit retiree health care and life insurance plans, which 
cover certain salaried and hourly employees. Most of the retiree health care plans require retiree contributions and 
contain other cost-sharing features. The retiree life insurance plans are primarily noncontributory.

Funded Status of Company-Sponsored Plans

As required by current standards governing the accounting for defined benefit pension and other postretirement plans, 
we  recognized  the  funded  status  of  our  company-sponsored  plans  on  our  Consolidated  Balance  Sheets  at 
December 31, 2014 and 2013. The funded status is measured as the difference between plan assets at fair value (with 
limited exceptions) and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; 
for any other postretirement employee benefit plan, such as a retiree health care plan, the benefit obligation is the 
accumulated postretirement employee benefit obligation. We use a December 31 measurement date for our benefit 
plans.

The  changes  in  benefit  obligation,  plan  assets  and  funded  status  for  company-sponsored  benefit  plans  as  of 
December 31 are as follows:

Pension Benefit Plans

Other Postretirement
Employee Benefit Plans

(In thousands)
Benefit obligation at beginning of year
Service cost
Interest cost
Plan changes
Actuarial losses (gains)
Medicare Part D subsidies received
Benefits paid
Benefit obligation at end of year
Fair value of plan assets at beginning of year
Actual return on plan assets
Employer contribution
Benefits paid
Fair value of plan assets at end of year
Funded status at end of year

2014
293,388 $
1,390
14,825
—
47,548
—
(19,150)
338,001
286,598
36,157
17,450
(19,150)
321,055
(16,946) $

$

$

61

2013
333,257 $
1,738
13,375
—
(36,859)
—
(18,123)
293,388
254,556
34,779
15,386
(18,123)
286,598

2013
134,618
552
4,730
5,106
(30,322)
308
(7,665)
107,327
19
1
—
—
20
(6,790) $ (104,695) $ (107,307)

2014
107,327 $
454
4,565
(8,384)
7,039
123
(6,409)
104,715
20
—
—
—
20

 
The December 31, 2014 pension and OPEB benefit obligations were unfavorably affected by lower discount rates and 
the adoption of new mortality tables.  

Amounts recognized in the Consolidated Balance Sheets:

(In thousands)
Noncurrent asset
Current liabilities
Noncurrent liabilities
Net amount recognized

Pension Benefit Plans

Other Postretirement
Employee Benefit Plans

2014

2013

2014

2013

$

$

4,738 $
(438)
(21,246)
(16,946) $

— $

4,488 $
(364)
(10,914)

—
(8,414)
(7,477)
(98,893)
(97,218)
(6,790) $ (104,695) $ (107,307)

Pre-tax amounts recognized in Accumulated Other Comprehensive Loss as of December 31 consist of:

(In thousands)
Net loss (gain)
Prior service cost (credit)
Net amount recognized

Pension Benefit Plans

2014
130,708 $
103
130,811 $

2013
109,218 $
308
109,526 $

$

$

Other Postretirement
Employee Benefit Plans

2014

2013

1,410 $
(7,101)
(5,691) $

(5,915)
(896)
(6,811)

Information as of December 31 for certain pension plans included above with accumulated benefit obligations in excess 
of plan assets were as follows:

(In thousands)
Projected benefit obligation
Accumulated benefit obligation
Fair value of plan assets

2014

2013

$ 338,001 $ 293,388
293,388
286,598

338,001
321,055

Pre-tax components of net periodic cost and other amounts recognized in Other Comprehensive (Loss) Income for 
the years ended December 31 were as follows:

Net Periodic Cost:

(In thousands)
Service cost

Interest cost

Expected return on plan assets

Amortization of prior service cost (credit)

Amortization of actuarial loss (gain)

Curtailments

Net periodic cost

$

Pension Benefit Plans

Other Postretirement
Employee Benefit Plans

2014
1,390 $

$

2013

2012

2014

2013

2012

1,738 $

2,485 $

454 $

552 $

693

14,825

(20,196)
205
10,097

13,375
(18,352)
337

14,693
(19,685)
634

14,840

12,085

4,565
—
(2,179)

(286)

4,730
—
(502)

—

—

769
6,321 $ 12,707 $ 10,689 $

477

—
2,554 $

—
4,780 $

5,815
—
(2,680)

—

—
3,828

62

 
 
 
Other amounts recognized in Other Comprehensive (Loss) Income:

(In thousands)

2014

2013

2012

2014

2013

2012

Pension Benefit Plans

Other Postretirement
Employee Benefit Plans

Net loss (gain)
Curtailments
Prior service (credit) cost
Amortization of prior service (cost) credit
Amortization of actuarial (loss) gain

Total recognized in other comprehensive
  loss (income) 

Total recognized in net periodic cost and
  other comprehensive loss (income)

$ 31,587 $ (53,285) $ 12,989 $
(769)
—
(337)

(477)
—
(634)

—
—
(205)
(10,097)

(14,840)

(12,085)

7,039 $ (30,323) $

—
(8,384)
2,179

286

—
5,106
502

—

3,150
—
(5,278)
2,680

—

$ 21,285 $ (69,231) $

(207) $

1,120 $ (24,715) $

552

$ 27,606 $ (56,524) $ 10,482 $

3,674 $ (19,935) $

4,380

The  estimated  net  loss  and  prior  service  cost  for  the  defined  benefit  pension  plans  that  will  be  amortized  from 
accumulated other comprehensive loss into net periodic cost (benefit) over the next fiscal year are $12.3 million and 
$0.1 million, respectively. The estimated prior service credit for the OPEB plans that will be amortized from accumulated 
other comprehensive loss into net periodic cost (benefit) over the next fiscal year is $2.2 million.

During 2014, $6.6 million of net periodic pension and OPEB costs were charged to "Cost of sales," and $2.3 million 
were charged to "Selling, general and administrative expenses" in the accompanying Consolidated Statements of 
Operations, as compared to $14.2 million and $3.3 million, respectively, during 2013.

The Medicare Prescription Drug Improvement and Modernization Act of 2003 introduced a drug benefit under Medicare 
Part D and a federal subsidy to sponsors of retiree health care benefit plans that provide an equivalent benefit. Our 
actuaries determined that certain benefits provided under our plans are actuarially equivalent to the Medicare Part D 
standard plan and are eligible for the employer subsidy. During 2014 and 2013, we received subsidy payments totaling 
$0.1 million and $0.3 million for each respective year.

Weighted average assumptions used to determine the benefit obligation as of December 31 were:

Discount rate

Pension Benefit Plans

Other Postretirement
Employee Benefit Plans

2014

2013

2012

2014

2013

2012

4.25%

5.20%

4.15%

4.15%

5.05%

4.05%

Weighted average assumptions used to determine the net periodic cost for the years ended December 31 were:

Discount rate
Expected return on plan assets

Pension Benefit Plans

Other Postretirement
Employee Benefit Plans

2014

2013

2012

2014

2013

2012

5.20%
7.50

4.15%
7.50

4.90%
8.00

5.05%
—

4.05%
—

4.95%
—

The discount rate used in the determination of pension benefit obligations and pension expense was determined based 
on a review of long-term high-grade bonds as well as management’s expectations. The discount rate used to calculate 
OPEB obligations was determined using the same methodology we used for our pension plans.

The expected return on plan assets assumption is based upon an analysis of historical long-term returns for various 
investment categories, as measured by appropriate indices. These indices are weighted based upon the extent to 
which plan assets are invested in the particular categories in arriving at our determination of a composite expected 
return.

63

 
 
 
 
 
 
 
  
The assumed health care cost trend rate used to calculate OPEB obligations and expense was 6.30% in 2014, grading 
to a range of 4.30% to 4.50% over approximately 70 years. This assumption has a significant effect on the amounts 
reported. A one percentage point change in the health care cost trend rates would have the following effects:

(In thousands)
Effect on total of service and interest cost components
Effect on postretirement employee benefit obligation

1% Increase

$

493 $

10,277

1% Decrease
(414)
(8,657)

The investments of our defined benefit pension plans are held in a Master Trust. The assets of our OPEB plans are 
held within an Internal Revenue Code section 401(h) account for the payment of retiree medical benefits within the 
Master Trust.

As of December 31, 2014, the Master Trust no longer has a securities lending agreement. 

Current accounting rules governing fair value measurement establish a framework for measuring fair value, which 
provides  a  fair  value  hierarchy  that  prioritizes  the  inputs  to  valuation  techniques  used  to  measure  fair  value. The 
hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 
measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair 
value hierarchy are described below:

Level 1

Inputs to the valuation methodology are unadjusted quoted prices for identical assets or
liabilities in active markets that the plans have the ability to access.

Level 2

Inputs to the valuation methodology include:

   Quoted prices for similar assets or liabilities in active markets;

   Quoted prices for identical or similar assets or liabilities in inactive markets;

   Inputs other than quoted prices that are observable for the asset or liability; and

   Inputs that are derived principally from or corroborated by observable market data by 

correlation or other means

If the asset or liability has a specified (contractual) term, the Level 2 input must be
observable for substantially the full term of the asset or liability.

Level 3

Inputs to the valuation methodology are unobservable and significant to the fair value
measurement.

The asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any 
input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable 
inputs and minimize the use of unobservable inputs.

There have been no changes in the methodologies used during 2014, however, in 2014, a majority of our investments 
were transferred into a common and collective trust. Investments in common and collective trust funds, hedge funds 
and liquidating trusts that maintain investments in mortgage-backed securities are generally valued based on their 
respective net asset value, or NAV, (or its equivalent), as a practical expedient to estimate fair value due to the absence 
of readily available market prices. Investments that may be fully redeemed at NAV in the near-term are generally 
classified as Level 2.

The methods described above may produce a fair value calculation that may not be indicative of net realizable value 
or reflective of future fair values. Furthermore, while management believes the valuation methods are appropriate and 
consistent with other market participants, the use of different methodologies or assumptions to determine the fair value 
of certain financial instruments could result in a different fair value measurement at the reporting date.

64

 
  
  
  
The following tables set forth by level, within the fair value hierarchy, the investments at fair value for our company-
sponsored pension benefit plans:

(In thousands)
Cash and cash equivalents
Common and collective trust:
Collective investment funds
Total investments at fair value

(In thousands)
Cash and cash equivalents
Common and collective trusts:

International small cap
Global/International equity
International equity emerging markets

Common stocks:

Industrials
Energy
Consumer
Healthcare
Finance
Utilities
Information technology
Foreign

Mutual funds:

Foreign large blend
Long-term bond fund
  Mid-cap growth fund
Subtotal
Payable held under securities lending agreement
Total investments at fair value

December 31, 2014

Level 1

Level 2

Level 3

Total

2,023 $

— $

— $

2,023

—

319,032

2,023 $ 319,032 $

—
319,032
— $ 321,055

$

$

December 31, 2013

Level 1

Level 2

Level 3

Total

$

4,314 $

— $

— $

4,314

—
—
—

15,845
21,198
17,809

9,307
2,663
8,002
6,013
11,566
1,711
8,785
6,175

—
—
—
—
—
—
—
—

18,492
137,031
18,009
$ 232,068 $

—
—
—
54,852 $

—
—
—

—
—
—
—
—
—
—
—

15,845
21,198
17,809

9,307
2,663
8,002
6,013
11,566
1,711
8,785
6,175

18,492
—
137,031
—
—
18,009
— $ 286,920
(322)
$ 286,598

Our OPEB plan had approximately $20,000 held in cash and equivalents at December 31, 2014, which were categorized 
as level 1.

We have formal investment policy guidelines for our company-sponsored plans. These guidelines were set by our 
Benefits Committee, which is comprised of members of our management and has been assigned its fiduciary authority 
over management of the plan assets by our Board of Directors. The Committee’s duties include periodically reviewing 
and modifying those investment policy guidelines as necessary and insuring that the policy is adhered to and the 
investment objectives are met.

The investment policy includes guidelines for specific categories of equity and fixed income securities. Assets are 
managed by professional investment managers who are expected to achieve a reasonable rate of return over a market 
cycle. Long-term performance is a fundamental tenet of the policy.

65

 
 
The general policy states that plan assets would be invested to seek the greatest return consistent with the fiduciary 
character of the pension funds and to allow the plans to meet the need for timely pension benefit payments. The 
specific investment guidelines stipulate that management is to maintain adequate liquidity for meeting expected benefit 
payments by reviewing, on a timely basis, contribution and benefit payment levels and appropriately revising long-
term and short-term asset allocations. Management takes reasonable and prudent steps to preserve the value of 
pension fund assets, avoid the risk of large losses and also attempt to preserve the funded status of the plans. Major 
steps taken to provide this protection included:

Assets are diversified among various asset classes, such as domestic equities, international equities, fixed 
income and cash. The long-term asset allocation ranges are as follows:

Domestic equities
International equities, including emerging markets
Corporate bonds
Liquid reserves

14%-22%   
13%-22%   
50%-70%   
0%-5%   

Periodically, reviews of allocations within these ranges are made to determine what adjustments should be made 
based on changing economic and market conditions and specific liquidity requirements.

Assets were managed by professional investment managers and could be invested in separately managed 
accounts or commingled funds.

Assets were not invested in securities rated below BBB- by S&P or Baa3 by Moody’s.

The investment guidelines also required that the individual investment managers were expected to achieve a reasonable 
rate  of  return  over  a  market  cycle.  Emphasis  was  placed  on  long-term  performance  versus  short-term  market 
aberrations. Factors considered in determining reasonable rates of return included performance achieved by a diverse 
cross section of other investment managers, performance of commonly used benchmarks (e.g., Russell 3000 Index, 
MSCI World ex-U.S. Index, Barclays Capital Long Credit Index), actuarial assumptions for return on plan investments 
and specific performance guidelines given to individual investment managers.

As of December 31, 2014, ten active investment managers managed substantially all of the pension funds, each of 
whom  had  responsibility  for  managing  a  specific  portion  of  these  assets.  Plan  assets  were  diversified  among  the 
various asset classes within the allocation ranges approved by the Benefits Committee.

In 2014, we contributed $17.0 million to our qualified pension plans. Our cash contributions in 2015 are estimated to 
be approximately $12 million. We also contributed $0.5 million to our non-qualified pension plan in 2014. We are not 
required to make contributions to our qualified pension plans during 2015, and we do not anticipate funding our OPEB 
plans in 2015 except to pay benefit costs as incurred during the year by plan participants..

Estimated future benefit payments are as follows for the years indicated:

(In thousands)
2015
2016
2017
2018
2019
2020-2023

Pension Benefit 
Plans

Other
Postretirement
Employee
Benefit Plans
7,497
7,794
7,728
7,781
7,526
31,412

19,023 $
19,318
19,683
20,055
20,543
104,772

$

66

   
   
   
   
Multiemployer Defined Benefit Pension Plans

Hourly employees at two of our manufacturing facilities participate in multiemployer defined benefit pension plans: the 
PACE Industry Union-Management Pension Fund, or PIUMPF, which is managed by United Steelworkers, or USW, 
Benefits; and the International Association of Machinist & Aerospace Workers National Pension Fund, or IAM NPF. 
We make contributions to these plans, as well as make contributions to a trust fund established to provide retiree 
medical benefits for a portion of these employees, which is also managed by USW Benefits. The risks of participating 
in these multiemployer plans are different from single-employer plans in the following respects:

Assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees 
of other participating employers.
If a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne 
by the remaining participating employers.
Under  applicable  federal  law,  any  employer  contributing  to  a  multiemployer  pension  plan  that  completely 
ceases participating in the plan while it is underfunded is subject to an assessment of such employer's allocable 
share of the aggregate unfunded vested benefits of the plan. In certain circumstances, an employer can also 
be  assessed  a  withdrawal  liability  for  a  partial  withdrawal  from  a  multiemployer  pension  plan.  Based  on 
information  as  of  December  31,  2013  provided  by  PIUMPF  and  reviewed  by  our  actuarial  consultant,  we 
estimate  the  aggregate  pre-tax  liability  that  we  would  have  incurred  if  we  had  completely  withdrawn  from 
PIUMPF in 2014 would have been in excess of $72 million. However, the exact amount of potential exposure 
could be higher or lower than the estimate, depending on, among other things, the nature and timing of any 
triggering events and the funded status of PIUMPF at that time. A withdrawal liability is recorded for accounting 
purposes when withdrawal is probable and the amount of the withdrawal obligation is reasonably estimable.

Our participation in these plans for the annual period ended December 31, 2014, is outlined in the table below. The 
“EIN" and "Plan Number” columns provide the Employee Identification Number, or EIN, and the three-digit plan number. 
The most recent Pension Protection Act, or PPA, zone status available in 2014 and 2013 is for a plan’s year-end as 
of December 31, 2014 and December 31, 2013, respectively. The zone status is based on information we received 
from the plans and is certified by each plan's actuary. Among other factors, plans in the red zone are generally less 
than 65 percent funded, plans in the yellow zone are less than 80 percent but more than 65 percent funded, and plans 
in the green zone are at least 80 percent funded. The “FIP/RP Status Pending/Implemented” column indicates plans 
for which a Funding Improvement Plan, or FIP, or a Rehabilitation Plan, or RP, is either pending or has been implemented 
as required by the PPA as a measure to correct its underfunded status. The last column lists the expiration date(s) of 
the collective-bargaining agreement(s) to which the plans are subject. 

In 2013, the contribution rates for the IAM NFP plan increased to $4.00 an hour, up from $3.25 an hour in 2012, affecting 
the comparability of the contributions year over year. In 2011, contribution rates for PIUMPF were increased as part 
of the RP in lieu of the legally required surcharge, paid by the employers, to assist the fund’s financial status. We were 
listed in PIUMPF’s Form 5500 report as providing more than five percent of the total contributions for the years 2013 
and 2012. At the date of issuance of our consolidated financial statements, Form 5500 reports for these plans were 
not available for the 2014 plan year.

PPA Zone

Status      

Contributions
(in thousands)

Pension
Fund

IAM NPF

PIUMPF

EIN

Plan
Number

2014

2013

FIP/
RP Status Pending/
Implemented

2014

2013

2012

51-6031295

11-6166763

002

001

Green Green

N/A

$

343

$

343

$

288

Red

Red

Implemented

5,665

5,718

5,673

Total Contributions:

$ 6,008

$ 6,061

$ 5,961

Expiration
 Date
of Collective
Bargaining
  Agreement 1

5/31/2016

8/31/2014

Surcharge
Imposed

No

No

1 

The Collective Bargaining Agreement at Lewiston, Idaho for employees associated with PIUMPF expired on 8/31/2014. As of the date of this 
report, a new agreement is still being negotiated. 

67

NOTE 14 Earnings Per Share

Basic (loss) earnings per share are based on the weighted average number of shares of common stock outstanding. 
Diluted earnings per share are based upon the weighted average number of shares of common stock outstanding plus 
all potentially dilutive securities that were assumed to be converted into common shares at the beginning of the period 
under the treasury stock method. This method requires that the effect of potentially dilutive common stock equivalents 
be excluded from the calculation of diluted earnings per share for the periods in which net losses are reported because 
the effect is anti-dilutive. For the year ended December 31, 2014, 566,041 of our incremental shares related to restricted 
stock units, performance shares, and stock options were excluded from our earnings per share calculation due to their 
anti-dilutive effect as a result of our net loss during the period. 

The following table reconciles the number of common shares used in calculating the basic and diluted net earnings 
per share: 

Basic average common shares outstanding1
Incremental shares due to:

Restricted stock units
Performance shares
Stock options

Diluted average common shares outstanding
Basic net (loss) earnings per common share
Diluted net (loss) earnings per common share
Anti-dilutive shares excluded from calculation

2014
20,129,557

2013
22,081,026

2012
23,298,663

—
—
—
20,129,557
$

53,803
129,003
—
22,263,832

(0.11) $
(0.11)
566,041

4.84 $
4.80
41,337

24,086
291,036
—
23,613,785
2.75
2.72
9,992

1 

Basic average common shares outstanding include restricted stock awards that are fully vested, but are deferred for future issuance. See 
Note 15, "Equity-Based Compensation Plans" for further discussion.

NOTE 15 Equity-Based Compensation Plans

The  Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan,  or  Stock  Plan,  which  has  been  approved  by  our 
stockholders,  provides  for  equity-based  awards  in  the  form  of  restricted  shares,  restricted  stock  units,  or  RSUs, 
performance  shares,  stock  options,  or  stock  appreciation  rights  to  selected  employees,  outside  directors,  and 
consultants  of  the  company. The  Stock  Plan  became  effective  on  December 16,  2008.  Under  the  Stock  Plan,  as 
amended, we are authorized to issue up to approximately 4.1 million shares, which includes approximately 0.7 million 
additional shares authorized in connection with our acquisition of Cellu Tissue that are available for issuance as equity-
based awards only to any employees, outside directors, or consultants who were not employed on December 26, 2010 
by Clearwater Paper Corporation or any of its subsidiaries. At December 31, 2014, approximately 1.9 million shares 
were available for future issuance under the Stock Plan.

We recognize equity-based compensation expense for all equity-based payment awards made to employees and 
directors, including RSUs, performance shares and stock options, based on estimated fair values and net of estimates 
of future forfeitures. The expense is classified in "Selling, general and administrative expense" in our Consolidated 
Statements of Operations and is recognized on a straight-line basis over the requisite service periods of each award. 
Based on the terms of the Stock Plan, retirement-eligible employees become fully vested in outstanding awards on 
the later of that date they reach retirement eligibility or at the end of the first calendar year of each respective grant. 
We account for this feature when determining the service period over which to recognize expense for each grant of 
RSUs, performance shares, and stock options.

Employee equity-based compensation expense was recognized as follows: 

(In thousands)
Restricted stock units
Performance shares
Stock options

Total employee equity-based compensation

Related tax benefit

68

2014

2013

2012

1,966 $
4,964
1,254
8,184 $
2,955 $

1,801 $
5,075
—
6,876 $
2,049 $

970
7,364
—
8,334
2,886

$

$
$

RESTRICTED STOCK UNITS

RSUs granted under our Stock Plan are generally subject to a vesting period of one to three years. RSU awards will 
accrue dividend equivalents based on dividends paid, if any, during the RSU vesting period. The dividend equivalents 
will be converted into additional RSUs that will vest in the same manner as the underlying RSUs to which they relate. 
RSUs granted under our Stock Plan do not represent common stock, and therefore the holders do not have voting 
rights unless and until shares are issued upon settlement.

A summary of the status of outstanding unvested RSU awards as of December 31, 2014, 2013 and 2012, and changes 
during those years, is presented below: 

Unvested shares outstanding at

January 1
Granted

Vested

Forfeited

Unvested shares outstanding at
  December 31
Aggregate intrinsic value (in
  thousands)

2014

2013

2012

Weighted
Average
Grant Date
Fair Value

Shares

Weighted
Average
Grant Date
Fair Value

Shares

Weighted
Average
Grant Date
Fair Value

Shares

102,658 $

31,567

(32,117)
(8,854)

39.85

66.33

38.94

52.28

63,727 $

72,702

(30,190)

(3,581)

35.57

43.44

39.21

42.03

169,344 $

52,294

(155,177)

(2,734)

11.33

34.59

8.82

34.07

93,254

47.95

102,658

39.85

63,727

35.57

$

6,393

$

5,390

$

2,496

During 2014, 75,400 shares of RSUs were distributed. Of these shares, 27,933 were RSU shares that were settled 
and distributed in the fourth quarter of 2014. The remaining 47,467 shares were RSU shares that were settled in prior 
years but distribution had been deferred to preserve tax deductibility for the company in the respective years because 
distribution of these shares would have resulted in certain executive compensation being above the Internal Revenue 
Code section 162(m) threshold for those years. After adjusting for minimum tax withholdings, a net 48,476 shares 
were issued during 2014. The minimum tax withholdings payment made in 2014 in connection with issued shares was 
$1.5 million. 

During 2013, 126,726 shares of RSUs were distributed. Of these shares, 22,370 were RSU shares that were settled 
and  distributed  in  the  fourth  quarter  of  2013.  The  remaining  104,356  shares  had  been  deferred  to  preserve  tax 
deductibility for the company under Internal Revenue Code section 162(m). After adjusting for minimum tax withholdings 
and deferred shares, a net 73,154 shares were issued during 2013. The minimum tax withholdings payment made in 
2013 in connection with issued shares was $2.6 million. 

As of December 31, 2014 a total of 37,135 shares remain deferred under Internal Revenue Code section 162(m).

The fair value of each RSU share award granted during 2014 was estimated on the date of grant using the grant date 
market price of our common stock. The total fair value of share awards that vested during 2014 was $1.3 million. 

As of December 31, 2014, there was $2.3 million of total unrecognized compensation cost related to outstanding RSU 
awards. The cost is expected to be recognized over a weighted average period of 1.5 years.

PERFORMANCE SHARES

Performance share awards granted under our Stock Plan have a three-year performance period, with generally the 
same service period, and shares are issued after the end of the period if the employee provides the requisite service 
and the performance measure is met. The performance measure is a comparison of the percentile ranking of our total 
stockholder  return  compared  to  the  total  stockholder  return  performance  of  a  selected  peer  group  or  index.  The 
performance measure is considered to represent a “market condition” under authoritative accounting guidance, and 
thus, the market condition is considered when determining the estimate of the fair value of the performance share 
awards. The number of shares actually issued, as a percentage of the amount subject to the performance share award, 
could range from 0%-200%.

69

 
 
Performance share awards granted under our Stock Plan do not represent common stock, and therefore the holders 
do not have voting rights unless and until shares are issued upon settlement. During the performance period, dividend 
equivalents accrue based on dividends paid, if any, and are converted into additional performance shares, which vest 
or are forfeited in the same manner as the underlying performance shares to which they relate. Generally, if an employee 
terminates prior to completing the requisite service period, all or a portion of their awards are forfeited and the previously 
recognized  compensation  cost  is  reversed.  If  an  employee  provides  the  requisite  service  through  the  end  of  the 
performance period, but the performance measure is not met, following authoritative guidance for awards with a market 
condition, previously recognized compensation cost is not reversed.

The fair value of performance share awards is estimated using a Monte Carlo simulation model. For performance 
shares granted in 2014, the following assumptions were used in our Monte Carlo model:

Closing price of stock on date of grant
Risk free rate
Measurement period
Volatility

$

66.97

0.66%
3 years
30%

In addition to the above assumptions, the dividend yields for all companies were assumed to be zero since dividends 
are included in the definition of total shareholder return.

A summary of the status of outstanding performance share awards as of December 31, 2014, 2013 and 2012, and 
changes during those years, is presented below:

Outstanding share awards at
  January 1
Granted

Settled

Forfeited

Outstanding share awards at
  December 31
Aggregate intrinsic value (in
  thousands)

2014

2013

2012

Weighted
Average
Grant Date
Fair Value

Shares

Weighted
Average
Grant Date
Fair Value

Shares

Weighted
Average
Grant Date
Fair Value

Shares

259,841 $

54,379

—

50.87
105.08

392,655 $

124,513

— (246,592)

(13,356)

71.03

(10,735)

44.67

63.46

47.19

54.87

749,538 $

150,865

(499,680)

(8,068)

19.52

40.24

5.65

42.15

300,864

59.77

259,841

50.87

392,655

44.67

$

20,624

$

13,642

$

15,376

On December 31, 2014, the performance period for performance shares granted in 2012 ended, and those performance 
shares will be settled and distributed, subject to the approval of the Board of Directors' Compensation Committee, at 
a range of 0%-200% of shares granted, in the first quarter of 2015. On December 31, 2013, the three-year performance 
period for 108,366 performance shares granted in 2011 ended. The requisite market condition performance measure 
was not met, and as such no shares were paid or issued under these awards.

As  of  December 31,  2014,  there  was  $5.3  million  of  unrecognized  compensation  cost  related  to  outstanding 
performance share awards. The cost is expected to be recognized over a weighted average period of 1.1 years.

STOCK OPTIONS

In 2014, stock options were granted to certain employees under our Stock Plan. The stock options are generally 
subject to a vesting period of one to three years, with generally the same service period. Upon vesting, the holder is 
entitled to purchase a specified number of shares of Clearwater Paper common stock at a price per share equal to 
the closing market price of Clearwater Paper common stock on the date of grant. The options are exercisable for ten 
years from the date of grant.

Stock options granted under our Stock Plan do not represent common stock, and therefore the holders do not have 
voting rights unless and until shares have been issued to the employee.

70

 
 
The fair value of stock option awards was determined using a Black-Scholes option-pricing model. The Black-Scholes 
model utilizes a range of assumptions related to dividend yield, volatility, risk-free interest rate and employee exercise 
behavior. Expected volatility is based on Clearwater Paper's historical stock prices. The risk-free interest rate is based 
on constant maturity treasury rates with maturities matching the options' expected life on the grant date. The expected 
life,  estimated  in  accordance  with  Securities  and  Exchange  Commission  Staff  Accounting  Bulletin  110,  is  the 
approximate mid-point between the expected vesting time and the remaining contractual life. The weighted-average 
fair value of stock options granted in 2014 on the grant date was estimated at $22.99 per option based on the following 
assumptions:

Volatility
Risk-free interest rate
Expected life-years

30%
2.05%
6.4

A summary of the status of outstanding stock option awards as of December 31, 2014, and changes during the year, 
is presented below:

Outstanding options at January 1
Granted

Forfeited

Outstanding options at December 31
Aggregate intrinsic value (in thousands)

2014

Weighted
Average
Grant Date
Fair Value

Shares

— $

163,137

(12,557)

150,580

$

—

66.85

66.97

66.84

258

As of December 31, 2014, there was  $2.1 million of unrecognized compensation cost related to nonvested stock 
options. The cost is expected to be recognized over a weighted average period of 1.8 years.

DIRECTOR AWARDS

In connection with joining our Board of Directors, in January 2009 our outside directors at that time were granted an 
award of phantom common stock units, which were credited to an account established on behalf of each director and 
vested ratably over a three-year period with the final vesting in January 2012. Subsequent equity awards have been 
granted annually in May, or on a pro-rata basis as applicable, to our outside directors in the form of phantom common 
stock units as part of their annual compensation, which are credited to their accounts. These awards vest ratably over 
a one-year period. These accounts will be credited with additional phantom common stock units equal in value to 
dividends paid, if any, on the same amount of common stock. Upon separation from service as a director, the vested 
portion of the phantom common stock units held by the director in a stock unit account are converted to cash based 
upon the then market price of the common stock and paid to the director. Due to its cash-settlement feature, we account 
for these awards as liabilities rather than equity and recognize the equity-based compensation expense or income at 
the end of each reporting period based on the portion of the award that is vested and the increase or decrease in the 
value  of  our  common  stock.  We  recorded  director  equity-based  compensation  expense  totaling  $4.6  million,  $4.1 
million and $1.4 million for the years ended December 31, 2014, 2013 and 2012, respectively. At December 31, 2014 , 
the liability amounts associated with director equity-based compensation included in "Other long-term obligations" and 
"Accounts payable and accrued liabilities" on our Consolidated Balance Sheets were $13.5 million and $1.4 million, 
respectively. At December 31, 2013, all liability amounts associated with director equity-based compensation, totaling  
$13.2 million, were included in "Other long-term obligations."

71

 
 
NOTE 16 Fair Value Measurements

The estimated fair values of our financial instruments as of our balance sheet dates are presented below:

(In thousands)

December 31, 2014

December 31, 2013

Carrying
Amount

Fair
Value

Carrying
Amount

Fair
Value

Cash, short-term investments and restricted cash (Level 1)
Long-term debt (Level 1)

$

81,101 $

81,101 $

95,206 $

95,206

575,000

558,000

650,000

651,313

Accounting guidance establishes a framework for measuring the fair value of financial instruments, providing a hierarchy 
that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority 
to unadjusted quoted prices in active markets for identical assets or liabilities, or “Level 1” measurements, followed 
by quoted prices of similar assets or observable market data, or “Level 2” measurements, and the lowest priority to 
unobservable inputs, or “Level 3” measurements.

The asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any 
input that is significant to the fair value measurement. Valuation techniques used should seek to maximize the use of 
observable inputs and minimize the use of unobservable inputs.

Cash,  short-term  investments,  restricted  cash  and  long-term  debt  are  the  only  items  measured  at  fair  value  on  a 
recurring basis. The carrying amount of our short-term investments approximates fair value due to their very short 
maturity periods, and such investments are at or near market yields.

We do not have any financial assets measured at fair value on a nonrecurring basis. Nonfinancial assets measured 
at fair value on a nonrecurring basis include items such as long-lived assets held and used that are measured at fair 
value resulting from impairment, if deemed necessary.

NOTE 17 Commitments and Contingencies

LEASE COMMITMENTS

Our operating leases cover manufacturing, office, warehouse and distribution space, equipment and vehicles, which 
expire at various dates through 2028. Additionally, we have capital leases related to our North Carolina converting and 
manufacturing facilities. As leases expire, it can be expected that, in the normal course of business, certain leases will 
be renewed or replaced.

As of December 31, 2014, under current operating and capital lease contracts, we had future minimum lease payments 
as follows:

(In thousands)
2015
2016
2017
2018
2019
Thereafter
Total future minimum lease payments
Less interest portion

Present value of future minimum lease payments

Capital

Operating

$

$

$

2,530 $
2,576
2,623
2,670
2,697
32,193
45,289 $
(21,238)
24,051

14,588
11,899
9,669
6,351
3,293
7,503
53,303

Rent expense for operating leases was $18.6 million, $19.4 million and $16.6 million for the years ended December 31, 
2014, 2013 and 2012, respectively.

72

 
 
NOTE 18 Segment Information
We are organized in two reportable operating segments: Consumer Products and Pulp and Paperboard. The following 
is a tabular presentation of business segment information for each of the past three years. Corporate information is 
included to reconcile segment data to the financial statements. 

(In thousands)
Segment net sales1:
Consumer Products
Pulp and Paperboard
Total segment net sales
Operating income:

Consumer Products
Loss on divested assets2
Pulp and Paperboard

Corporate
Income from operations
Depreciation and amortization:

Consumer Products
Pulp and Paperboard
Corporate

Total depreciation and amortization
Assets:

Consumer Products
Pulp and Paperboard

Corporate
Total assets
Capital expenditures:
Consumer Products
Pulp and Paperboard

Corporate

Total capital expenditures

2014

2013

2012

$ 1,183,385 $ 1,149,692 $ 1,134,556
739,748
$ 1,967,139 $ 1,889,830 $ 1,874,304

783,754

740,138

$

$

$

$

34,131 $
(40,159)
144,171
138,143
(58,332)
79,811 $

52,799 $
—
95,781
148,580
(49,252)
99,328 $

93,347
—
103,910
197,257
(51,870)
145,387

61,504 $
25,452
3,189

90,145 $

65,197 $
23,266
1,809

90,272 $

54,547
23,113
1,673
79,333

$ 1,037,912 $ 1,215,919 $ 1,178,438
344,614
1,523,052
110,404
$ 1,585,928 $ 1,744,825 $ 1,633,456

413,143
1,451,055
134,873

359,735
1,575,654
169,171

$

$

43,562 $
45,146
88,708
10,892
99,600 $

46,647 $
30,846
77,493
9,015

86,508 $

183,330
19,954
203,284
3,831
207,115

1 

2 

In 2013 and 2012, pulp not utilized internally was sold by the Pulp and Paperboard segment to external customers resulting in net sales of 
$5.8 million and $9.0 million respectively. Commencing in 2014, the majority of excess pulp is sold by the Consumer Products segment and 
totaled $2.1 million.

These  costs  relate  to  the  sale  of  our  Consumer  Products  segment’s  specialty  business  and  mills.  For  additional  discussion,  see  Note  4, 
“Divested Assets”.

73

Our  manufacturing  facilities  and  all  other  assets  are  located  within  the  continental  United  States,  except  for  one 
production facility in St. Catharines, Ontario, Canada. Our St. Catharines mill was sold on December 30, 2014 as part 
of the sale of the specialty business and mills to a private buyer. We sell and ship our products to customers in many 
foreign countries. Geographic information regarding our net sales is summarized as follows:

(In thousands)
United States
Japan
Canada
Korea
Australia
Mexico
Taiwan
China
Other foreign countries
Total net sales

2014

2012

2013
$ 1,840,726 $ 1,751,001 $ 1,726,561
63,368
29,557
9,655
7,786
6,102
11,061
3,488
16,726
$ 1,967,139 $ 1,889,830 $ 1,874,304

67,728
26,161
10,899
7,924
2,964
1,755
5,404
15,994

63,831
25,411
11,105
7,219
3,385
2,000
1,876
11,586

NOTE 19 Financial Results by Quarter (Unaudited)

(In thousands—
  except per-share
  amounts)
Net sales

Costs and
  expenses:
Cost of sales

Selling, general and
  administrative
  expenses

Loss on divested
  assets

Impairment of
  assets

Total operating
  costs and
  expenses

Income (loss) from
  operations

Net earnings (loss)

Net earnings (loss)
  per common share

Basic

Diluted

March 31

June 30

September 30

December 31

2014

2013

2014

2013

2014

2013

2014

2013

$ 484,920

$ 460,824

$ 498,759

$ 471,002

$ 511,142

$ 487,845

$ 472,318

$ 470,159

Three Months Ended

(426,629)

(414,209)

(434,111)

(414,521)

(434,457)

(441,237)

(413,643)

(401,404)

(33,514)

(34,132)

(31,565)

(26,767)

(31,817)

(27,766)

(33,206)

(30,466)

—

(4,259)

—

—

—

—

—

—

—

(890)

—

—

(40,159)

(3,078)

—

—

(464,402)

(448,341)

(465,676)

(441,288)

(467,164)

(469,003)

(490,086)

(431,870)

20,518

12,483

33,083

29,714

43,978

18,842

(17,768)

38,289

$

6,226

$

(882) $

12,453

$

11,658

$

6,253

$

13,317

$ (27,247) $

82,862

$

0.30

0.29

$

(0.04) $

(0.04)

$

0.61

0.61

$

0.52

0.52

$

0.32

0.31

0.60

0.60

$

(1.39) $

(1.39)

3.91

3.87

74

 
 
NOTE 20 Supplemental Guarantor Financial Information
All of our directly and indirectly owned, domestic subsidiaries guarantee the 2014 Notes and the 2013 Notes on a joint 
and several basis. There are no significant restrictions on the ability of the guarantor subsidiaries to make distributions 
to Clearwater Paper, the issuer of the 2014 Notes and 2013 Notes. The following tables present the results of operations, 
financial position and cash flows of Clearwater Paper and its subsidiaries, the guarantor and non-guarantor entities, 
and the eliminations necessary to arrive at the information for Clearwater Paper on a consolidated basis.

Clearwater Paper Corporation
Consolidating Statement of Operations and Comprehensive Income (Loss)
Twelve Months Ended December 31, 2014 

(In thousands)
Net sales

Cost and expenses:

Cost of sales

Guarantor

Non-
Guarantor
Subsidiaries Subsidiaries Eliminations

Total

Issuer

$ 1,573,912

$

531,520

$

43,929

$

(182,222) $ 1,967,139

(1,321,143)

(526,192)

(43,727)

182,222

(1,708,840)

Selling, general and administrative expenses

(107,141)

Loss on divested assets

Impairment of assets

—

—

(22,747)

(40,159)

(8,227)

(214)

—

—

—

—

—

(130,102)

(40,159)

(8,227)

Total operating costs and expenses

(1,428,284)

(597,325)

(43,941)

182,222

(1,887,328)

Income (loss) from operations

145,628

(65,805)

Interest expense, net

Debt retirement costs

Earnings (loss) before income taxes

Income tax (provision) benefit

Equity in loss of subsidiary

Net (loss) earnings

Other comprehensive loss, net of tax
Comprehensive loss

(39,091)

(24,420)

82,117

(47,694)

(58,953)

(59)

—

(65,864)

7,439

(528)

(12)

—

—

(12)

(516)

—

—

—

—

—

22,215

59,481

79,811

(39,150)

(24,420)

16,241

(18,556)

—

$

$

(24,530) $

(58,953) $

(528) $

81,696

$

(2,315)

(12,770)

—

—

—

(12,770)

(37,300) $

(58,953) $

(528) $

81,696

$

(15,085)

Clearwater Paper Corporation
Consolidating Statement of Operations and Comprehensive Income (Loss)
Twelve Months Ended December 31, 2013

Selling, general and administrative expenses

(94,861)

(22,918)

Total operating costs and expenses

(1,363,968)

(575,924)

(1,269,107)

(553,006)

(In thousands)
Net sales

Cost and expenses:

Cost of sales

Income (loss) from operations

Interest expense, net

Debt retirement costs

Earnings (loss) before income taxes

Income tax benefit (provision)

Equity in loss of subsidiary

Net earnings (loss)

Guarantor

Non-
Guarantor
Subsidiaries Subsidiaries Eliminations

Total

Issuer

$ 1,474,103

$

565,783

$

54,978

$

(205,034) $ 1,889,830

110,135

(44,031)

(17,058)

49,046

61,778

(15,370)

(10,141)

(5)

—

(10,146)

(4,420)

(804)

(54,292)

(1,352)

(55,644)

(666)

—

—

(666)

(138)

—

205,034

(1,671,371)

—

(119,131)

205,034

(1,790,502)

—

—

—

—

11,501

16,174

99,328

(44,036)

(17,058)

38,234

68,721

—

$

95,454

$

(15,370) $

(804) $

27,675

$

106,955

Other comprehensive income, net of tax
Comprehensive income (loss)

57,600

—

—

—

57,600

$

153,054

$

(15,370) $

(804) $

27,675

$

164,555

75

Clearwater Paper Corporation
Consolidating Statement of Operations and Comprehensive Income (Loss)
Twelve Months Ended December 31, 2012 

Selling, general and administrative expenses

(96,668)

(22,268)

Total operating costs and expenses

(1,274,816)

(524,147)

(1,178,148)

(501,879)

(In thousands)
Net sales

Cost and expenses:

Cost of sales

Income from operations

Interest expense, net

Earnings before income taxes

Income tax provision

Equity in income of subsidiary

Net earnings

Other comprehensive loss, net of tax
Comprehensive income

Guarantor

Non-
Guarantor
Subsidiaries Subsidiaries Eliminations

Total

Issuer

$ 1,404,467

$

539,570

$

59,442

$

(129,175) $ 1,874,304

129,651

(33,796)

95,855

(42,440)

1,339

15,423

—

15,423

(14,362)

278

(57,020)

(2,109)

(59,129)

129,175

(1,607,872)

—

(121,045)

129,175

(1,728,917)

313

—

313

(35)

—

—

—

—

9,377

(1,617)

145,387

(33,796)

111,591

(47,460)

—

$

$

54,754

$

1,339

$

278

$

7,760

$

64,131

(428)

—

—

—

(428)

54,326

$

1,339

$

278

$

7,760

$

63,703

76

Clearwater Paper Corporation
Consolidating Balance Sheet
At December 31, 2014 

(In thousands)
ASSETS

Current assets:

Cash

Restricted cash
Short-term investments
Receivables, net
Taxes receivable
Inventories
Deferred tax assets
Prepaid expenses

Total current assets

Property, plant and equipment, net

Goodwill

Intangible assets, net

Intercompany receivable (payable)

Investment in subsidiary

Pension assets

Other assets, net

TOTAL ASSETS

LIABILITIES AND STOCKHOLDERS’
  EQUITY
Current liabilities:

Accounts payable and accrued 
  liabilities

Current liability for pensions and 
  other postretirement employee 
  benefits

Total current liabilities

Long-term debt

Liability for pensions and other 
  postretirement employee benefits

Other long-term obligations
Accrued taxes

Deferred tax liabilities

Accumulated other comprehensive loss,
  net of tax
Stockholders’ equity excluding
  accumulated other comprehensive loss
TOTAL LIABILITIES AND
  STOCKHOLDERS’ EQUITY

Issuer

Guarantor
Subsidiaries

Non-
Guarantor
Subsidiaries Eliminations

Total

$

27,331 $

1,500
50,000
117,970
6,760
246,210
14,733
3,734
468,238

657,369

209,087

5,224

33,703

137,282

4,738

8,496
$1,524,137 $

— $
—
—
16,557
(15,758)
40,416
5,206
457

46,878

153,618

19,732

(21,629)

—

—

1,087

— $
—
—
—
—
—
—
—

—

—

—

—

—

—

—

—

— $
—
—
(613)
10,253
—
1,821
—

11,461

—

—

—

(12,074)

(137,282)

—

—

27,331
1,500
50,000
133,914
1,255
286,626
21,760
4,191

526,577

810,987

209,087

24,956

—

—

4,738

9,583

199,686 $

— $ (137,895) $1,585,928

$ 193,326 $

23,113 $

— $

(613) $ 215,826

7,915

201,241

575,000

118,464

56,029
1,902

73,964

—

23,113

—

—
827

794

37,670

(70,863)

—

568,400

137,282

—

—

—

—
—

—

—

—

—

—

(613)

—

—
—

—

—

—

7,915

223,741

575,000

118,464
56,856

2,696

111,634

(70,863)

(137,282)

568,400

$1,524,137 $

199,686 $

— $ (137,895) $1,585,928

77

 
Clearwater Paper Corporation
Consolidating Balance Sheet
At December 31, 2013 

(In thousands)
ASSETS

Current assets:

Cash

Restricted cash
Short-term investments
Receivables, net
Taxes receivable
Inventories
Deferred tax assets
Prepaid expenses

Total current assets

Property, plant and equipment, net

Goodwill

Intangible assets, net

Intercompany receivable (payable)

Investment in subsidiary

Pension assets

Other assets, net

TOTAL ASSETS

LIABILITIES AND STOCKHOLDERS’
  EQUITY
Current liabilities:

Accounts payable and accrued 
  liabilities

Current liability for pensions and 
  other postretirement employee 
  benefits

Total current liabilities

Long-term debt

Liability for pensions and other 
  postretirement employee benefits

Other long-term obligations

Accrued taxes

Deferred tax liabilities

Accumulated other comprehensive loss,
  net of tax
Stockholders’ equity excluding
  accumulated other comprehensive loss

TOTAL LIABILITIES AND
  STOCKHOLDERS’ EQUITY

Issuer

Guarantor
Subsidiaries

Non-
Guarantor
Subsidiaries Eliminations

Total

$

18,273 $

1,500
70,000
119,278
3,709
198,476
42,289
4,704
458,229

636,662

229,533

—

91,865

196,763

4,488

8,772
$1,626,312 $

— $
—
—
38,063
(15,882)
65,017
6,094
695

93,987

231,225

—

39,619

(63,932)

5,575

—

1,155

5,402 $
—
—
2,700
324
4,295
5
124

12,850

16,811

—

1,159

— $
—
—
(1,167)
22,352
—
(10,850)
—

10,335

—

—

—

(16,431)

(11,502)

—

—

—

(202,338)

—

—

23,675
1,500
70,000
158,874
10,503
267,788
37,538
5,523

575,401

884,698

229,533

40,778

—

—

4,488

9,927

307,629 $

14,389 $ (203,505) $1,744,825

$ 140,125 $

45,736 $

5,954 $

(1,167) $ 190,648

8,778

148,903

650,000

109,807

51,740

1,430

59,338

—

45,736

—

—

1,202

911

63,017

(58,093)

—

—

5,954

—

—

—

317

2,543

—

—

(1,167)

—

—

—

—

—

—

8,778

199,426

650,000

109,807

52,942

2,658

124,898

(58,093)

663,187

196,763

5,575

(202,338)

663,187

$1,626,312 $

307,629 $

14,389 $ (203,505) $1,744,825

78

 
Clearwater Paper Corporation
Consolidating Statement of Cash Flows
Twelve Months Ended December 31, 2014 

(In thousands)

CASH FLOWS FROM OPERATING
  ACTIVITIES
Net loss

Adjustments to reconcile net loss to net cash
  flows from operating activities:

Depreciation and amortization

Equity-based compensation expense

Impairment of assets

Deferred tax provision (benefit)

Employee benefit plans

Deferred issuance costs and discounts
  on long-term debt
Loss on divestiture of assets

Disposal of plant and equipment, net

Non-cash adjustments to unrecognized
  taxes

Changes in working capital, net

Change in taxes receivable, net

Excess tax benefits from equity-based
  payment arrangements
Change in non-current accrued taxes, net

Funding of qualified pension plans

Other, net

Net cash flows from operating activities

CASH FLOWS FROM INVESTING
  ACTIVITIES
Change in short-term investments, net

Additions to plant and equipment

Net proceeds from divested assets

Proceeds from the sale of assets

Net cash flows from investing activities

CASH FLOWS FROM FINANCING
  ACTIVITIES
Proceeds from long-term debt

Repayment of long-term debt

Purchase of treasury stock

Investment from (to) parent

Payments for long-term debt issuance costs
Payment of tax withholdings on equity-
  based payment arrangements
Excess tax benefits from equity-based
  payment arrangements
Other, net

Increase (decrease) in cash

Cash at beginning of period

Cash at end of period

Issuer

Guarantor
Subsidiaries

Non-
Guarantor
Subsidiaries Eliminations

Total

$

(24,530) $

(58,953) $

(528) $

81,696 $

(2,315)

59,373

12,790

—

50,943

2,115

6,141

—

471

472

(8,162)

(3,051)

(864)

—

(16,955)

(636)

78,107

20,000

(73,223)

107,740

38

54,555

300,000

(375,000)

(100,000)

47,527

(3,002)

(1,523)

864

7,530

28,468

—

8,227

2,304

—

—

—

—

—

(21,921)

(2,538)

(12,671)

—

—

29,059

488

(117)

(4,711)

79

—

290

—

(707)

(19,798)

—

(19,450)

—

937

(18,513)

—

—

—

—

—

—

—

(317)

625

121

—

—

—

—

—

—

—

—

—

—

12,099

—

—

—

—

(333)

81,124

—

(355)

—

—

(355)

—

—

—

—

—

—

—

—

—

—

—

38,311

(4,714)

(81,124)

—

—

—

—

—

—

—

—

(4,714)

(5,402)

5,402

—

—

—

—

—

—

90,145

12,790

8,227

13,813

2,115

6,141

29,059

959

38

(12,248)

9,248

(864)

290

(16,955)

(1,343)

139,100

20,000

(93,028)

107,740

975

35,687

300,000

(375,000)

(100,000)

—

(3,002)

(1,523)

864

7,530

3,656

23,675

27,331

9,058

18,273

—

—

$

27,331

$

— $

— $

— $

79

Net cash flows from financing activities

(123,604)

38,311

(81,124)

(171,131)

Clearwater Paper Corporation
Consolidating Statement of Cash Flows
Twelve Months Ended December 31, 2013 

(In thousands)
CASH FLOWS FROM OPERATING
  ACTIVITIES

Issuer

Guarantor
Subsidiaries

Non-
Guarantor
Subsidiaries Eliminations

Total

Net earnings (loss)

$

95,454

$

(15,370) $

(804) $

27,675

$

106,955

Adjustments to reconcile net earnings (loss) to 
  net cash flows from operating activities:

Depreciation and amortization

Equity-based compensation expense

Deferred tax provision (benefit)

Employee benefit plans

Deferred issuance costs and discounts
  on long-term debt
Disposal of plant and equipment, net

Non-cash adjustments to unrecognized
  taxes

Changes in working capital, net

Change in taxes receivable, net

Change in non-current accrued taxes, net

Funding of qualified pension plans

Other, net

Net cash flows from operating activities

CASH FLOWS FROM INVESTING
  ACTIVITIES
Change in short-term investments, net

Additions to plant and equipment

Net cash flows from investing activities

CASH FLOWS FROM FINANCING
  ACTIVITIES
Proceeds from long-term debt

Repayment of long-term debt

Purchase of treasury stock

Investment from (to) parent

Payments for long-term debt issuance costs

Payment of tax withholdings on
  equity-based payment arrangements
Net cash flows from financing activities

Increase (decrease) in cash

Cash at beginning of period

Cash at end of period

54,291

10,960

3,185

10,131

4,964

201

(75,308)

(31,256)

17,003

1,423

(15,050)

(452)

75,546

33,712

—

(9,072)

—

—

1,291

—

11,747

15,998

(860)

—

891

2,269

—

(125)

—

—

11,641

—

—

1

—

4,487

(324)

6

—

—

—

—

—

—

—

(22,352)

—

—

—

90,272

10,960

5,629

10,131

4,964

1,493

(75,308)

(15,022)

10,325

569

(15,050)

439

38,337

5,510

16,964

136,357

(50,000)

(65,708)

(115,708)

—

(22,562)

(22,562)

—

(2,323)

(2,323)

275,000

(150,000)

(100,000)

31,998

(4,837)

(4,831)

47,330

7,168

11,105

—

—

—

(15,780)

—

—

(15,780)

(5)

5

—

—

—

746

—

—

746

3,933

1,469

—

—

—

—

—

—

(16,964)

—

—

(16,964)

—

—

$

18,273

$

— $

5,402

$

— $

(50,000)

(90,593)

(140,593)

275,000

(150,000)

(100,000)

—

(4,837)

(4,831)

15,332

11,096

12,579

23,675

80

Clearwater Paper Corporation
Consolidating Statement of Cash Flows
Twelve Months Ended December 31, 2012 

(In thousands)
CASH FLOWS FROM OPERATING
  ACTIVITIES

Issuer

Guarantor
Subsidiaries

Non-
Guarantor
Subsidiaries Eliminations

Total

Net earnings

$

54,754

$

1,339

$

278

$

7,760

$

64,131

48,191

9,703

9,840

9,366

2,010

622

3,275

25,252

(11,755)

(15,837)

(242)

(20,627)

1,317

115,869

29,030

—

4,009

—

—

1,381

—

36,596

593

—

22

—

(264)

72,706

2,112

—

(188)

—

—

—

—

(567)

334

—

1,180

—

—

—

—

(791)

—

—

—

—

—

—

—

—

—

—

3,149

6,969

79,333

9,703

12,870

9,366

2,010

2,003

3,275

61,281

(10,828)

(15,837)

960

(20,627)

1,053

198,693

Adjustments to reconcile net earnings to net
  cash flows from operating activities:

Depreciation and amortization

Equity-based compensation expense

Deferred tax provision (benefit)

Employee benefit plans

Deferred issuance costs and discounts
  on long-term debt
Disposal of plant and equipment, net

Non-cash adjustments to unrecognized
  taxes

Changes in working capital, net

Change in taxes receivable, net

Excess tax benefits from equity-based
  payment arrangements
Change in non-current accrued taxes, net

Funding of qualified pension plans

Other, net

Net cash flows from operating activities

CASH FLOWS FROM INVESTING
  ACTIVITIES
Change in short-term investments, net

Additions to plant and equipment

Proceeds from the sale of assets

Cash paid for acquisitions, net of
  cash acquired

CASH FLOWS FROM FINANCING
  ACTIVITIES
Purchase of treasury stock

Investment from (to) parent

Payments for long-term debt issuance costs

Payment of tax withholdings on
  equity-based payment arrangements
Excess tax benefits from equity-based
  payment arrangements
Other, net

Net cash flows from financing activities

Increase (decrease) in cash

Cash at beginning of period

Cash at end of period

35,001

(190,296)

—

—

(11,632)

1,035

(9,264)

—

—

(1,848)

—

—

Net cash flows from investing activities

(164,559)

(10,597)

(1,848)

—

—

—

—

—

35,001

(203,776)

1,035

(9,264)

(177,004)

—

(18,650)

(18,650)

75,198

(2)

(13,234)

15,837

(1,500)

57,649

8,959

2,146

—

(66,463)

—

(1,766)

—

—

—

—

—

—

—

—

(6,969)

—

—

—

—

(66,463)

(4,354)

4,359

(1,766)

(465)

1,934

(6,969)

—

—

—

(2)

(13,234)

15,837

(1,500)

(17,549)

4,140

8,439

$

11,105

$

5

$

1,469

$

— $

12,579

81

REPORT OF INDEPENDENT REGISTERED PUBLIC 
ACCOUNTING FIRM

The Board of Directors and Stockholders
Clearwater Paper Corporation:

We have audited the accompanying consolidated balance sheets of Clearwater Paper Corporation (the Company) 
and  subsidiaries  as  of  December 31,  2014  and  2013,  and  the  related  consolidated  statements  of  operations, 
comprehensive (loss) income, cash flows, and stockholders’ equity for each of the years in the 
period ended 
December 31, 2014. These consolidated financial statements are the responsibility of the Company’s management. 
Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United 
States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether 
the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence 
supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting 
principles used and significant estimates made by management, as well as evaluating the overall financial statement 
presentation. We believe that our audits provide a reasonable basis for our opinion.

In  our  opinion,  the  consolidated  financial  statements  referred  to  above  present  fairly,  in  all  material  respects,  the 
financial position of Clearwater Paper Corporation and subsidiaries as of December 31, 2014 and 2013, and the results 
of their operations and their cash flows for each of the years in the 
period ended December 31, 2014, in 
conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United 
States), Clearwater Paper Corporation’s internal control over financial reporting as of December 31, 2014, based on 
criteria  established  in  Internal  Control  -  Integrated  Framework  (1992)  issued  by  the  Committee  of  Sponsoring 
Organizations of the Treadway Commission (COSO), and our report dated February 26, 2015 expressed an unqualified 
opinion on the effectiveness of the Company’s internal control over financial reporting.

/s/ KPMG LLP

Seattle, Washington

February 26, 2015

82

 
REPORT OF INDEPENDENT REGISTERED PUBLIC 
ACCOUNTING FIRM

The Board of Directors and Stockholders
Clearwater Paper Corporation:

We  have  audited  Clearwater  Paper  Corporation’s  (the  Company’s)  internal  control  over  financial  reporting  as  of 
December 31, 2014, based on criteria established in Internal Control - Integrated Framework (1992) issued by the 
Committee  of  Sponsoring  Organizations  of  the  Treadway  Commission  (COSO).  Clearwater  Paper  Corporation’s 
management is responsible for maintaining effective internal control over financial reporting and for its assessment of 
the effectiveness of internal control over financial reporting, included in the accompanying Management Report on 
Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control 
over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United 
States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether 
effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining 
an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and 
testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit 
also included performing such other procedures as we considered necessary in the circumstances. We believe that 
our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding 
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with 
generally accepted accounting principles. A company’s internal control over financial reporting includes those policies 
and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect 
the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions 
are  recorded  as  necessary  to  permit  preparation  of  financial  statements  in  accordance  with  generally  accepted 
accounting principles, and that receipts and expenditures of the company are being made only in accordance with 
authorizations  of  management  and  directors  of  the  company;  and  (3) provide  reasonable  assurance  regarding 
prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have 
a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. 
Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become 
inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may 
deteriorate.

In our opinion, Clearwater Paper Corporation maintained, in all material respects, effective internal control over financial 
reporting as of December 31, 2014, based on criteria established in Internal Control - Integrated Framework (1992) 
issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United 
States), the consolidated balance sheets of Clearwater Paper Corporation and subsidiaries as of December 31, 2014 
and  2013,  and  the  related  consolidated  statements  of  operations,  comprehensive  (loss)  income,  cash  flows,  and 
stockholders’ equity for each of the years in the 
period ended December 31, 2014, and our report dated 
February 26, 2015 expressed an unqualified opinion on those consolidated financial statements.

/s/ KPMG LLP

Seattle, Washington

February 26, 2015

83

ITEM 9.
Changes in and Disagreements with Accountants on Accounting and
Financial Disclosure

None.

ITEM 9A.
Controls and Procedures

Evaluation of Controls and Procedures

We maintain "disclosure controls and procedures," as such term is defined in Rule 13a-15(e) under the Securities 
Exchange Act of 1934, or the Exchange Act, that are designed to ensure that information required to be disclosed by 
us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within 
the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to 
our management, including our Chief Executive Officer, or CEO, and Chief Financial Officer, or CFO, as appropriate, 
to  allow  timely  decisions  regarding  required  disclosure.  In  designing  and  evaluating  our  disclosure  controls  and 
procedures, management recognized that disclosure controls and procedures, no matter how well conceived and 
operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and 
procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was 
required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. 
The design of disclosure controls and procedures is also based in part upon certain assumptions about the likelihood 
of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all 
potential future conditions.

Subject to the limitations noted above, our management, with the participation of our CEO and CFO, has evaluated 
the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the fiscal year 
covered by this annual report on Form 10-K. Based on that evaluation, the CEO and CFO have concluded that, as of 
such date, our disclosure controls and procedures are effective to meet the objective for which they were designed 
and operate at the reasonable assurance level.

Changes in Internal Controls

There was no change in our internal control over financial reporting during our most recent fiscal quarter that has 
materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Management Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as 
defined in Rules 13a-15(f) of the Exchange Act).

Under the supervision of and with the participation of our CEO and our CFO, our management conducted an assessment 
of the effectiveness of our internal control over financial reporting based on the framework and criteria established in 
the Internal Control — Integrated Framework (1992), issued by the Committee of Sponsoring Organizations of the 
Treadway Commission. Based on this assessment, our management has concluded that as of December 31, 2014 
our internal control over financial reporting was effective. The effectiveness of our internal control over financial reporting 
as of December 31, 2014 has been audited by KPMG LLP, our independent registered public accounting firm, as stated 
in its report which is included in this Annual Report on Form 10-K.

ITEM 9B.
Other Information

None.

84

Part III

ITEM 10.
Directors, Executive Officers and Corporate Governance

Information regarding our directors is set forth under the heading “Board of Directors” in our definitive proxy statement, 
to be filed on or about March 24, 2015, for the 2015 annual meeting of stockholders, referred to in this report as the 
2015  Proxy  Statement,  which  information  is  incorporated  herein  by  reference.  Information  concerning  Executive 
Officers is included in Part I of this report in Item 1. Information regarding reporting compliance with Section 16(a) for 
directors,  officers  or  other  parties  is  set  forth  under  the  heading  “Section  16(a)  Beneficial  Ownership  Reporting 
Compliance” in the 2015 Proxy Statement and is incorporated herein by reference.

We have adopted a Code of Business Conduct and Ethics that applies to all directors and employees and a Code of 
Ethics  for  Senior  Financial  Officers  that  applies  to  our  CEO,  CFO,  the  President,  the  Controller  and  other  Senior 
Financial Officers identified by our Board of Directors. You can find each code on our website by going to the following 
address: www.clearwaterpaper.com, selecting “Investor Relations” and “Corporate Governance,” then selecting the 
link for “Code of Business Conduct and Ethics" or "Code of Ethics for Senior Financial Officers.” We will post any 
amendments, as well as any waivers that are required to be disclosed by the rules of either the SEC or the New York 
Stock Exchange, on our website. To date, no waivers of the Code of Ethics for Senior Financial Officers have been 
considered or granted.

Our Board of Directors has adopted corporate governance guidelines and charters for the Board of Directors’ Audit 
Committee, Compensation Committee, and Nominating and Governance Committee. You can find these documents 
on  our  website  by  going  to  the  following  address:  www.clearwaterpaper.com,  selecting  “Investor  Relations”  and 
“Corporate Governance,” then selecting the appropriate link.

The Audit Committee of our Board of Directors is an “audit committee” for purposes of Section 3(a)(58) of the Exchange 
Act. As of December 31, 2014, the members of that committee were Boh A. Dickey (Chair), Beth E. Ford, and William 
D. Larsson. The Board of Directors has determined that Messrs. Dickey and Larsson are each an “audit committee 
financial expert” and that all of the members of the Audit Committee are “independent” as defined under the applicable 
rules and regulations of the SEC and the listing standards of the New York Stock Exchange.

ITEM 11.
Executive Compensation

Information required by Item 11 of Part III is included under the heading “Executive Compensation Discussion and 
Analysis” in our 2015 Proxy Statement, to be filed on or about March 24, 2015, relating to our 2015 Annual Meeting 
of Shareholders and is incorporated herein by reference.

85

ITEM 12.
Security Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters

Information required by Item 12 of Part III is included in our 2015 Proxy Statement, to be filed on or about March 24, 
2015, relating to our 2015 Annual Meeting of Shareholders and is incorporated herein by reference.

The following table provides certain information as of December 31, 2014, with respect to our equity compensation 
plans:

Plan Category
Equity compensation plans
  approved by security holders
Equity compensation plans not
  approved by security holders
Total

Number Of Securities
To Be Issued Upon
Exercise Of
Outstanding Options,
Warrants And Rights1

Weighted Average
Exercise Price Of
Outstanding Options,
Warrants And Rights2

Number of Securities
Remaining Available
For Future Issuance
Under Equity
Compensation Plans

904,040

—
904,040

—

—
—

1,872,047

—
1,872,047

1  

Includes 601,728 performance shares, 150,580 stock options, and 151,732 restricted stock units, or RSUs, which are the maximum number 
of shares that could be awarded under the performance share, stock option, and RSU programs, not including future dividend equivalents, if 
any are paid.

2   Performance shares, and RSUs do not have exercise prices, and there are no stock options that are vested therefore do not have exercise 

prices, as such there are no shares to include in the weighted average exercise price calculation. 

ITEM 13.
Certain Relationships and Related Transactions, and Director Independence

Information required by Item 13 of Part III is included under the heading “Transactions with Related Persons” in our 
2015 Proxy Statement, to be filed on or about March 24, 2015, relating to our 2015 Annual Meeting of Shareholders 
and is incorporated herein by reference.

ITEM 14.
Principal Accounting Fees and Services

Information required by Item 14 of Part III is included under the heading “Fees Paid to Independent Registered Public 
Accounting Firm” in our 2015 Proxy Statement, to be filed on or about March 24, 2015, relating to our 2015 Annual 
Meeting of Shareholders and is incorporated herein by reference.

86

PART IV

ITEM 15.
Exhibits, Financial Statement Schedules

FINANCIAL STATEMENTS

Our consolidated financial statements are listed in the Index to Consolidated Financial Statements on page 40 of this 
report.

FINANCIAL STATEMENT SCHEDULES

All schedules have been omitted because the required information is not present or is not present in amounts sufficient 
to require submission of the schedule, or because the information required is included in the consolidated financial 
statements, including the notes thereto.

EXHIBITS

Exhibits are listed in the Exhibit Index on pages 89-93 of this report.

87

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly 
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

CLEARWATER PAPER CORPORATION

(Registrant)

By  

/S/    Linda K. Massman
Linda K. Massman 
President, Chief Executive Officer and Director 
(Principal Executive Officer)

Date: February 26, 2015 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following 
persons on behalf of the registrant and in the capacities and on the dates indicated. 

By

By   

By   

/S/    Linda K. Massman
Linda K. Massman

/S/    John D. Hertz
John D. Hertz

/S/    Johnathan D. Hunter
Johnathan D. Hunter

President, Chief Executive Officer
and Director (Principal Executive
Officer)

  Senior Vice President, Finance
and Chief Financial Officer (Duly
Authorized Officer; Principal
Financial Officer)

Vice President, Corporate
Controller (Duly Authorized
Officer; Principal Accounting
Officer)

Date
February 26, 2015

February 26, 2015

February 26, 2015

*
Boh A. Dickey

*
Frederic W. Corrigan

*
Beth E. Ford

*
Kevin J. Hunt

*
William D. Larsson

*
Michael T. Riordan

  Director and Chair of the Board

February 26, 2015

February 26, 2015

February 26, 2015

February 26, 2015

February 26, 2015

February 26, 2015

*By  

/S/    Michael S. Gadd
Michael S. Gadd
(Attorney-in-fact)

  Director

Director

Director

  Director

  Director

88

 
 
   
   
    
  
 
    
    
 
    
  
    
  
    
  
    
  
    
   
 
Exhibit Index

EXHIBIT
NUMBER
2.1*

2.2*

3.1*

3.2*

4.1*

4.2*

4.3*

4.4*

4.5*

10.1*

10.1(i)*

10.1(ii)*

DESCRIPTION
Separation  and  Distribution  Agreement,  dated  December  15,  2008,  between  Clearwater 
Paper Corporation (the “Company”) and Potlatch Corporation (incorporated by reference to 
Exhibit  2.1  to  the  Company’s  Current  Report  on  Form  8-K  filed  with  the  Securities  and 
Exchange Commission (the “Commission”) on December 18, 2008).

Agreement and Plan of Merger, dated as of September 15, 2010, by and among the Company, 
Cellu  Tissue  Holdings,  Inc.,  and  Sand  Dollar  Acquisition  Corporation  (incorporated  by 
reference  to  Exhibit  2.1  to  the  Company’s  Current  Report  on  Form  8-K  filed  with  the 
Commission on September 21, 2010).

Restated Certificate of Incorporation of the Company, effective as of December 16, 2008, as 
filed with the Secretary of State of the State of Delaware (incorporated by reference to Exhibit 
3.1 to the Company’s Current Report on Form 8-K filed with the Commission on December 
18, 2008).

Amended  and  Restated  Bylaws  of  the  Company,  effective  as  of  December  16,  2008 
(incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed 
with the Commission on December 18, 2008).

Indenture, dated as of January 23, 2013, by and among Clearwater Paper Corporation (the 
“Registrant”), the Guarantors (as defined therein) and U.S. Bank National Association, as 
trustee, (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 
8-K filed with the Commission on January 24, 2013).

Form  of  4.500%  Senior  Notes  due  2023  (incorporated  by  reference  to  Exhibit  4.2  to  the 
Company's Current Report on Form 8-K filed with the Commission on January 24, 2013).

Registration Rights Agreement, dated as of January 23, 2013, by and among the Registrant, 
the Guarantors (as defined therein), Goldman Sachs & Co. and Merrill Lynch, Pierce Fenner 
& Smith Incorporated, as the initial purchasers, (incorporated by reference to Exhibit 4.3 to 
the Company's Current Report on Form 8-K filed with the Commission on January 24, 2013).

Indenture,  dated  as  of  July  29,  2014,  by  and  among  Clearwater  Paper  Corporation  (the 
“Registrant”), the Guarantors (as defined therein) and U.S. Bank National Association, as 
trustee, (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 
8-K filed with the Commission on July 29, 2014).

Form  of  5.375%  Senior  Notes  due  2025  (incorporated  by  reference  as  Exhibit A  to  the 
Indenture filed as Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the 
Commission on July 29, 2014).

Loan and Security Agreement, dated as of November 26, 2008, by and among the Company 
and  Bank  of  America,  N.A.,  as  administrative  agent,  and  the  lenders  party  thereto 
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed 
with the Commission on December 3, 2008).

First Amendment to Loan and Security Agreement, dated as of September 15, 2010, by and 
among the financial institutions signatory thereto, Bank of America, N.A. and the Company 
(incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed 
with the Commission on September 21, 2010).

Second Amendment to Loan and Security Agreement, dated as of October 22, 2010, by and 
among the financial institutions signatory thereto, Bank of America, N.A. and the Company 
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed 
with the Commission on October 27, 2010).

89

 
 
 
 
 
 
 
 
 
10.1(iii)*

10.1(iv)*

10.1(v)*

10.1(vi)*

10.1(vii)*

10.1(viii)*

10.1(ix)*

10.1(x)

10.2*1

10.3*1

10.3(i)*1

10.4*1

10.4(i)*1

Third Amendment to Loan and Security Agreement, dated as of February 7, 2011, by and 
among the financial institutions signatory thereto, Bank of America, N.A. and the Company 
(incorporated by reference to Exhibit 10.3(iii) to the Company’s Annual Report on Form 10-
K filed with the Commission on March 11, 2011).

Fourth Amendment to  Loan  and  Security Agreement, dated  as  of  March 2,  2011, by  and 
among the financial institutions signatory thereto, Bank of America, N.A. and the Company 
(incorporated by reference to Exhibit 10.3(iv) to the Company’s Annual Report on Form 10-
K filed with the Commission on March 11, 2011).

Fifth Amendment to  Loan  and  Security Agreement, dated  as  of August 17,  2011, by  and 
among the financial institutions signatory thereto, Bank of America, N.A. and the Company 
(incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q 
filed with the Commission for the quarter ended September 30, 2011).

Sixth Amendment to Loan and Security Agreement, dated as of September 28, 2011, by and 
among the financial institutions signatory thereto, Bank of America, N.A. and the Company 
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed 
with the Commission on September 30, 2011).

Seventh Amendment to Loan and Security Agreement, dated as of September 27, 2012, by 
and among the financial institutions signatory thereto, Bank of America, N.A. and the Company 
(incorporated by reference to Exhibit 10.3(vii) to the Company's Annual Report on Form 10-
K filed with the Commission on February 25, 2013).

Eighth Amendment to Loan and Security Agreement, dated as of January 17, 2013, by and 
among the financial institutions signatory thereto, Bank of America, N.A. and the Company 
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed 
with the Commission on January 24, 2013).

Ninth Amendment to Loan and Security Agreement, dated as of July 24, 2014, by and among 
the  financial  institutions  signatory  thereto,  Bank  of  America,  N.A.  and  the  Company 
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed 
with the Commission on July 29, 2014).

Tenth Amendment to Loan and Security Agreement, dated as of December 30, 2014, by and 
among the financial institutions signatory thereto, Bank of America, N.A. and the Company.

Form  of  Indemnification  Agreement  entered  into  between  the  Company  and  each  of  its 
directors and executive officers (incorporated by reference to Exhibit 10.15 to Amendment 
No. 4 to the Company’s Registration Statement on Form 10 filed with the Commission on 
November 19, 2008).

Employment  Agreement  between  Linda  K.  Massman  and  the  Company,  dated  effective 
January 1, 2013 (incorporated by reference to Exhibit 10.7 to the Company's Annual Report 
on Form 10-K filed with the Commission on February 25, 2013).

Clearwater Paper Corporation 2008 Stock Incentive Plan-Restricted Stock Unit Agreement, 
dated as of January 1, 2013, with Linda K. Massman (incorporated by reference to Exhibit 
10.7(i) to the Company's Annual Report on Form 10-K filed with the Commission on February 
25, 2013).

Clearwater Paper Corporation 2008 Stock Incentive Plan (incorporated by reference to Exhibit 
10.1 to the Company’s Current Report on Form 8-K filed with the Commission on December 
19, 2008).

Amendment No. 1 to Clearwater Paper Corporation 2008 Stock Incentive Plan (incorporated 
by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the 
Commission on December 28, 2010).

90

 
 
 
 
 
 
 
 
10.4(ii)*1

10.5*1

10.5(i)*1

10.5(ii)1

10.5(iii)1

10.6*1

10.6(i)*1

10.6(ii)*1

10.6(iii)*1

10.6(iv)*1

10.6(v)*1

10.6(vi)*1

10.6(vii)*1

Amendment No. 2 to Clearwater Paper Corporation 2008 Stock Incentive Plan (incorporated 
by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed with the 
Commission for the quarter ended September 30, 2011).

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Performance  Share 
Agreement,  to  be  used  for  annual  performance  share  awards  approved  subsequent  to 
December  31,  2011 (incorporated  by  reference  to  Exhibit  10.6  to  the  Company’s Current 
Report on Form 8-K filed with the Commission December 14, 2011).

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Performance  Share 
Agreement as amended and restated February 11, 2014, to be used for annual performance 
share awards approved subsequent to December 31, 2013, (incorporated by reference to 
Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission February 
18, 2014).

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Amendment  of 
Performance Share Agreement, effective as of January 1, 2015. 

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Performance  Share 
Agreement  to  be  used  for  annual  performance  share  awards  approved  subsequent  to 
December 31, 2014. 

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Restricted  Stock  Unit 
Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on 
Form 8-K filed with the Commission on December 19, 2008).

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Restricted  Stock  Unit 
Agreement,  as  amended  and  restated  May  12,  2009,  to  be  used  for  restricted  stock  unit 
awards approved subsequent to May 12, 2009 (incorporated by reference to Exhibit 10.12(i) 
to the Company’s Quarterly Report on Form 10-Q filed with the Commission for the quarter 
ended June 30, 2009).

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Restricted  Stock  Unit 
Agreement, as amended and restated December 1, 2009, to be used for annual restricted 
stock unit awards approved subsequent to December 31, 2009, (incorporated by reference 
to Exhibit 10.12(ii) to the Company's Current Report on Form 8-K filed with the Commission 
on December 4, 2009).

Clearwater Paper Corporation 2008 Stock Incentive Plan—Form of RSU Deferral Agreement 
for Founders Grant RSUs (incorporated by reference to Exhibit 10.4 to the Company’s Current 
Report on Form 8-K filed with the Commission on December 14, 2011).

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Restricted  Stock  Unit 
Agreement,  to  be  used  for  annual  restricted  stock  unit  awards  approved  subsequent  to 
December  31,  2011 (incorporated  by  reference  to  Exhibit  10.5  to  the  Company’s Current 
Report on Form 8-K filed with the Commission on December 14, 2011).

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan-Form  of  Restricted  Stock  Unit 
Agreement, to be used for special restricted stock unit awards (incorporated by reference to 
Exhibit 10.10(vii) to the Company's Quarterly Report on Form 10-Q filed with the Commission 
for the quarter ended September 30, 2012).

Clearwater Paper Corporation 2008 Stock Incentive Plan-Form of RSU Deferral Agreement 
for Annual  LTIP  RSUs  (incorporated  by  reference  to  Exhibit  10.10(viii)  to  the  Company's 
Quarterly Report on Form 10-Q filed with the Commission for the quarter ended September 
30, 2012).

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan-Form  of  Restricted  Stock  Unit 
Agreement, as amended and restated February 11, 2014, to be used for annual restricted 
stock unit awards approved subsequent to December 31, 2013 (incorporated by reference 
to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on 
February 18, 2014).

91

 
 
 
 
 
 
 
 
10.6(viii)*1

10.6(ix)1

10.6(x)1

10.6(xi)1

10.7*1

10.7(i)1

10.7(ii)1

10.8*1

10.9*1

10.9(i)*1

10.10*1

10.11*1

10.11(i)*1

10.12*1

10.12(i)*1

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Restricted  Stock  Unit 
Agreement, to be used for special restricted stock unit awards (incorporated by reference to 
Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed with the Commission for 
the quarter ended June 30, 2014).

Clearwater Paper Corporation 2008 Stock Incentive Plan—Form of Amendment of Restricted 
Stock Unit Agreement, effective as of January 1, 2015.

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Restricted  Stock  Unit 
Agreement,  to  be  used  for  annual  restricted  stock  unit  awards  approved  subsequent  to 
December 31, 2014.

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of  Restricted  Stock  Unit 
Agreement,  to  be  used  for  special  restricted  stock  unit  awards  approved  subsequent  to 
December 31, 2014.

Clearwater Paper Corporation 2008 Stock Incentive Plan—Form of Stock Option Agreement 
(incorporated by reference to Exhibit 10.3 to the Company’s current Report on Form 8-K filed 
with the Commission on February 18, 2014).

Clearwater  Paper  Corporation  2008  Stock  Incentive  Plan—Form  of Amendment  of  Stock 
Option Agreement, effective as of January 1, 2015.

Clearwater Paper Corporation 2008 Stock Incentive Plan—Form of Stock Option Agreement, 
to be used for annual restricted stock units awards approved subsequent to December 31, 
2014.

Clearwater Paper Corporation Annual Incentive Plan (incorporated by reference to Exhibit 
10.1 to the Company’s Current Report on Form 8-K filed with the Commission on May 9, 
2014).

Amended and Restated Clearwater Paper Corporation Management Deferred Compensation 
Plan (incorporated by reference to Exhibit 10.15(i) to the Company’s Quarterly Report on 
Form 10-Q filed with the Commission for the quarter ended March 31, 2010).

Amendment to Clearwater Paper Corporation Management Deferred Compensation Plan, 
dated December 17, 2013 (incorporated by reference to Exhibit 10.11(i) to the Company’s 
Annual Report on Form 10-K filed with the Commission on February 20, 2014). 

Clearwater Paper Executive Severance Plan (incorporated by reference to Exhibit 10.12 to 
the Company’s Annual Report on Form 10-K filed with the Commission on February 20, 2014).

Amended and Restated Clearwater Paper Corporation Salaried Supplemental Benefit Plan 
(incorporated by reference to Exhibit 10.15 to the Company's Annual Report on Form 10-K 
filed with the Commission for the year ended December 31, 2011).

Amendment  to  Clearwater  Paper  Corporation  Salaried  Supplemental  Benefit  Plan,  dated 
December 17, 2013 (incorporated by reference to Exhibit 10.13(i) to the Company’s Annual 
Report on Form 10-K filed with the Commission on February 20, 2014).

Clearwater  Paper  Corporation  Benefits  Protection  Trust  Agreement  (incorporated  by 
reference  to  Exhibit  10.18  to  the  Company’s Annual  Report  on  Form  10-K  filed  with  the 
Commission for the year ended December 31, 2008).

Amendment  to  the  Clearwater  Paper  Corporation  Benefits  Protection Agreement,  dated 
August 8, 2013 (incorporated by reference to Exhibit 10.16(i) to the Company's Quarterly 
Report on Form 10-Q filed with the Commission for the quarter ended September 30, 2013).

92

 
 
 
10.13*1

10.14*1

10.15*1

10.15(i)*1

Clearwater Paper Corporation Deferred Compensation Plan for Directors (incorporated by 
reference  to  Exhibit  10.10  to  the  Company’s  Current  Report  on  Form  8-K  filed  with  the 
Commission on December 19, 2008).

Clearwater Paper Change of Control Plan (incorporated by reference to Exhibit 10.16 to the 
Company’s Annual Report on Form 10-K filed with the Commission on February 20, 2014).

Offer Letter, dated June 25, 2012, with John D. Hertz, (incorporated by reference to Exhibit 
10.10(vi) to the Company's Quarterly Report on Form 10-Q filed with the Commission for the 
quarter ended June 30, 2012).

Clearwater Paper Corporation 2008 Stock Incentive Plan-Restricted Stock Unit Award, dated 
July 3, 2012, with John D. Hertz (incorporated by reference to Exhibit 10.18 to the Company's 
Quarterly Report on Form 10-Q filed with the Commission for the quarter ended June 30, 
2012).

(12)

(21)

(23)

(24)

(31)

(32)

101

*

1

Computation of Ratio of Earnings to Fixed Charges.

Clearwater Paper Corporation Subsidiaries.

Consent of Independent Registered Public Accounting Firm.

Powers of Attorney.

Rule 13a-14(a)/15d-14(a) Certifications.

Furnished statements of the Chief Executive Officer and Chief Financial Officer under 18 
U.S.C. Section 1350.

Pursuant  to  Rule  405  of  Regulation  S-T,  the  following  financial  information  from  the 
Registrant’s Annual Report on Form 10-K for the year ended December 31, 2014, is formatted 
in XBRL interactive data files: (i) Consolidated Statements of Operations for the years ended 
December 31, 2014, 2013 and 2012; (ii) Consolidated Statements of Comprehensive Income 
for the years ended December 31, 2014, 2013 and 2012; (iii) Consolidated Balance Sheets 
at December 31, 2014 and 2013, (iv) Consolidated Statements of Cash Flows for the years 
ended December 31, 2014, 2013 and 2012, (v) Consolidated Statements of Stockholders’ 
Equity for the years ended December 31, 2014, 2013 and 2012 and (vi) Notes to Consolidated 
Financial Statements.

Incorporated by reference.

Management contract or compensatory plan, contract or arrangement.

93

 
 
 
 
 
 
 
 
 
(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

[THIS PAGE LEFT INTENTIONALLY BLANK] 

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

[THIS PAGE LEFT INTENTIONALLY BLANK] 

Performance Graph  
The below graph compares the cumulative total stockholder return of our common stock for the period beginning 
December 31, 2009 and ending December 31, 2014, with the cumulative total return during such period of the 
Russell 2000® Index, the group of peer companies listed below and the S&P MidCap 400® Index (excluding 
those companies classified as members of the GICS® Financials sector).  The comparison assumes $100 was 
invested on December 31, 2009, in our common stock and in the indices and peer group and assumes 
dividends were reinvested.  The stock performance shown on the below graph represents historical stock 
performance and is not necessarily indicative of future stock price performance. 

We measure our relative corporate performance for purposes of performance-based equity awards issued to our 
executive officers against either a peer group of companies or a specific index.  Each year, a peer group or 
index is established to apply to performance-based equity awards issued in that year.  Prior to 2014, peer group 
members were primarily selected based on the industry in which they operate and secondarily on annual 
revenues and market capitalization.  In 2014, we chose to measure our relative performance, for purposes of 
performance-based equity awards, against a specific index, the S&P MidCap 400® Index (excluding those 
companies classified as members of the GICS® Financials sector).  The cumulative return for that index is listed 
below, as well as the return for the peer group that was used in the previous year.  The peer group used in 2013 
consists of the following companies:  Boise, Inc.; Buckeye Technologies, Inc.; Domtar Corporation; Graphic 
Packaging Holding Company; Greif, Inc.; International Paper Company; KapStone Paper and Packaging 
Corporation; Kimberly-Clark Corporation; MeadWestvaco Corporation; Neenah Paper, Inc.; Packaging 
Corporation of America; P.H. Glatfelter Company; Rock-Tenn Company; Schweitzer-Mauduit International, Inc.; 
Sonoco Products Company; Wausau Paper Corporation; and Weyerhaeuser Company. 

Comparison of Cumulative Five Year Total Return* 

$280

$240

$200

$160

$120

$80

12/31/09

12/31/10

12/31/11

12/31/12

12/31/13

12/31/14

Clearwater Paper Corporation
Russell 2000  Index
Peer Group
S&P Mid-Cap 400® Index (excluding members of the GICS® Financials sector)

®

*This comparison assumes $100 was invested on December 31, 2009, in our common stock and in the indices 
and peer group and assumes dividends were reinvested. 

 
 
 
 
 
Corporate Information

MANAGEMENT

Linda K. Massman 
(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)

John D. Hertz 
(cid:54)(cid:72)(cid:81)(cid:76)(cid:82)(cid:85)(cid:3)(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:15)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)(cid:3)

Thomas A. Colgrove 
(cid:54)(cid:72)(cid:81)(cid:76)(cid:82)(cid:85)(cid:3)(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:15)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:88)(cid:80)(cid:72)(cid:85)(cid:3)(cid:51)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:86)(cid:3)(cid:39)(cid:76)(cid:89)(cid:76)(cid:86)(cid:76)(cid:82)(cid:81)

Danny G. Johansen  
(cid:54)(cid:72)(cid:81)(cid:76)(cid:82)(cid:85)(cid:3)(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:15)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:51)(cid:88)(cid:79)(cid:83)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:51)(cid:68)(cid:83)(cid:72)(cid:85)(cid:69)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)(cid:39)(cid:76)(cid:89)(cid:76)(cid:86)(cid:76)(cid:82)(cid:81)

Michael S. Gadd 
(cid:54)(cid:72)(cid:81)(cid:76)(cid:82)(cid:85)(cid:3)(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:15)(cid:3)(cid:42)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:3)(cid:38)(cid:82)(cid:88)(cid:81)(cid:86)(cid:72)(cid:79)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:54)(cid:72)(cid:70)(cid:85)(cid:72)(cid:87)(cid:68)(cid:85)(cid:92)

Kari G. Moyes 
(cid:54)(cid:72)(cid:81)(cid:76)(cid:82)(cid:85)(cid:3)(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:15)(cid:3)(cid:43)(cid:88)(cid:80)(cid:68)(cid:81)(cid:3)(cid:53)(cid:72)(cid:86)(cid:82)(cid:88)(cid:85)(cid:70)(cid:72)(cid:86)

BOARD OF DIRECTORS

Boh A. Dickey 
Chair of the Board, Director since 2008 

Fredric W. Corrigan 
Director since 2009 

Beth E. Ford 
Director since 2013 

Kevin J. Hunt 
Director since 2013 

William D. Larsson 
Director since 2008 

Linda K. Massman 
(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)(cid:15)(cid:3)(cid:39)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:3)(cid:86)(cid:76)(cid:81)(cid:70)(cid:72)(cid:3)2013

Michael T. Riordan 
Director since 2008 

EXECUTIVE OFFICES

601(cid:3)(cid:58)(cid:72)(cid:86)(cid:87)(cid:3)(cid:53)(cid:76)(cid:89)(cid:72)(cid:85)(cid:86)(cid:76)(cid:71)(cid:72)(cid:3)(cid:36)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72) 
Suite 1100 
(cid:54)(cid:83)(cid:82)(cid:78)(cid:68)(cid:81)(cid:72)(cid:15)(cid:3)(cid:58)(cid:36)(cid:3)99201 
Phone: 509(cid:17)344(cid:17)5900

FORWARD-LOOKING STATEMENTS

STOCK LISTING

Clearwater Paper common stock is listed under the  
(cid:86)(cid:92)(cid:80)(cid:69)(cid:82)(cid:79)(cid:3)(cid:38)(cid:47)(cid:58)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:49)(cid:72)(cid:90)(cid:3)(cid:60)(cid:82)(cid:85)(cid:78)(cid:3)(cid:54)(cid:87)(cid:82)(cid:70)(cid:78)(cid:3)(cid:40)(cid:91)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:17)

ANNUAL MEETING

The 2015(cid:3)(cid:36)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:48)(cid:72)(cid:72)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:3)(cid:54)(cid:87)(cid:82)(cid:70)(cid:78)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:69)(cid:72)(cid:3)(cid:75)(cid:72)(cid:79)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:48)(cid:82)(cid:81)(cid:71)(cid:68)(cid:92)(cid:15)(cid:3)
(cid:48)(cid:68)(cid:92)(cid:3)4, 2015, at 9:00(cid:3)(cid:68)(cid:17)(cid:80)(cid:17)(cid:3)(cid:11)(cid:51)(cid:68)(cid:70)(cid:76)(cid:191)(cid:70)(cid:3)(cid:55)(cid:76)(cid:80)(cid:72)(cid:12)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:80)(cid:72)(cid:72)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:69)(cid:72)(cid:3)(cid:75)(cid:72)(cid:79)(cid:71)(cid:3)(cid:68)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:42)(cid:85)(cid:68)(cid:81)(cid:71)(cid:3)(cid:43)(cid:92)(cid:68)(cid:87)(cid:87)(cid:15)(cid:3)721(cid:3)(cid:51)(cid:76)(cid:81)(cid:72)(cid:3)(cid:54)(cid:87)(cid:85)(cid:72)(cid:72)(cid:87)(cid:15)(cid:3)(cid:54)(cid:72)(cid:68)(cid:87)(cid:87)(cid:79)(cid:72)(cid:15)(cid:3)(cid:58)(cid:68)(cid:86)(cid:75)(cid:76)(cid:81)(cid:74)(cid:87)(cid:82)(cid:81)(cid:15)(cid:3)98101(cid:17)

TRANSFER AGENT

MAILING ADDRESSES

(cid:54)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:3)(cid:70)(cid:82)(cid:85)(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:71)(cid:72)(cid:81)(cid:70)(cid:72)(cid:3)(cid:86)(cid:75)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:69)(cid:72)(cid:3)(cid:80)(cid:68)(cid:76)(cid:79)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:29) 
Computershare 
(cid:51)(cid:17)(cid:50)(cid:17)(cid:3)(cid:37)(cid:50)(cid:59)(cid:3)30170 
(cid:38)(cid:82)(cid:79)(cid:79)(cid:72)(cid:74)(cid:72)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:55)(cid:59)(cid:3)77842-3170

(cid:50)(cid:89)(cid:72)(cid:85)(cid:81)(cid:76)(cid:74)(cid:75)(cid:87)(cid:3)(cid:70)(cid:82)(cid:85)(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:71)(cid:72)(cid:81)(cid:70)(cid:72)(cid:3)(cid:86)(cid:75)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:69)(cid:72)(cid:3)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:29) 
Computershare 
211 Quality Circle, Suite 210 
(cid:38)(cid:82)(cid:79)(cid:79)(cid:72)(cid:74)(cid:72)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:55)(cid:59)(cid:3)77845

SHAREHOLDER WEBSITE

(cid:90)(cid:90)(cid:90)(cid:17)(cid:70)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:17)(cid:70)(cid:82)(cid:80)(cid:18)(cid:76)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:82)(cid:85)

Shareholder online inquiries

(cid:75)(cid:87)(cid:87)(cid:83)(cid:86)(cid:29)(cid:18)(cid:18)(cid:90)(cid:90)(cid:90)(cid:16)(cid:88)(cid:86)(cid:17)(cid:70)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:17)(cid:70)(cid:82)(cid:80)(cid:18)(cid:76)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:82)(cid:85)(cid:18)(cid:38)(cid:82)(cid:81)(cid:87)(cid:68)(cid:70)(cid:87)

(cid:55)(cid:82)(cid:79)(cid:79)(cid:3)(cid:41)(cid:85)(cid:72)(cid:72)(cid:3)(cid:49)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:3)

(cid:50)(cid:88)(cid:87)(cid:86)(cid:76)(cid:71)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:56)(cid:17)(cid:54)(cid:17)(cid:3)(cid:3)

(cid:43)(cid:72)(cid:68)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:44)(cid:80)(cid:83)(cid:68)(cid:76)(cid:85)(cid:72)(cid:71)(cid:3)(cid:3)

TDD International Shareholders 

ADDITIONAL INFORMATION

866-205-6799

201-680-6578

800-490-1493

781-575-4592

(cid:38)(cid:82)(cid:83)(cid:76)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:191)(cid:79)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:54)(cid:72)(cid:70)(cid:88)(cid:85)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:40)(cid:91)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)
(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:86)(cid:86)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:42)(cid:88)(cid:76)(cid:71)(cid:72)(cid:79)(cid:76)(cid:81)(cid:72)(cid:86)(cid:15)(cid:3)(cid:38)(cid:82)(cid:71)(cid:72)(cid:3)
of Business Conduct and Ethics, and Charters of the Committees of  
(cid:87)(cid:75)(cid:72)(cid:3)(cid:37)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)(cid:39)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:68)(cid:89)(cid:68)(cid:76)(cid:79)(cid:68)(cid:69)(cid:79)(cid:72)(cid:3)(cid:73)(cid:85)(cid:72)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:70)(cid:75)(cid:68)(cid:85)(cid:74)(cid:72)(cid:3)(cid:68)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)
(cid:90)(cid:72)(cid:69)(cid:86)(cid:76)(cid:87)(cid:72)(cid:15)(cid:3)(cid:90)(cid:90)(cid:90)(cid:17)(cid:70)(cid:79)(cid:72)(cid:68)(cid:85)(cid:90)(cid:68)(cid:87)(cid:72)(cid:85)(cid:83)(cid:68)(cid:83)(cid:72)(cid:85)(cid:17)(cid:70)(cid:82)(cid:80)(cid:17)

This report contains, in addition to historical information, certain forward-looking statements within the meaning of the Private Securities Litigation 

Reform Act of 1995, including statements regarding EBITDA margins and model, strategic capital projects, cost structure, pulp output, quality and 

(cid:76)(cid:81)(cid:87)(cid:72)(cid:74)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:72)(cid:73)(cid:191)(cid:70)(cid:76)(cid:72)(cid:81)(cid:70)(cid:76)(cid:72)(cid:86)(cid:15)(cid:3)(cid:70)(cid:88)(cid:86)(cid:87)(cid:82)(cid:80)(cid:72)(cid:85)(cid:3)(cid:86)(cid:72)(cid:85)(cid:89)(cid:76)(cid:70)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:15)(cid:3)(cid:69)(cid:72)(cid:81)(cid:72)(cid:191)(cid:87)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:55)(cid:82)(cid:87)(cid:68)(cid:79)(cid:3)(cid:51)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:48)(cid:68)(cid:76)(cid:81)(cid:87)(cid:72)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:15)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:76)(cid:81)(cid:88)(cid:82)(cid:88)(cid:86)(cid:3)(cid:76)(cid:80)(cid:83)(cid:85)(cid:82)(cid:89)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:15)(cid:3)

(cid:69)(cid:72)(cid:81)(cid:72)(cid:191)(cid:87)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:39)(cid:53)(cid:44)(cid:57)(cid:40)(cid:3)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:72)(cid:74)(cid:92)(cid:15)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:72)(cid:68)(cid:85)(cid:81)(cid:76)(cid:81)(cid:74)(cid:86)(cid:17)(cid:55)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:90)(cid:68)(cid:85)(cid:71)(cid:16)(cid:79)(cid:82)(cid:82)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:80)(cid:68)(cid:81)(cid:68)(cid:74)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:70)(cid:88)(cid:85)(cid:85)(cid:72)(cid:81)(cid:87)(cid:3)

(cid:72)(cid:91)(cid:83)(cid:72)(cid:70)(cid:87)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:72)(cid:86)(cid:87)(cid:76)(cid:80)(cid:68)(cid:87)(cid:72)(cid:86)(cid:15)(cid:3)(cid:68)(cid:86)(cid:86)(cid:88)(cid:80)(cid:83)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:17)(cid:3)(cid:50)(cid:88)(cid:85)(cid:3)(cid:68)(cid:70)(cid:87)(cid:88)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:80)(cid:68)(cid:92)(cid:3)(cid:71)(cid:76)(cid:73)(cid:73)(cid:72)(cid:85)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:87)(cid:75)(cid:82)(cid:86)(cid:72)(cid:3)

(cid:72)(cid:91)(cid:83)(cid:85)(cid:72)(cid:86)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:85)(cid:3)(cid:76)(cid:80)(cid:83)(cid:79)(cid:76)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:90)(cid:68)(cid:85)(cid:71)(cid:16)(cid:79)(cid:82)(cid:82)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:17)(cid:3)(cid:44)(cid:80)(cid:83)(cid:82)(cid:85)(cid:87)(cid:68)(cid:81)(cid:87)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:70)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:3)(cid:82)(cid:85)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:76)(cid:69)(cid:88)(cid:87)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:71)(cid:76)(cid:73)(cid:73)(cid:72)(cid:85)(cid:72)(cid:81)(cid:70)(cid:72)(cid:86)(cid:3)

include those discussed in the “Risk Factors” and “Developments and Trends in Our Business” sections contained in our Annual Report on Form 

10(cid:16)(cid:46)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:72)(cid:81)(cid:71)(cid:72)(cid:71)(cid:3)(cid:39)(cid:72)(cid:70)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)31, 2014(cid:15)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:76)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:17)(cid:3)(cid:41)(cid:82)(cid:85)(cid:90)(cid:68)(cid:85)(cid:71)(cid:16)(cid:79)(cid:82)(cid:82)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:80)(cid:68)(cid:81)(cid:68)(cid:74)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)

(cid:89)(cid:76)(cid:72)(cid:90)(cid:86)(cid:3)(cid:82)(cid:81)(cid:79)(cid:92)(cid:3)(cid:68)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:17)(cid:3)(cid:58)(cid:72)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:87)(cid:68)(cid:78)(cid:72)(cid:3)(cid:81)(cid:82)(cid:3)(cid:82)(cid:69)(cid:79)(cid:76)(cid:74)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:88)(cid:69)(cid:79)(cid:76)(cid:70)(cid:79)(cid:92)(cid:3)(cid:88)(cid:83)(cid:71)(cid:68)(cid:87)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:90)(cid:68)(cid:85)(cid:71)(cid:16)(cid:79)(cid:82)(cid:82)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:90)(cid:75)(cid:72)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:68)(cid:86)(cid:3)(cid:68)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:81)(cid:72)(cid:90)(cid:3)

(cid:76)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:72)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:90)(cid:76)(cid:86)(cid:72)(cid:17)

FSC®-CERTIFIED PAPER

(cid:38)(cid:79)(cid:72)(cid:68)(cid:85)(cid:90)(cid:68)(cid:87)(cid:72)(cid:85)(cid:3)(cid:51)(cid:68)(cid:83)(cid:72)(cid:85)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:182)(cid:86)(cid:3)(cid:36)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:90)(cid:68)(cid:86)(cid:3)(cid:83)(cid:85)(cid:76)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:53)(cid:53)(cid:3)(cid:39)(cid:82)(cid:81)(cid:81)(cid:72)(cid:79)(cid:79)(cid:72)(cid:92)(cid:3)(cid:72)(cid:81)(cid:87)(cid:76)(cid:85)(cid:72)(cid:79)(cid:92)(cid:3)(cid:82)(cid:81)(cid:3)(cid:41)(cid:54)(cid:38)(cid:16)(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:191)(cid:72)(cid:71)(cid:3)(cid:83)(cid:68)(cid:83)(cid:72)(cid:85)(cid:17)(cid:3)(cid:38)(cid:75)(cid:68)(cid:76)(cid:81)(cid:16)(cid:82)(cid:73)(cid:16)(cid:38)(cid:88)(cid:86)(cid:87)(cid:82)(cid:71)(cid:92)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:191)(cid:70)(cid:68)(cid:87)(cid:72)(cid:3)

TT-COC-004624(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:36)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:90)(cid:68)(cid:86)(cid:3)(cid:83)(cid:85)(cid:76)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:39)(cid:82)(cid:80)(cid:87)(cid:68)(cid:85)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:50)(cid:83)(cid:68)(cid:84)(cid:88)(cid:72)(cid:3)(cid:55)(cid:72)(cid:91)(cid:87)(cid:3)(cid:80)(cid:68)(cid:81)(cid:88)(cid:73)(cid:68)(cid:70)(cid:87)(cid:88)(cid:85)(cid:72)(cid:71)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:41)(cid:54)(cid:38)(cid:16)(cid:85)(cid:72)(cid:70)(cid:92)(cid:70)(cid:79)(cid:72)(cid:71)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:72)(cid:81)(cid:87)(cid:17)

Clearwater Paper Corporation
601 West Riverside Avenue, Suite 1100
Spokane, WA 99201
www.clearwaterpaper.com